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Abstract 
The relationship between meal structure and composition can modulate 
gastrointestinal processing and the resulting sense of satiety. This applies also 
to the fat component of meals and particularly to the surface area available for 
digestion. The main hypothesis underpinning this thesis work was that fat 
emulsion droplet size has a profound effect on fat digestion and, in turn, on the 
gastrointestinal and satiety responses. To test this hypothesis two fat emulsion 
meal systems were used. They had exactly the same composition but a small 
(termed the Fine emulsion, with a droplet size of 400 nm) or a large (termed 
the Coarse emulsion, with a droplet size of 8 µm) emulsified fat droplet size. 
The two fat emulsion systems were manufactured and characterised using a 
range of bench techniques, in vitro digestion models and MRI techniques in 
vitro. The difference in microstructure caused different temporal creaming 
characteristics for the emulsions and different percentage hydrolysis profiles in 
a gastric digestion model in vitro. The Fine emulsion showed initial rapid 
hydrolysis whilst the Coarse emulsion showed an initial slow hydrolysis phase 
with the hydrolysis rate increasing at later stages. This indicated that there was 
indeed a droplet size effect on fat hydrolysis whereby the smaller droplet size 
with a larger surface area hydrolysed faster than a larger droplet size. The 
HPXOVLRQV¶SHUIRUPDQFHZDV finally tested in vivo in healthy volunteers using 
MRI in a series of pilot studies leading to a main physiological study. Creaming 
differences in the gastric lumen were addressed by redesigning the meals 
using a locust bean gum (LBG) thickener that made them stable throughout 
the gastric emptying process. A main three-way physiological and satiety study 
in healthy volunteers showed that a highly emulsified, intragastrically stable 
emulsion delayed gastric emptying, increased small bowel water content and 
reduced consumption of food at the end of the study day. Finally, magnetic 
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resonance imaging, relaxometry and spectroscopy were further evaluated to 
assess fat emulsion parameters in vitro and in vivo in the gastric lumen. Main 
static magnetic field and droplet size effects on T2 relaxation times of the Fine 
and the Coarse emulsions were observed. There was reasonable correlation 
between m-DIXON and spectroscopy methods to quantify fat fraction both in 
vitro and in vivo. Differences in T2 relaxation times for different droplet sizes of 
20% fat emulsions were detected in vitro. These changes were however 
difficult to separate from creaming effects in vivo with a view of drawing 
meaningful inferences on droplet sizes. The main conclusion from this work 
was that manipulating food microstructure especially intragastric stability and 
fat emulsion droplet size can influence human gastrointestinal physiology and 
satiety responses and that MRI and MRS provide unique non invasive insights 
into these processes. This improved knowledge could help designing foods 
with desired health-promoting characteristics which could help to fight the 
rising tide of obesity. 
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1 Introduction 
 
 
 
1.1 Background 
 
Magnetic Resonance Imaging (MRI) is based on the concept of nuclear 
magnetic resonance (NMR). MRI has become widely available around the 
globe as a non-invasive imaging modality since its LQFHSWLRQLQWKH¶VE\ 
Professors Mansfield [1] and Lauterbur [2]. Since then, MRI has undergone 
continuous transformation and development which has made it the most 
versatile imaging technique for both clinical and research applications. These 
continuous developments were made mostly by academics from around the 
world innovating both the hardware and the software of the scanners. Pivotal 
developments have been made in signal processing, spatial resolution of 
scanners, speed of scan time, newly developed sequences, magnets, gradient 
coils, receiver coils and parallel imaging.   
MRI is known for its high resolution and non-invasiveness, but hindered by its 
relatively low sensitivity. Recent advances in image processing, acquisition, 
new software and computational techniques have allowed MRI to move from 
anatomical applications to functional ones. MRI is not limited to clinical 
application but also employed in many other sectors such as pharmaceutical 
and food industries. This imaging modality can measure a range of powerful 
parameters that enable it, for example, to assess the action of new 
formulations in humans and to provide in-depth information about the fate of 
oral dosage forms [3, 4]. Nottingham is home to EPI and slice selection and 
Chapter 1 ± Introduction 
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RYHU WKH \HDUV WKH µ6LU 3HWHU 0DQVILHOG 0DJQHWLF 5HVRQDQFH &HQWUH¶ RU
µ63005&¶ KDV developed many aspects of the technique of MRI. One of 
these key aspects is MRI of gastrointestinal function and the in-body 
monitoring of food components in the gastrointestinal tract and the 
assessment of their bioavailability and impact on gastrointestinal physiology in 
vivo [5-15]. Many of these studies were carried out both with funding from the 
Biological and Biotechnological Sciences Research Council (BBSRC) and in 
partnership with Unilever [16-22], with a particular interest in studying intra-
gastric handling of fat emulsions and, in turn, its impact on gastrointestinal 
physiology [23-26]. Improved knowledge of the physiological and satiety 
responses to physical factors in foods could lead to the development of novel 
food products with improved health-promoting characteristics.  
This is the overall background and conceptual framework behind the 
collaboration between the University of Nottingham and Unilever that 
generated and funded the joint Industrial Partnership CASE award of this 
studentship. Specifically for this work, there is scientific and industrial 
relevance in being able to carry out non-invasive monitoring of the 
gastrointestinal fate of fat emulsions of different temporal stability and droplet 
size in order to better relate the microstructure and location of different fatty 
food formulations with, for example, the time it takes to empty from the 
stomach, the levels of hormones in the blood and the sensation of satiety. This 
will aid not only the design of novel foods but also allow to check their 
predicted performance in vivo. The combined use of magnetic resonance 
imaging and spectroscopy is a novel and exciting approach to investigate the 
journey of fat through the gastrointestinal tract. 
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1.2 Overall aims of this thesis 
 
The overall aim of this thesis was therefore to explore MRI and MRS methods 
to  
a) characterise model fat emulsion meals of different temporal stability 
and droplet size on the bench and  
b) study the behaviour and physiological responses to these model fat 
emulsion meals in vivo in healthy volunteers. 
  
1.3 Thesis overview 
 
The work described in this thesis was carried out at the SPMMRC, School of 
Physics and Astronomy, University of Nottingham and Unilever Discovery at 
Colworth from Jan 2008 to September 2012. The research described in this 
thesis is original, unless otherwise stated.  
 
The layout and content of the thesis chapters is as follows: 
 
Chapter 2: This is a background chapter. The theory of nuclear magnetic 
resonance is introduced. The nuclear spin, the relaxation phenomena and 
relaxation times (T1 and T2) are described. The Chapter then describes the 
basic principles of magnetic resonance imaging including linear gradients and 
gradient coils, slice selection, k-space and imaging sequences. Following this, 
it briefly describes aspects of magnetic resonance spectroscopy (MRS) 
including chemical shift and spatial localisation based on single voxel 
techniques. 
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Chapter 3: This chapter first contains an overview of the anatomy and 
physiology of the gastrointestinal tract (GIT).  Secondly it describes briefly how 
human digestion works, with particular reference to the digestion of fat and of 
the GI tract. 
 
Chapter 4: This chapter highlights some of the methods that were used during 
fat emulsion sample preparation including characterisation of samples, 
MRI/MRS protocols and cholecystokinin (CCK) assays. The Ethics approvals 
DQGµ*RRG&OLQLFDO3UDFWLFH¶*&3SURFHVVHVDUHDOVRGHVFULEHG 
 
Chapter 5:  The title of this cKDSWHU LV ³'evelopment work´ as it describes 
extensive bench work done to characterise the fat emulsion meals and to 
study their behaviour in vitro. The chapter then describes a range of pilot 
studies in vivo that were carried out in order to test fat emulsion samples and 
hypotheses for main studies. 
 
Chapter 6: A major physiological MRI and MRS study is described here. Fat 
emulsions of different stability and droplet size were fed to healthy volunteers 
and the physiological responses measured with a range of techniques 
including also blood sampling and objective measures of satiety. The chapter 
includes methods of sample preparation, MRI protocols, results and 
discussion. 
 
Chapter 7:  Building on the experience gained, in vitro and in vivo studies 
were carried out to further explore and optimise intragastric monitoring of fat. 
This work is described in this chapter comprising relaxometry, cross-field and 
fat/water imaging methods such as m-DIXON. 
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Chapter 8: This final chapter contains an overall conclusion paragraph 
followed by a reflection on advantages and limitations of the work carried out. 
An outlook on possible future work is also given. 
Chapter 2 ± NMR, MRI and MRS  
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2 NMR, MRI and MRS 
 
 
This Chapter summarises briefly the theoretical background of nuclear 
magnetic resonance, magnetic resonance imaging and magnetic resonance 
spectroscopy as described in many standard textbooks [27-29]. This chapter 
is divided into 3 sections: firstly, the description of the nuclear magnetic 
resonance phenomenon is given in section 2.1. Secondly, magnetic 
resonance imaging (MRI) is briefly discussed in section 2.2 with an 
introduction to how an MR image is formed. Signal localization is introduced 
and the concept of k-space is described. Some relevant imaging pulse 
sequences used in the experimental work in this thesis are also briefly 
introduced. Finally, a concise description of magnetic resonance 
spectroscopy, chemical shift and chemical shift imaging are provided in 
section 2.3.   
 
 
2.1 Nuclear Magnetic Resonance 
 
Magnetic resonance imaging also referred to as nuclear magnetic resonance 
imaging exploits properties of magnetism to extract images of body interiors 
(Table 2.1). The history of NMR goes back to as early as the 1940s, when 
Rabi measured more precisely the nuclear magnetic moments and then Bloch 
and Purcell advanced the method magnetic resonance detection.   
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2.1.1 The nuclear spin 
 
1XFOHLPD\SRVVHVVVSLQDQJXODUPRPHQWXP-LIWKHPDVVQXPEHUDQG
WKHDWRPLFQXPEHUDUHQRWERWKHYHQQXPEHUV2QO\QXFOHLZLWK-FDQJLYH
rise to NMR. Associated to this spin is a magnetic moment µ so that  
  JJ P .       [2.1] 
The vectors J and µ DUHSDUDOOHODQGWKHVFDODUFRQVWDQWRISURSRUWLRQDOLW\ȖLV
FDOOHGWKHJ\URPDJQHWLFUDWLRȖʌ has a value of 42.57 106 Hz/T for protons, 
Nuclei of interest in biomedicine include the hydrogen proton 1H, 13C, 19F, 23Na 
and 31P. Table 2.1 summarises some of their properties. Protons give the 
greatest signal (because they have the largest gyromagnetic ratio and largest 
abundance in biological tissues). Therefore virtually all MRI is based on proton 
imaging, and here only hydrogen protons (which have spin ½) will be 
considered. 
 
2.1.2 Quantisation of energy 
 
In the quantum mechanical description both J and µ are quantised. 
Introducing the angular momentum operator I (which is dimensionless) and 
PlancN¶Vconstant! , J and I can be written as 
  J= ! I .      [2.2] 
In this context the z component of angular momentum I along some axis 
z, Iz , is the observable of interest and it can have (2I+1) values as 
Iz=!m  ,      [2.3] 
with 
  I,1I,...,1I,Im  .    [2.4] 
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Isotopes Nuclear Spin Gyromagnetic ratio 
Ȗʌ0+]7 
Natural 
Abundance (%) 
1H 1/2 42.58 99.9 
 
2H 
 
1 6.54 0.015 
13C 1/2 10.71 
 
1.1 
19F 1/2 40.05 100 
    
23Na 
 
3/2 11.42 100 
31P 
 
1/2 17.24 100 
 
Table 2.1: Properties of some nuclear isotopes used in magnetic resonance. 
 
 
Therefore for a proton (for which I = ½), m = ± ½. Under normal conditions 
these states are degenerate with the same energy level. 
The application of a magnetic field B0 to the magnetic moment P of an 
isolated nucleus produces an interaction energy E (the potential energy will be 
the work done to rotate the dipole in the field) given by 
  0E B P .      [2.5] 
Therefore for protons in a magnetic field, the degeneracy is removed and 
there are two energy levels 
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  0
2
1 B2
1E Jr 
r
! ,     [2.6] 
which now have a separation in energy of 
0BE J ' ! .      [2.7] 
This energy levels structure is known as the Zeeman splitting of the energy 
states. This is shown in Figure 2.1. 
 
 
 
 
 
 
Figure 2.1: Energy level diagram of the hydrogen nucleus (spin  ) in a 
magnetic field B0. Transitions can be induced between the spin states by 
DGGLQJHQHUJ\ǻ(HTXDOWRWKHGLIIHUHQFHEHWZHHQHQHUJ\OHYHOVRIWKHVSOLW
to the system 
 
 
 
 
Applying radiation of frequency Q will cause a transition between the two 
energy levels provided that 
ǻ( KQ  ƫZ =  J ƫ% ,     [2.8] 
i.e. Z
 
= J B,
 
      [2.9]
 
 
which is the Larmor equation.  
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This frequency of precession is known as the Larmor frequency. 
Radiation applied at the Larmor frequency (ZL) will be just as likely to cause a 
flip up as down, therefore for absorption to occur there must be a net 
difference in population of the two energy levels. 
 
2.1.3 Energy level populations 
 
Considering a spin system at thermal equilibrium, the spins will be distributed 
between the two Zeeman energy levels, nn SDUDOOHO µXS¶ DQG ORZ HQHUJ\
aligned state) and pn  DQWLSDUDOOHO µGRZQ¶ DQG KLJKHU HQHUJ\ VWDWH WR %0 
respectively, separated by 'E and governed by a Boltzmann distribution such 
that 
  
Tk
E
Be
n
n
'
n
p  ,      [2.10] 
where ǻ(LVWKHHQHUJ\GLIIHUHQFHEHWZHHQWKHWZR=HHPDQOHYHOV Bk  is the 
%ROW]PDQQ¶VFRQVWDQWDQG7LVWKHDEVROXWHWHPSHUDWXUH*LYHQWKDWWKHUHDUH
only two states, the total number of spins n is such that pn  nnn , then the 
difference in population (or polarisation of the sample) can be written as 
¸¸¹
·
¨¨©
§ J 

  J
J
pn Tk2
B
tanhn
e1
e1
nnn
B
0
Tk
B
Tk
B
B
0
B
0
!
!
!
.  [2.11] 
The energy splitting of the levels is small compared with TkB  (a quantum of 
thermal energy), thus Eq. 2.11 can be approximated to 
Tk2
B
nnn
B
0J  pn ! .     [2.12] 
This polarisation can then be written as a net magnetisation M0 as 
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Tk4
nB
2
nnM
B
0
2
0
!! 
pn
J J .   [2.13] 
 
2.1.4 Spin and angular momentum 
 
Although the nature of the NMR phenomenon requires a quantum mechanical 
description, the use of a semi-classical, phenomenological approach is 
adequate when a large number of non (or weakly) interacting spins is 
considered. This is the case for the water protons, with which the work 
described in this thesis is concerned. 
Equation 2.9 does not contain PlancN¶VFRQVWDQW7KLVVXJJHVWVWKDWD
semi-classical approach to describe the motion of the magnetic moment 
vector should prove satisfactory. Consider a magnetic moment µ. The angular 
momentum J is a colinear vector so that 
  JJ P .      [2.14] 
 
When placed in a uniform magnetic field B, µ will experience a torque ī 
given by 
  Bu P* .      [2.15] 
The angular momentum J must satisfy the equation 
  * 
dt
dJ
,      [2.16] 
therefore, substituting equations 2.14 and 2.15 into 2.16, the rate of change of 
the magnetic moment is given by 
  BuJ PP
dt
d
.     [2.17] 
This shows that the rate of change of µ is always perpendicular to both µ and 
B.  
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2.1.5 The Larmor precession 
 
If B is time independent and directed along zÖ  this will result in a precession of 
µ around the B axis at a fixed angle ș EHWZHHQ µ and B (Fig. 2.2) with a 
Larmor precession frequency given by 
  z0 BJ Z .      [2.18] 
 
 
 
Figure 2.2: Precession of a magnetic moment µ about the static field 
B0=Bz zÖ at a constant angle T in the laboratory reference frame. 
 
The minus sign indicates that the Larmor precession is anticlockwise for a 
SRVLWLYHȖ7KHUHLVDFRQYHQWLRQDOFRRUGLQDWHV\VWHPXVHGLQ105WKH]-axis 
is aligned with the applied (Bo) field and equilibrium bulk magnetisation. 
This is known as the longitudinal direction. The xy-plane is 
perpendicular to Bo and is known as the transverse plane. 
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2.1.6 The Bloch equation of motion 
 
In reality not one single spin, but a large ensemble of spins µi will be under 
examination in a sample. Introducing the vector M, sum of all the magnetic 
moments so that 
¦ 
i
iPM ,      [2.19] 
the Bloch equation of motion becomes 
  BMM uJ 
dt
d
.     [2.20] 
 
2.1.7 Interaction with electromagnetic radiation 
 
Radiofrequency (RF) magnetic fields of appropriate energy (frequency) are 
applied to excite transitions between the Zeeman energy levels. These 
magnetic fields are conventionally known as B1 fields and are not static (but 
time-dependent, i.e. they are a vector B1(t). Let B0=B0 zÖ  and B1(t) be applied 
perpendicular to the zÖ  axis in the laboratory reference frame and rotating in 
the x,y plane at a frequency ȦVRWKDW B1(t) can be written as 
     tsinÖtcosÖBt 1 ZZ yxB1 .    [2.21] 
Eq. 2.21 shows that B1(t) is now rotating at the same frequency as the 
precessing magnetisation. The total magnetic field applied to the 
magnetisation M is the sum of B0 and B1(t). Substituting into Eq. 2.20, the 
Bloch equation of motion becomes  
   1BzMM uJ ÖBdt
d
0 .    [2.22] 
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The term in parenthesis is called the effective field Beff applied to M in the 
laboratory reference frame. Equation 2.22 shows that the additional effect of 
B1(t) is to tip the magnetisation vector away from the zÖ  axis. 
It is convenient now to transform the laboratory reference frame x,y,z into 
D IUDPH [¶\¶]¶ URWDWLQJ DERXW zÖ  at the frequency Z to achieve an easier 
visualisation of the precession of M. In the rotating reference frame the field B1 
appears stationary and directed along the xcÖ  axis (Figure 2.3a).  
 
 
Figure 2.3: The effective magnetic field Beff (a) and the precession of a 
magnetic moment µ about Beff (b) in the rotating frame of reference. 
 
Hence, by choosing a rotating frame with Ȧ -Ȗ%0 the equation of motion of the 
magnetisation in the rotating frame of reference becomes simply 
 
 1BMM uJ w
w
t
 ,  [2.23] 
showing that M precesses now about the direction of B1 (Fig 2.3.b).  
The field B1 is usually applied as a short burst of radiofrequency (called a RF 
pulse). If a RF pulse of magnitude B1 is applied only for a period tp then the 
angle of precession T about the z-axis is given by 
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  p1 tBJ T .      [2.24] 
A RF field that rotates the equilibrium magnetisation to the y axis is called a 
90q or ʌ  SXOVH DQG RQH WKDW URWDWHV WKH PDJQHWLVDWLRQ WR WKH ±z axis is 
called a 180q RUʌSXOVH 
 
2.1.8 Free induction decay 
 
After a 90o RF pulse the magnetisation vector has been tipped into the x-y 
plane and at this moment all the spins are in phase with no difference in 
SRSXODWLRQEHWZHHQWKHVWDWHVµXS¶DQGµGRZQ¶ 
When the RF pulse is switched off, this xy magnetisation will now precess 
about the main field Bo at the Larmor frequency. This rotating magnetisation 
can induce an oscillating field in a receiver coil which is detected via a phase 
sensitive detector. The initial amplitude of the induced electromagnetic field 
will be proportional to the bulk nuclear magnetisation M0, yet many nuclear 
and chemical interactions in the sample will reduce the signal over time with a 
characteristic decay envelope. This signal decay is called the Free Induction 
Decay. 
 
2.1.9 The relaxation times T1 and T2 and their measurement 
 
The semi-classical approach described so far applies to an ensemble of 
isolated spins in a magnetic field B0. In reality the spins will be part of a 
molecular sample structure (lattice) and interacting with it. When the difference 
in the Boltzmann population of the states is perturbed by a RF pulse, the spins 
will return to the thermal equilibrium state by interactions with their 
surroundings, particularly with magnetic fields arising from the surrounding 
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dipoles via dipole-dipole interactions. The magnetisation of the spins therefore 
relaxes back to its equilibrium state along the B0 field with a first-order process 
at a rate characterised by the time constant T1 (called the spin-lattice or 
longitudinal relaxation time).  
This is described by the Bloch equation 
  
 
1
0ZZ
T
MM
dt
dM   ,    [2.25] 
which has the exponential solution  
    ¸¸¹
·
¨¨©
§   11 T
t
0
T
t
ZZ e1Me(0)MtM .   [2.26] 
The application of a RF pulse tips the magnetisation away from the z axis, 
hence a transverse component of the magnetisation is also produced in the x-
y plane. Such component decays exponentially as well, but the decay 
mechanism is now due to irreversible and random dephasing of the spins (loss 
of phase coherence). The relaxation of the transverse magnetisation is 
generally complex and cannot be described with a single time constant. 
However, in the liquid phase the mechanism simplifies and can be described 
with a first-order process characterised by a single time constant called spin-
spin relaxation time (or transverse relaxation time) T2. The Bloch equations 
describing this process are  
  
2
yx,yx,
T
M
dt
dM  ,     [2.27] 
which have exponential solutions 
  
    2Ttyx,yx, e0MtM  .    [2.28] 
Figure 2.4 represents schematically the T1 and T2 relaxation processes. 
Various physical processes determine the relaxation rates T1 and T2, but in 
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general: T2 < T1; T2 ~ T1 in systems in which the molecules are highly mobile 
(such as water); T2 << T1 in solids. 
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Figure 2.4: The relaxation process once the RF pulses are switched off. 
$GDSWHG IURP 3URIHVVRU -RVHSK +DMQDO¶V ,PSHULDO &ROOHJH +DPPHUVPLWK
Campus, (Lecture notes, 2005). 
 
The incoherent dephasing effects by static field inhomogeneities can 
be reversed in the transverse plane using the spin-echo method introduced by 
Hahn (Figure 2.5). The excitation 90q pulse is followed, after a time delay 
TE/2, by a 180q pulse. The effect of the 180q pulse is to invert (neglecting spin 
diffusion) any phase evolution that the spin may have gained in the transverse 
plane during the interval TE/2. Hence this action will cancel out the incoherent 
phase accumulation and produce, at a further time interval TE/2 after the 180q 
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pulse (the time after the 90° pulse at which the spin-echo is formed is called 
the echo time TE), an echo which purely reflects a T2 decay process.  
 
The relaxation time T1 may be measured using the Inversion Recovery 
(IR) pulse sequence (Fig. 2.5.a). The initial 180º pulse rotates the equilibrium 
magnetisation along the ±z axis. Hence no transverse component is 
generated. A purely longitudinal (spin-lattice) relaxation is allowed to take 
place for an interval TI (inversion time) after which a 90º pulse tips the 
remaining longitudinal magnetisation into the transverse plane where it can be 
measured. From Eq. 2.26, with Mz(0)= -M0, the initial amplitude of the 
corresponding FID is given by 
  ¸¸¹
·
¨¨©
§   1T
TI
0Z e21MTIM .    [2.29] 
 
 
 
Figure 2.5: Schematic diagram of the inversion recovery sequence (a) and 
variation of the longitudinal magnetisation Mz with the inversion time TI (b). 
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The sequence is then repeated with increasing TI. Providing that a sufficient 
repetition time TR (TR > 5 T1) is allowed between each repetition to allow full 
recovery of the initial magnetisation, the curve of the variation of Mz with TI 
(Fig. 2.5b) can be plotted and fitted to Eq. 2.29 to obtain the value of T1.  
 
The transverse relaxation time T2 can be measured using a simple Hahn spin-
echo sequence as described in Fig 2.6.  
For a given echo time TE the initial amplitude of the FID can be described 
by 
  2TTE0 eMTEM  .     [2.30] 
The spin echo experiment is then repeated for increasing values of TE 
(allowing again a time TR> 5 T1 between experiments). The curve of the 
variation of M with TE can be fitted to Equation 2.30 to provide the value of T2. 
 
 
Figure 2.6: Schematic representation of the spin-echo sequence. 
 
 
The spin echo measurement of T2 described above is made under the 
assumptions that no spin diffusion or movement occurred during the 
measurement. Spin diffusion or RF imperfections will affect the spin echo T2 
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measurement. Various modifications of these basic techniques for measuring 
relaxation times, have been introduced to improve speed and reduce 
systematic errors. Other interactions can affect the characteristics of the NMR 
signal and provide valuable information on the spatial and physico-chemical 
properties of the system.  
 
2.1.10 Fourier transform NMR 
 
The FID signal obtained irradiating a group of spins with a 90° RF pulse 
may be written as  
  *Tttii 2eeeatS 'ZI  ,    [2.31] 
where a is a constant (depending on the instrumental gain and on the 
sample), I is the receiver phase and 'Z is the resonant offset so that 'Z=Z0-
Zref.  
This time signal can be represented in the frequency domain by use of a 
Fourier transform (FT) so that 
       22
2iti
0 *Ti1
*T
eadtetSH Z'Z  Z
IZ
f³ . [2.32] 
This gives the real and imaginary components of the spectrum as 
 > @    222
2i
*T1
*T
eaHRe Z'Z Z
I
 and  [2.33] 
  
 > @       222
2
2i
*T1
*T
eaHIm Z'Z
Z'Z Z I .  [2.34] 
  
Equation 2.33 and 2.34 describe, respectively, the absorption and the 
dispersion spectra. Usually, only the absorption spectrum is of interest. It has 
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a Lorentzian shape peak centred at 'Z, with a full width at half maximum of 
2/T2*. 
Figure 2.7 below summarises the entire NMR process. 
 
 
 
Figure 2.7: the summary of processes of received signals (Adapted from 
3URIHVVRU-RVHSK+DMQDO¶V ,PSHULDO&ROOHJH+DPPHUVPLWK&DPSXV/HFWXUH
notes, 2005). 
 
 
2.2 Magnetic Resonance Imaging 
 
The previous section (section 2.1) described the basic principles of nuclear 
magnetic resonance. From 1950 until early 1970 NMR was used for chemical 
and physical molecular analysis. MRI was invented independently by 
Lauterbur and Mansfield. In 1973, Paul Lauterbur proposed imaging using 
gradients in the magnetic field such that a 2D image of a sample can be 
produced by applying a linear gradient at different angles to a sample and 
combining these projections using a back-projection reconstruction method 
[2]. In the same year, Peter Mansfield proposed spatial discrimination by use 
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RI JUDGLHQWV DQG EDVHG RQ GLIIUDFWLRQ SULQFLSOHV 6HFWLRQ  EHORZ (UQVW¶V
group proposed the first Fourier imaging using non-selective excitation [1, 30]. 
In 1977 Mansfield introduced the ultra-fast imaging technique known as echo 
Planar imaging (EPI). In 1977 the first magnetic resonance imaging was 
performed on a human. In 2003 Lauterbur and Mansfield were rewarded with 
a Nobel Prize LQµSK\VLRORJ\RUPHGLFLQH¶for their contribution to the discovery 
of MRI [31]. Magnetic resonance imaging is growing fast and there have been 
many developments in the last 4 decades. MRI has become one of the most 
powerful imaging techniques and there are numerous research centres around 
the globe who dedicate themselves to further developments and 
improvements. 
This section introduces the basic principles of magnetic resonance 
imaging which are extensively described in a number of text books and other 
publications [32-37].  
 
2.2.1 Linear gradients and gradient coils 
 
In the NMR experiment described above, the signal is produced by the 
spins in the sample, precessing at approximately the same frequency, with no 
spatial information. To obtain a spatially resolved map of the spins in the 
sample one needs to make the Larmor frequency spatially dependant. This is 
usually done on all modern scanners by varying spatially the main static 
magnetic field B0 because Equation 2.18 shows that the Larmor frequency 
depends linearly on the applied polarising, homogeneous field B0. This implies 
that the superimposition of a linearly varying spatial magnetic field gradient G 
to B0 will apply a predictable spatial variation in the Larmor frequency of the 
spins. The Larmor frequency at a position r may then be written 
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 rGr JJ Z 0B .     [2.35] 
Equation 2.35 shows that the scalar product rG   defines planes normal 
to G in which Ȧ LVFRQVWDQW7KHJUDGLHQWG is generally a tensor. However, 
one is generally only interested in the Bz components ( xBz ww , yBz ww  
and zBz ww ), so the tensor may be reduced to a vector and Eq. 2.35 may be 
reduced to 
  ¸¸¹
·
¨¨©
§
w
ww
ww
wJJ Z z
z
By
y
B
x
x
BB zzz0r .  [2.36] 
This represents the starting point of the process of two-dimensional MR 
imaging. Magnetic field gradient coils are designed to produce linearly-varying 
magnetic fields. One of the simplest coil designs for use with a cylindrical 
whole body imaging system is shown in Figure 2.8. The movement of the 
gradient coil wires in the magnetic field as strong electric currents are pulsed 
through them is the reason that MRI is so acoustically noisy. Because of the 
high current carried by coils during an imaging sequence (600 A), the coils are 
often water cooled to prevent overheating. 
 
 
Figure 2.8: Schematic diagram of Maxwell Pair gradient coils: this design can 
be used to produce a magnetic field gradient along the bore of the magnet. 
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2.2.2 Slice selection 
 
In order to produce a two-dimensional MR image of a desired plane within 
a three-dimensional object, the spins in a given plane need to be prepared first 
for a subsequent planar encoding. This is achieved using the process of slice 
selection, as indicated originally by Garroway, Grannell and Mansfield in 1974. 
This process is based on the application of a RF pulse with a limited 
bandwidth in conjunction with a linear magnetic field gradient, applied in a 
direction orthogonal to the slice.  
The diagram in Fig 2.9 illustrates this concept. Consider a cylindrical 
object filled with water and positioned with its axis along a polarising field 
B0=B0 zÖ . Let a linear magnetic field gradient Gz be applied along the z axis. Gz 
will cause the Larmor frequency of the spins to vary linearly along z according 
to Eq. 2.36, hence every plane perpendicular to the z axis will have a constant 
Ȧ] 
 
Figure 2.9: Selection of a slice centred on z0 and perpendicular to the z axis 
WKURXJKDF\OLQGULFDOREMHFW7KHVOLFHWKLFNQHVVLVǻ]WKH5)SXOVHIUHTXHQF\
LVFHQWUHGRQȦP and a linear gradient Gz is used. 
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The resonant frequency is then given by 
 > @zzGB z0P J Z  .    [2.37] 
If a RF pulse with a limited bandwidth is now applied along the x axis in 
conjunction with the gradient GzRQO\VSLQVQHDU LWVFHQWUH IUHTXHQF\Ȧp will 
be excited. Neglecting relaxation effects, Eq. 2.37 describes then the selective 
excitation of a finite slice of the sample perpendicular to the polarising field 
and centred on the position z0, corresponding to the RF carrier frequency (Fig. 
2.9). 
 
2.2.3 k space 
 
&RQVLGHU QRZ D VOLFH RI DQ REMHFW RI VSLQ GHQVLW\ ȡr), which has been 
selected perpendicular to the z axis. The FID signal s(t), demodulated at the 
reference frequency, may be written as a spatially varying phase evolution 
    rr Gr des(t)
t
0
tdti ³U 
ccJ³ ,    [2.38] 
where G is a linearly varying gradient applied for a time t and dr is a volume of 
integration. This equation highlights the relationship between the spin density 
ȡr) and the time signal s(t) as a Fourier pair. It is convenient now to introduce 
the reciprocal space vector k (also called spatial frequency, with units of m-1) 
   ³ ccJ t
0
tdtt Gk ,     [2.39] 
and to substitute k in Eq. 2.38, thus obtaining 
  rrk rk de)s( i ³U .     [2.40] 
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7KLV ³N-VSDFH´ GHVFULSWLRQ ZDV ILUVW LQWURGXFHG E\ 0DQVILHOG DQG *UDQQHOO LQ
DQDORJ\ ZLWK RSWLFDO SODQH ZDYH VFDWWHULQJ 7KH ³05, ZDYH´ LV ILFWLWLRXV EXW
KDVDQHIIHFWLYHZDYHOHQJWKȜJLYHQE\ 
k
S O 2 .      [2.41] 
,QDQDORJ\ZLWKWKHZDYHYHFWRULQRSWLFVWKH05,UHVROXWLRQǻUWKDWFDQ
be achieved in the direction r, using a gradient of intensity Gr, applied for a 
time tG, will be determined by the maximum value of k, kr(max), as 
  Grmaxr tG
2
k
2
r J
S S ' .    [2.42] 
The Fourier transform of Eq. 2.40 becomes 
  kkr rk des)( i- ³ U .    [2.43] 
In analogy with the scattering of X-rays, the MRI signal, s(k), is the reciprocal 
ODWWLFHRIȡr). Hence, sampling the k-space map of an object and calculating 
the Fourier transform of s(kZLOO\LHOGWKHVSLQGHQVLW\PDSȡr) of the object, 
which is its MRI image. 
The k-space description simplifies the analysis of any MRI technique. 
Having selected a slice through the object of interest, the direction of the x and 
y components of the k vector are determined by the direction of the x and y 
components of the gradient vector G respectively. S(k) may thus be plotted as 
a function of kx and ky drawing a trajectory in k-space. 
 
2.2.4 Imaging sequences  
 
The ability to select a slice within an object and to manipulate the signal 
spatial dependence using linear gradients, opened the possibility to acquire 
two-dimensional planar MR images of the spin density within a reasonable 
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experimental time. There are many ways of producing an image in MRI, and 
just a few of them will be considered here. 
 
Time
RF
Gslice
Gread
Signal
ky
kx
pulse sequence k-space trajectory
Typically Gz
Typically GT
Repeat for 
n different 
values of T
 
Figure 2.10: Projection reconstruction sequence. 
 
 
The projection reconstruction imaging method is shown in Figure 2.10. 
This shows the time course of the gradient and RF waveforms. The first line 
shows the slice selective RF pulse, and the second line shows the slice 
selection gradient. The third line shows the image encoding (frequency 
encoding/ readout) gradient. The fourth line shows the magnitude of the signal 
that will be acquired. 
Using this method one can take images by sampling very quickly after 
excitation, hence projection reconstruction is useful for imaging samples with a 
short T2* (for example the lungs) however scanning times may be long. 
Another method is Spin Warp imaging whereby k space is sampled on 
a regular grid. Figure 2.11 shows a diagram of the Spin Warp method. This 
was introduced by Edelstein, who proposed increasing the amplitude of the 
gradient Gy whilst keeping constant the time it is applied. In this way, each line 
in k-space is sampled at constant time intervals, consequently minimising 
differences in phase shifts due to B0 variations and relaxation weighting. This 
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is one of the most widely used sequences though it has relatively long imaging 
times and suffers from motion-related artifacts. 
 
Time
RF
Gslice 
Gphase
Gread
ky
kx
Spin-warp
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Spin-warp
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B C
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2
3
n
1
2
3
n
Signal
z
y
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Figure 2.11: The spin warp imaging sequence. 
 
 
 
Another method is Echo planar imaging. This was invented by 
Professor Sir Peter Mansfield in Nottingham. EPI uses a single RF excitation 
followed by a very rapid, full sampling of k-space, using one of the orthogonal 
gradients to recall the magnetisation each time a line in k-space is swept, and 
the other gradient to pace consecutive phase encoding steps as shown in 
Figure 2.12.  
 
 EPI pulse sequence
RF
Gslice
Gphase
Gread
Time
Repeat 
128 times
A B C
A
B C
kx
ky
EPI k-space trajectory
 
Figure 2.12: The EPI pulse sequence 
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EPI is so fast there are virtually no motion artifacts, it therefore can scan 
dynamic physiological processes very well and is particularly suited to 
measure quantitative parameters such as T1 and T2. EPI has also some 
limitations such as low spatial resolution and is very sensitive to distortion. 
 
2.2.5 Fat suppression 
 
The signal from fat in 1H MRI images can provide valuable information but is 
often undesired because it can cause artifacts (such as ghosting and chemical 
shift) and it had a high signal on T1 weighted images due to its short relaxation 
times so it can obscure tissues of interest. To overcome this problem various 
fat suppression techniques have been developed, such as fat saturation, 
inversion-recovery imaging, and opposed-phase imaging. 
 
2.2.5.1 Fat saturation 
 
This fat suppression technique uses a frequency selective RF saturation pulse 
with the same resonance frequency as the frequency of fat and it is applied to 
each slice selection. The advantages of this method are that it is lipid specific, 
it provides good contrast of T1 weighted images and it is very useful for tissue 
characterisation especially in areas with a large amount of fat. This method is 
also useful for avoiding chemical shift misregistration artifact. However, there 
are a number of disadvantages associated with this method. In order to 
achieve fat saturations the frequency of the frequency-selective pulse must be 
equal to the resonance frequency of lipid. However this is often not the case 
because of inhomogeneities of static magnetic field, for instance due to local 
magnetic susceptibilities. Such inhomogeneities will reduce the efficiency of 
fat saturation. 
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2.2.5.2 Inversion recovery imaging 
 
This fat suppression technique is based on the fact that the T1 of the tissue or 
sample of interest can be different from the T1 of the fat around it. Some 
tissues such as adipose tissues have shorter T1 than the T1 of water. After a 
180° inversion pulse is applied, the longitudinal magnetisation of adipose 
tissue will recover faster than water.  However, if a 90° excitation pulse is used 
at the null point of fat, TInull (Figure 2.13), then the adipose tissue will provide 
no signal whilst water has not been nulled and will continue to produce 
signals.  
Fat
Water
Time
M
a
g
n
e
ti
s
a
ti
o
n
180°
90°
TInull
 
Figure 2.13: Schematic diagram of the inversion recovery fat suppression 
method. 
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Fat T1 is short so this means that in order to achieve good fat suppression; 
one has to use a shorter T1 inversion recovery. This is also known as STIR 
(Short T1 inversion recovery) and it is based on fast spin echo readout 
sequences. STIR has an important advantage over other fat saturation 
techniques as it is insensitive to magnetic field inhomogeneities. This 
technique works best with both long T1 and T2 values of the sample of interest 
and it is good for tumour detections.  
 
2.2.5.3 Opposed phase imaging  
 
This is another technique used for fat suppression. This method uses the 
difference between resonance frequencies of the fat protons and the water 
protons as the phases of these protons relative to each other change after the 
initial excitation. Therefore, immediately after the excitation the lipid proton 
and water protons are in phase but the water protons precess faster than lipid 
protons. It is therefore possible to take images of the water and fat protons in 
phase or out of phase by simply varying the TE. This method is very simple, 
fast and available on every MRI system. The main disadvantage of this 
technique is that it does not suppress the signal from adipose tissue. There 
are specific versions of this such as m-DIXON which is described in more 
detail in Chapter 7. 
 
2.3 Magnetic Resonance Spectroscopy 
 
Magnetic resonance spectroscopy is a specialised technique complementary 
to MRI as a non-invasive imaging modality. There are many biorelevant nuclei 
that MRS can monitor such as 31P and 13C. The most widely used however is 
the proton (1H MRS) with which the work described in this thesis is concerned. 
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The first MRS in vivo brain spectra was published in the 1980s. The first 
studies in vivo were performed on patients who had stroke or brain tumour.  1H 
MRS has become clinical routine in neurology applications [38]. The reasons 
for this are not only because of the clinical/academic relevance: the brain is 
nearly spherical and suffers from minimal motion. Proton MRS is also 
particularly suited to assess the amount of fat in sample and body organ. MRS 
of fat fraction has recently become popular for the study of the liver [39] but it 
has not been applied yet to study in vivo the intragastric fat component of 
foods. 
 
2.3.1 Chemical shift 
 
The resonance frequency of different metabolites in a MRS spectrum (also 
called their chemical shift) depends on the physicochemical environment of 
those metabolites. This modifies the individual resonance frequency for each 
species and allows them to be separated and measured. The historical 
GHILQLWLRQVRI WKH µGLUHFWLRQ¶RI WKHVFDOH LQSDUWVSHUPLOOLRQSSPDURVHIURP
the time when the field was changed in continuous wave spectrometers and is 
programmed into the scanners. A negative frequency shift is a positive shift in 
SSPDQGLVUHIHUUHGWRDVEHLQJµXSILHOG¶ 
 
2.3.2 Spatial localisation based on single voxel technique 
 
The simplest way to acquire a spectrum of a region of the human body is to 
use a surface coil which will probe a small volume of approximately the same 
dimensions as the coil itself. It is of course desirable to be able to localise 
small volumes within the human body more precisely and this can be achieved 
using different methods to localize a discrete spatial voxel region. One method 
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is single volume spectroscopy with STimulated Echo Acquisition Mode 
(STEAM) [40]. The method involves the use of gradients to localise a volume 
of interest within a sample in conjunction with three 90° pulses. 
 
Figure 2.14: Schematic STEAM pulse sequence diagram including a water 
suppressing CHESS prepulse. Adapted from [41]. 
 
 In the work described in this thesis the STEAM method was used. 
Figure 2.14 shows a schematic STEAM pulse sequence diagram. 
Multivoxel methods are an attractive methodology to perform Chemical 
Shift Imaging (CSI) also known as magnetic resonance spectroscopic imaging 
(MRSI). 
 
2.3.3 MRS spectra quantification 
 
In an ideal situation the area under the peaks of a MRS spectrum will reflect 
directly the concentration of the metabolites scanned. However the different 
relaxation times of different species and possible field inhomogeneities can 
affect quantitation. Phantom work, assessment of the spectral changes with 
varying TEs and knowledge of the relaxation times of the various species can 
improve quantitation methods. In reality spectral width, shimming and 
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relaxation limit the resolution of individual metabolites. However the water and 
the fat peak (including CH2 and other lipid resonances) of samples like the fat 
emulsions used in this work are separated well enough to allow measurement. 
  
2.3.4 Limitation of MRS 
 
NMR spectroscopy in vitro usually is performed at very high field (10T-14T), in 
small ex vivo samples spinning rapidly in very homogeneous fields. MRS in 
vivo is instead performed at medium field strength (e.g. 1.5T-3T) with limited 
field homogeneity due to the nature of the human sample, power deposition 
limits and low signal to noise ratio. The spatial resolution is limited to volumes 
of a few cm3. 
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3 The gastrointestinal tract and its 
response to fat: MRI assessment 
 
 
 
This chapter describes briefly the anatomy and function of the gut and its 
response to food, with particular reference to the gastrointestinal response to 
fat. Magnetic resonance imaging of the gastrointestinal response to food is 
also summarised here.   
 
3.1 Background 
 
The gastrointestinal (GI) tract is the part of the human body dedicated to 
processing food. In the GI tract food undergoes mechanical grinding, dilution, 
chemical breakdown, mixing and transport and absorption. During these 
processes the GI tract sends key feedback signals that determine the sense of 
satiety and subsequent food intake. Most of the GI tract is difficult to access in 
order to study function and many old reports in the literature were based on 
invasive intubation studies or animal models. Imaging methods provide a clear 
advantage though ultrasound suffers from air/liquid interfaces and gamma 
scintigraphy provides poor resolution and cannot detect any secretions added 
to the chyme. Magnetic resonance imaging has many advantages over such 
techniques and in the last 15 years it has provided unique insights in 
gastrointestinal physiology and the processing of food. 
This chapter describes briefly the anatomy and function of the gut and its 
response to food, with particular reference to the gastrointestinal response to 
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fat. Advances in magnetic resonance imaging of the gastrointestinal response 
to food are subsequently summarised.   
 
3.2 Anatomy and function of the gastrointestinal tract 
 
The gastrointestinal tract consists of four main anatomical regions: the 
oral cavity (mouth), the stomach, the small bowel or intestine and the large 
intestine or colon (Figure 3.1). From the anatomical point of view, the GI tract 
is a muscular tube lined by a mucous membrane starting from the oral cavity 
to the rectum and anus. The epithelium of the GI tract consists of 4 main 
areas: the mucosa, the submucosa, the muscularis and the serosa. 
 
Mouth
pH 5-7
Salts
Enzymes
5-60 s
Biopolymers
Stomach
pH 1-3
Salts
Enzymes
Agitation
30 min ± 4 hours
Biopolymers
Small intestine
pH 6-7.5
Bile & Salts
Enzymes
Agitation
1-2 hours
Biopolymers
Colon
pH 5-7
Salts
Bacteria
Agitation
12-24 hours
Biopolymers
 
Figure 3.1: Schematic diagram of the anatomical regions of the human GI 
tract and of the physicochemical environment in them. The image of the 
human body was obtained from http://en.wikipedia.org/wiki/Digestive_tract 
(Copyright free).  
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The physiological structure of the cells (Figure 3.2) is quite similar along the GI 
tract. However some local variations occur in the different and more 
specialised parts. Of particular importance are the villi in small intestine which 
are finger-like structures in the mucosa wall.  These cell types increase the 
surface area and blood supply of the small intestine which ultimately increases 
capacity for absorption of nutrients in the small intestine. 
 
 
Figure 3.2: Schematic diagram of basic cross sectional structure of the 
human GI tract lumen. This image was obtained from 
http://www.virtualcancercentre.com.  
 
 
3.2.1 The oral cavity (mouth) 
 
From the anatomical point of view the mouth can be divided into three 
main areas: an epithelial surface, the lamina propria which is a supporting 
connective tissue and the muscularis mucosa which is a thin smooth muscle 
layer responsible for local movement and folding. The functions of the mouth 
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can be summarised as trituration, digestion, articulation and swallowing. Here 
the roles of ingestion and initial fragmentation of food will be considered.  
In the mouth complex physiochemical and physiological processes 
take place. This part of the GI tract is responsible for converting the food into a 
form that suitable for swallowing. Food type can be liquid, semi-liquid or solid. 
The mouth has a set of glands that release saliva with digestive enzymes such 
as lingual lipase, amylase and protease as well as electrolytes and 
glycoprotein. These initiate food digestion in a very efficient way [42]. The 
teeth are responsible for chewing and the tongue movement allows interaction 
of the secreted saliva and foods. The pH of human saliva is around 5.5 to 6.1 
when the body is fasting and this can drift more towards neutral (between 7 
and 8) after food ingestion [43].  The human body can secrete around 500 to 
1500 ml of saliva a day. The mucus contents of the saliva are capable of 
inducing flocculation and coalescence of ingested lipid droplets, whereas the 
protein fraction plays a major role in food digestion. This is complex and 
contains many different kinds of proteins, each with its own roles and 
functionalities [43, 44]. Foods spend only a relatively short amount of time in 
the mouth, but there are many physiochemical and physiological processes 
that occur during that time [45]. These processes will very much depend on 
the nature of ingested materials. There are various taste receptors in the oral 
cavity and some studies have indicated that the mouth actually contains 
receptors that are capable of detecting lipids [46]. Minimal food absorption 
takes place in the oral cavity. However, there is the possibility that small 
molecules could be absorbed via the oral epithelium by either the paracellular 
route (between cells) or the transcellular route (through the cells by passive 
diffusion). 
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3.2.2 The stomach 
 
The stomach is a reservoir that serves as temporary storage for food. 
Here complete food fragmentation occurs and food digestion progresses. The 
human stomach can be divided into 3 main physiological function regions: the 
upper region known as the cardia, the middle region divided in the stomach 
fundus and the stomach body which are responsible for storage and releasing 
the digestive enzymes and gastric juice and acids; and the lower region known 
as the antrum provides the mechanical forces for mixing and allows regulated 
stomach content transportation down to the small intestine for absorption [47]. 
The pH of the stomach depends on whether the person is fasting or fed and 
ranges from pH 1-3 under fasted condition and up to pH 6 for the fed stomach 
[48, 49]. There are a number of substances that are secreted in the stomach 
including gastric lipase, hydrochloric acid, pepsin and various minerals and 
mucus. Each one of these molecules has its own role of function for food 
digestion [48]. Gastric lipase binds to the surface of the lipid droplets, where it 
converts the encapsulated triacylglycerols (TAG) into diacylglycerols (DAG), 
monoacylglycerols (MAG), and free fatty acids (FFA). This process is called 
triglyceride hydrolysis or lipolysis in which the triglyceride molecule is broken 
down into FFA, MAG and DAG to complete the lipid digestion and ultimate 
absorption of fat. There is a minimal to zero absorption in stomach and the 
small intestine is the main absorption site for food and other active 
compounds/substances. Around 30-40% of lipid hydrolysis is achieved in the 
stomach and the reason for the hydrolysis not exceeding 40% is due to the 
droplets¶ surface. ThHGURSOHWV¶VXUIDFHbecomes covered with free fatty acids 
and therefore the lipase cannot access the TAG in order to complete the 
hydrolysis. The physicochemical mechanism for the inhibition of gastric lipase 
by fatty acids is believed to be the trapping of the lipase within a colloidal 
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structure (200 nm) that is comprised of FFA, DAG, MAG and phospholipids 
[50, 51]. 
 
3.2.3 The small bowel 
 
The small intestine is the mid-region in the GI tract between stomach and 
large intestines (colon). It can be considered to be a tube-like structure (about 
2.5 to 3 cm in diameter) consisting of three major regions: duodenum (about 
26 cm long), jejunum (about 2500 cm long) and ileum (about 3500 cm long).  
However, the actual total surface area of the small intestine in humans is 
much greater due to the presence of villi and microvilli which increase the 
surface area to approximately 200 m2. This large surface area makes the 
small bowel the main absorption site of the GI tract [52]. The pH of the small 
intestine varies from one region to another: it is around 5.8-6.5 at the duodenal 
site and increases to pH 7 at the lower part of the small intestine. The reason 
is that the duodenum is slightly more acidic because it is closer to the stomach 
where the pH is around 1-3 where pancreatic enzymes work effectively. Also, 
the bile salts and phospholipids from the gallbladder act as a surface acting 
agent to emulsify any TAG fat constituents of the food. Bile salts are extremely 
important for lipid digestion and absorption processes. As mentioned earlier, 
bile salts are surface acting molecules that adsorb to the oil water interface 
and form micelles and colloids in water. Bile salts are synthesised from 
cholesterol in the liver. Their chemical structure consists of a hydrophobic site, 
that interacts with molecules which are non-polar such as oil and an 
hydrophilic site, that interacts with polar molecules such as water. 
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3.2.4 The colon 
 
The large intestine, also known as the colon, has 3 main physiological regions: 
the ascending colon, the transverse colon and the descending colon. There 
are also other regions known as the caecum (this is a small region including 
the appendix and is located between the ascending colon and the end of the 
small intestine) and the sigmoid colon and anorectum regions at the other 
side. Overall, the length of human colon is approximately 1.5m long and 
around 7.5cm in diameter. Cell types in the colon are the same as those in the 
rest of the GI tract except that the small intestine villi are not present in the 
stomach nor in the colon. There are 3 major functions of the colon including: 
collecting all unabsorbed materials from GI tract to form a solid waste 
(faeces), re-absorption of minerals (such us vitamins, water, salts and sugars) 
and bacterial digestion. In summary, the colon absorbs and secretes fluid and 
thereby maintains normal salt and water homeostasis [52]. 
The colon is considered to be the most difficult region of the GI tract to 
simulate due to variations in bacterial populations that exist in different parts of 
the colon. The caecum and ascending colon are the areas of the intestine 
where microbial activity is higher [53]. The microbes in the large intestine 
digest food residues such as carbohydrates and proteins. Bacteria in this 
region of the GI tract are responsible for breaking down organic matter by 
anaerobic reaction or fermentation whereby these microorganisms gain 
energy [54]. There is limited absorption in the colonic region of the GI tract, 
however throughout the fermentation short chain fatty acids go through their 
final stage the digestive process.  Bacteria in the colon deconjugate bile acids 
and modify steroid which comes back to the liver via the enterohepatic 
circulation [33, 55]. 
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3.2.5 Gastrointestinal response to a meal 
 
There are numerous activities taking place in the GI tract in response to meal 
arrival, however the discussion in this section will briefly concentrate on three 
main responses which can be summarised as: 
x Physical response: for example the GI tract can accommodate large 
volumes of food in the stomach, can transfer chime material to the 
small intestine and colon and can collect waste at the end of the colon 
for excretion. 
x Physicochemical response: where a wide range of chemical reactions 
takes place from mouth to colon. This chemical reaction/interaction 
includes fermentation, emulsification, conjugation and more. 
x Hormonal and secretory response: the gut releases hormones and 
enzymes at each stage of digestion along the tract. For example 
lipase and pepsin in stomach, bile salts in small intestine, the peptide 
response to feeding such as the relevant cholecystokinin (CCK) 
responses to feeding, and the physiologic role of CCK in gallbladder 
contraction. 
 
3.2.6 Gastrointestinal responses to fat 
 
Fat is one the major components of our diet, it is a source of energy 
(phospholipids, triglycerides etc) and can be obtained from animals or plants 
directly or indirectly. Fats are incorporated into many processed foods in order 
to improve the texture, taste, appearance and palatability. The complex mix 
proteins, carbohydrates, vitamins and micronutrients that make up a meal may 
impact positively on stability, solubility and absorption of fat [56-58].  It is well 
documented that food ingestion triggers many stimuli within the GI tract that 
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modulate motility, salivary secretion, appetite and releasing gastrointestinal 
hormones such as CCK, peptide YY (PYY) and glucagon-like peptide (GLP) 
[59]. There are 2 major GI tract responses to nutrient intake and these are: the 
cephalic response (a number of vagal cholinergic activities initiated by smell, 
thought, sight and taste etc); and intestinal phase response where ingesting 
fat will stimulate the secretion of CCK, PYY and GLP, which eventually inhibit 
gastric emptying and appetite. Dietary fat, specifically the free fatty acids 
(FFAs), interact with the oral cavity and small intestine in order to adjust 
energy intake [60, 61].  Sensing of nutrients in the small intestine plays an 
important role in the regulation of GI tract function and energy intake [62]. 
Manipulation of the formulation of fat emulsions can modulate these 
responses. One possibility is to reduce the fat droplet size which will allow the 
lipase to have enough surface areas to bind [63]. This will allow FFA to be 
delivered into the small intestine and control gastric emptying. Another 
possibility is to change intragastric spatial distribution of the fat [64]. 
The consumption of high fat levels has been linked to medical conditions such 
as obesity and cardiovascular diseases. 
 
3.2.7 Fat bioavailability 
 
7KH WHUP ³ELRDYDLODELOLW\´ LV SULPDULO\ XVHG E\ SKDUPDFHXWLFDO DQG IRRG
industries to estimate the effect of an active ingredient in a formulation. 
According to Taylor & Lloyd [65], the term bioavailability is defined as ³the rate 
and the extent to which an active ingredient is absorbed and becomes 
available at the site of action and therefore gives a therapeutic response or 
nutrient effect´. There are other terms relating to bioavailability including 
relative bioavailability (this is comparing the rate and extent of two similar 
formulations e.g. standard product and test product) and absolute 
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bioavailability (this is comparing the same formulation in different delivery 
routes). There are number of physiological factors that can influence fat 
bioavailability including [65-68]: 
x Gastrointestinal motility including: segmentation, tonic contractions and 
peristalsis.  
x The pH in the GI tract which varies from one region to another. For 
example; low pH in the stomach (around pH 1 to 2) and high pH in 
small intestine and colon (at around pH 5-7). 
x Metabolism: this is complex and involves the interplay of many 
aspects, from enzymes (such as Cytochrome P450 3A4) to first-pass 
metabolism in the liver.   
x Individual variation: there are variations between individuals such as 
gender, age, race and disease state that can affect the oral 
bioavailability. 
x Other contents of gut including secretions and bile salts. 
The physiological factors are not the only aspects that influence oral 
bioavailability; however there are many other factors that can affect oral 
bioavailability such physicochemical factors including pKa, lipid solubility and 
partition coefficient and solubility. Other important factors that can affect oral 
bioavailability are particle size, droplet sizes and additives [3, 65].  
In order to determine bioavailability it is necessary to measure the amount of 
active ingredient in the blood plasma. This is normally done by taking blood 
samples which can be time consuming, inconvenient to many and it may also 
deter people from participating in studies. Therefore, an alternative way for 
measuring the bioavailability of formulations becomes an interesting topic of 
research. Non-invasive techniques such as magnetic resonance imaging 
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(MRI) and magnetic resonance spectroscopy may provide us with a method of 
monitoring the transit of food components through the gastrointestinal track to 
target organs such as the liver and muscles. 
 
3.2.8 Satiety responses 
 
The satiety response to fat may start well before ingesting food and the impact 
of this may last hours after the ingestion of fatty food. There are many cephalic 
responses such as the smell, thought and taste of food which influence the 
absorption and utilised nutrient through the vagal cholinergic activity [62].  
When fat is emptied from the stomach into the small intestine the small bowel 
releases hormones such as CCK to slow gastric emptying and signal satiety. It 
is also reported that carbohydrates behave similarly to fat by releasing these 
hormones to delay gastric emptying [59]. However, the length of chain of free 
fatty acids can modulate both energy intake and suppression of hunger. The 
gold standard method for assessing satiety is a self-report visual analogue 
scale (VAS) technique. This is difficult in terms of its accuracy due to subject 
to subject variation as well the physiological response. 
 
3.2.9  MRI of GI tract 
 
MRI of the GI tract initially developed slowly compared to MRI of other organs 
due to artifacts caused by respiratory movement (breathing) and peristaltic 
motion.  The first gastrointestinal MRI papers were published in the late 1980s 
to early 1990s [69, 70].  These early MRI images of the GI tract were acquired 
using EPI. EPI at low field (0.5 T) was well suited for dynamically assessing 
gastric physiology [71] and imaging the stomach contents with excellent 
contrast between water based meals and the surrounding tissues [69]. EPI 
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acquires images very rapidly (in under 130 ms) overcoming artifacts due to 
abdominal motion. Furthermore, the EPI pulse sequence gives intrinsically T2* 
weighted images, and hence provides excellent contrast between water-based 
liquid meals and surrounding tissues, and between the liquid and solid 
components of a meal [69, 72], without the need for the addition of MRI 
contrast agents. Over recent years there has been considerable progress and 
most modern imaging sequences can take good quality images of the 
abdominal organs at 1.5T and also 3T.  
A number of physiological parameters can be obtained using these techniques 
on the GI tract such gastric emptying (gastric volume with time), stomach 
spectroscopy, gallbladder contraction (volume with time), liver volume 
assessment, liver spectroscopy, small bowel water contents (SBWC) and 
colon volumes and assessing its functions or motility. 
 
3.2.10 Gastric volume measurement 
 
MRI is capable of providing good contrast between the stomach contents and 
the stomach wall as well as the surrounding areas (organs such as spleen, 
liver, heart). Therefore, it is easy to visualise the stomach contents over time. 
Gastric volume measurement were validated with gold standard methods such 
as gamma scintigraphy and intubation and both correlated well with MRI 
gastric emptying measurement [73, 74]. The rate of gastric emptying depends 
on the type of food, calorie load and its structural formation. For example 
liquids like water and beverages empty relatively rapidly compared to fat and 
solid food. The SPMMRC has published several papers on MRI of gastric 
emptying of a variety of food types [75-77]. 
 
 
Chapter 3 ± The GI tract and fat  
53 
 
3.2.11 MRI of gallbladder volume 
 
The gallbladder is small organ that is adjacent to the liver, links with the 
pancreas by the pancreatic duct and also links with the duodenum by the bile 
duct.  The content of the gallbladder is mainly bile salt produced by the liver 
and used for fat digestion. Using the bTFE sequences provides good contrast 
for the liquid in the gallbladder against the surrounding organs, and can be 
processed similarly to the stomach volumes. Gallbladder contraction can be 
considered as a biomarker for fat digestion. Therefore, there are many 
publications that highlight the link between gallbladder contraction, satiety 
hormones such as cholecystokinin (CCK) and fatty foods [78, 79]. 
Cholecystokinin cells are located in the small intestine, specifically in the 
duodenum and jejunum, but not in the ileum. CCK is release from these cells 
when they sense fat [80-82].  
 
3.2.12 MRI of small bowel water contents 
 
The small bowel is subject to large fluxes of fluid (on the order of 6-8 litres 
daily) and this fluid is crucial for the digestion and transport of nutrients. 
Secretion and absorption vary with different foods and disease. Therefore, 
there is a need to visualise and measure the state of small bowel water 
content as this may affect digestion. Monitoring of bowel fluid can be done by 
intubation but this is very unpleasant for the subjects and can sample only 
limited segments of the bowel. The anatomical details of the small bowel can 
be visualised non-invasively by using MRI sequences without using contrast 
agents or intubation. The SPMMRC developed a method to evaluate the 
amount of free water in the small bowel. This was developed and validated by 
Dr Caroline Hoad [83]. The method is based on using strongly T2 weighted 
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HASTE or RARE sequences (similar to magnetic resonance 
cholangiopacreatography or MRCP). The fluid signal is normalised against 
cerebrospinal fluid (CSF) because it is relatively free water and is in the centre 
of the field of view inside the subject, which has many advantages over 
external phantoms. In order to quantify the free water in the small bowel, we 
use in-house software written in IDL (Research Systems Inc. Boulder, 
Colorado, USA) by this group. The operator needs to set their threshold by 
using the spine fluids and select the ROI of small bowel segment filled with 
water. This method assumes that only pixels with a signal bigger than the 
threshold contain water, which can lead to an underestimation of the amount 
of free water because of partial volume effects.  
 
In summary the GI tract is presently poorly understood and MRI provides a 
non-invasive method of studying its function in health and disease. 
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4 Methods 
 
 
 
This chapter provides some more details of the equipment and methods that 
were used in the studies described in the following chapters and/or provides 
brief additional descriptions of techniques which were not given in those 
chapters due to size and logical flow. This chapter is divided into 4 main 
areas: Bench techniques at Unilever, MRI scanners, breath test and CCK 
plasma assay methods and ethical approvals and GCP standards. 
 
 
4.1 Bench techniques at Unilever 
 
There were number of techniques and equipment that were used in order to 
carry out sample preparation, sample characterization and routine checks of 
VDPSOHV¶VSHFLILFDWLRQVGURSOHWVL]HDQGUKHRORJ\DVVHVVPHQWV 
 
4.1.1 Homogenisers and microfluidiser 
 
Two homogenisers were used to prepare emulsion samples for both in vitro 
and in vivo studies. These were the Ultra-Turrax and the Silverson (Figure 4.1 
and Figure 4.2 respectively). The Ultra-Turrax is a rotor/stator system. Shear 
force and inert force in turbulent flow are the cause for the breakdown of the 
droplets, resulting in homogenisation. The machine has available five crushing 
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rotors, three types of seals and several special dispersing elements to adapt 
to a variety of applications. For this work all in vivo emulsions were prepared 
using an Ultra-Turrax (Model IKA T25BS2). 
 
 
 
Figure 4.1: an Ultra-Turrax (Model IKA T25BS2), image taken from the 
PDQXIDFWXUHU¶VZHEVLWH 
 
 
 
The Silverson is another mixer homogeniser which can produce a very unified 
particle size mixture. This uses and generates exceptionally high shear rates 
in a three stage mixing/homogenising process: the high speed rotor, the 
centrifugal force and hydraulic shear. The Silverson homogeniser can produce 
a fat emulsion droplet size at around 2 microns and above. This instrument 
has different meshes and variety of speed ranges for range of applications. 
This type of homogeniser (Silverson: model L5R) was used for Cross-field 
Coarse emulsion and preparations of locust bean gum (LBG) solutions.  
Chapter 4 ± Methods  
57 
 
 
 
Figure 4.2: the Silverson L5R homogeneiser, image taken from the 
PDQXIDFWXUHU¶VZHEVLWH 
 
 
The Microfluidizer is based on a high pressure emulsification system. It 
consists of a high pressure pump and a high pressure dispersal unit as shown 
in Figure 4.3.  
 
 
Figure 4.3: The Microfluidiser 110S® (Quelle). 
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The mixed compounds are put into the storage tank (A), which is connected 
with the reservoir (B). From there it is pressed into the interaction chamber (C) 
where the main reduction of the droplet size takes place. Within the interaction 
chamber the stream of fluid is separated by a barrier, creating two streams of 
fluid. These are then recombined at high speed and during this collision the 
droplets break-up and reduce their size. This instrument applies high pressure 
(range 3,000 psi to 23,000 psi) and was used to produce the Fine emulsions 
for these studies. 
 
4.1.2 Droplet size analysis 
 
There are number of instrumental methods available for particle size 
measurement. Laser diffraction methods were used to measure fat emulsions 
droplet sizes in this work.  
Laser diffraction is usually the preferred method to carry out particle 
size analysis because it offers a short analytical time, robustness, high 
precision, reproducibility, wide measurement range and flexibility of operation 
using liquid, spray and dry dispersion attachments. The instrument used was 
the Malvern Mastersizer 2000 (Malvern, Worcestershire, UK) as shown in 
Figure 4.4. 
The Mastersizer 2000 uses laser diffraction to measure the size of 
particles/droplets by measuring the intensity of light scattered as the laser 
beam passes through the sample. 
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Laser source
 
Figure 4.4: a photo of the Malvern Mastersizer 2000 used for this work. 
 
The refractive index of sunflower oil and water were selected to model the 
data. The name of the tested samples and the average of number of cycles 
were documented. Initially, the stirred regulator was set at 2000 rpm. The 
emulsion sample was dispersed into the sample chamber in re-circulating 
ZDWHU LQ WKH µ+\GUR60¶PHDVXULQJFHOOXQWLODQREVFXUDWLRQUDWHRI± 14% 
was obtained. The dispersed sample was stirred until homogeneous 
dispersion without agglomeration was achieved. The sample was then 
pumped through the measuring zone (the laser beam zone without bias or 
distortion) and it was circulated again for further measurement. The mean 
emulsion droplet size is commonly reported as D[3,2] (the surface area mean 
diameter) or D[0,5] (a mass median diameter). The measurement was carried 
out in triplicate on each emulsion. The results were represented as particle 
size distribution. The instrument was then cleaned using distilled water at 
maximum speed until the desired cleanness was achieved before proceeding 
with a new sample. 
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4.1.3 Rheology 
 
Rheology is defined as the study of deformation of solid matter and flow of 
liquid materials. The main interest for solid material rheology is based on its 
elasticity whereas the rheology of liquids is based on its viscosity 
measurement. Rheology measurement of the properties of food materials is 
important for the food industry because it allows design, monitoring and quality 
control of food. The most common viscometers are the steady shear and the 
oscillatory types. The rheometer that was used for this work was an Anton 
Paar Physica MCR 501 Rheometer as shown in Figure 4.5.  All samples were 
measured at 37°C in small amplitude oscillatory shear with 17 mm diameter 
parallel plates on the Anton Paar MCR (cc17-0.25). The amount of sample 
loaded was 3 ml for each emulsion. 
 
 
Figure 4.5: an Anton Paar Physica MCR 501 Rheometer (image taken from 
AntonPaar.com). 
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4.2 MRI scanners 
 
This section describes briefly the MRI methods used for this work which was 
carried out using state of the art, research dedicated Philips Achieva machines 
at 1.5T and 3T. The work that was carried out on the 3T Philip Achieva 
scanner was the pilot work (described in Chapter 5) and part of the in vitro 
Cross-field experiment (described in Chapter 7). All other work was carried out 
on the 1.5T MRI scanner shown in Figure 4.6. For the in vivo experiments at 
1.5T a range of abdominal scans were acquired in ~15 minutes. 
 
1.5T  scanner
16 element receive coil
 
Figure 4.6: The Philips Achieva 1.5T scanner. The top half of the 16 element 
parallel receiver coil used for this work can be seen, the other half is below the 
bed padding. 
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4.2.1 Scan day organisation 
 
The organisation of the study days on healthy volunteers was optimised to 
make best use of the expensive machine time. Two to three volunteers were 
interleaved per day and various staff including the research radiographer and, 
when necessary, the research nurses followed a printed day sheet which 
contained the timed interventions to be carried out such as taking breath or 
blood samples, preparing test meals and MRI scans. An example of such a 
day sheet is given in Figure 4.7. 
 
Figure 4.7: an example of a page of a daily scan sheet for the main 
physiological study at Chapter 6. 
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4.3 Breath test and plasma assay methods 
 
4.3.1 IRIS Machine for breath samples 
 
Stable isotopes such as 13C are safe to use for non-invasive diagnosis. A 13C 
substrate can be ingested with a meal and metabolised and excreted in the 
breath. This can be collected and analysed using infrared methods such as 
the infrared isotope analyzer IRIS® (Wagner Analysen Technik, Bremen, 
Germany), which allows a precise determination of the two isotopes, 13CO2 
and 12CO2. This was used in these studies. The results are presented as delta-
over baseline values (DOB) which indicates the change in the 13CO2/12CO2 
ratio brought about by the metabolic activity induced by the administration of 
the labelled substrate. The breath samples were collected by using breath 
bags (Figure 4.8) designed for the Infra Red ISotope Analyser (IRIS) machine 
(Wagner Analysen Technik, Bremen, Germany) shown in Figure 4.9. 
 
 
 
Figure 4.8: Image of the breath bag that was used to collect breath samples. 
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Two 13C-labelled compounds were used for this work and they were 13C-
triolein and 13C-Octanoic acid for pilot work and the main physiological study 
(Chapters 5 and 6 respectively). The volunteers were asked to breathe into 
the bag at an initial baseline and at regular intervals for 4-5 hours depending 
on the study. These breath samples were then analyzed by using the IRIS 
machine shown in Figure 4.9. The output from the IRIS machine consists of a 
plot of the delta over baseline (Figure 4.10), a fit to the data and a calculation 
of T1/2, Tlag and % of 13C metabolised during the time experiment.  
 
 
 
 
Figure 4.9: a photo of the IRIS machine used to analyse breath samples. 
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Figure 4.10: A typical breath test delta over baseline data obtained from the 
IRIS machine. 
 
 
4.3.2 CCK plasma assay 
 
The volunteers were cannulated in a forearm vein by a qualified research 
nurse as shown in Figure 4.11. 10 venous blood samples (6.5 ml) were 
collected by syringe at 30-min intervals for the first 2 h and 60-min intervals 
afterward up to 5 h. The blood was quickly transferred into chilled blood 
collection tubes containing 0.3 ml EDTA and 5,000 KIU aprotinin. The samples 
were cooled in an ice bath immediately. The plasma was readily separated by 
centrifugation (Figure: 4.12) at 4°C, and the plasma snap-frozen in liquid 
nitrogen DQG WKHQVWRUHGDW í&XQWLO DVVD\HGE\'U*XO]DU6LQJKDW WKH
School of Biomedical Sciences as described previously [26].  
Briefly, the methods were as follows. The plasma samples were extracted 
before assay to eliminate nonspecific interference from plasma proteins. One 
ml of plasma was added to 2 ml of 96% ethanol, vortex mixed in a glass tube. 
The tubes were allowed to stand on the bench for 10 min, before 
centrifugation at 3000 g for 10 min. The supernatant containing CCK was 
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decanted into another glass tube and evaporated to dryness in vacuum before 
being re-dissolved in 1 ml of phosphate buffer.  
 
 
Figure 4.11: shows the cannulation in a forearm vein of the volunteers and 
sample taking. 
 
 
centrifuge
Tubes
 
Figure 4.12: The fisher refrigerated centrifuge used to separate the plasma in 
the blood and all the blood tubes set-up for a study day. 
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The concentrations of CCK were then measured by radioimmunoassay (RIA) 
with commercially available kits according to the manufacturer's instructions 
(EURIA-CCK, Euro-Diagnostica, obtained from Immunodiagnostic Systems, 
Ids, Tyne and Wear, UK). Briefly, the samples and the standards competed 
with 125I-CCK-8 sulfate in binding to antibodies of CCK-8 sulfate. The 
antibody bound with 125I-CCK-8 sulfate was separated from the unbound 
fraction by using a double-antibody solid phase. The radioactivity of the bound 
fraction was then measured in a gamma counter. The minimum detectable 
concentration for CCK was 0.3 pmol/l of sample with intra- and interassay 
variations less than 6 and 15%, respectively. The antibody was highly specific, 
cross reactivity being <0.01% to CCK-(26-33) nonsulfated, CCK-(30-33) and 
gastrin-17, nonsulfated, 0.5% to gastrin-17, sulfated compared with CCK-(26-
33) sulfate (CCK-8).  
 
4.4 Ethical approvals and GCP standards 
 
Each study received full ethics approval from the local University of 
Nottingham Medical School Research Ethics Committee. Informed written 
consent was obtained from each subject participating in the study. The 
approval numbers were B/11/2008 for the initial pilot studies and the main 
physiological study and C10052012 for the final quantification phase.  
All human studies were conducted in compliance with their protocols, the 
Declaration of Helsinki and the principles of Good Clinical Practice. These 
include  
x keeping the rights, safety, and well-being of the trial subjects as the 
most important consideration 
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x recording, handling and storing all study information in a way that 
allows its accurate reporting, interpretation and verification (e.g. using 
Case Report Forms and Trial Master Files) 
x implementing systems and standard operating procedures that assure 
the quality of every aspect of the study  
$IWHU WKH LQLWLDOSLORWSKDVHIRUZKLFK WKHGDWDZHUHSURFHVVHG LQ µRSHQ ODEHO¶
fashion, the human studies were carried out to clinical trial standard. The test 
meals were given to the volunteers following a latin square randomisation 
schedule to avoid order effects. The volunteers were kept blind to the test 
meal type. The author prepared the meals and knew the randomisation 
schedule but after this one member of the team who was not involved with this 
study subsequently blinded the data file names according to approved 
standard operating procedures for analysis hence the trial become a double-
blind. A formal blind data review was carried out both at Nottingham by the 
study team and at Unilever and all data queries were answered before 
breaking the blind codes.  
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5 Development work on fat emulsion 
systems and their characterisation 
 
 
 
This thesis chapter describes the development and characterisation of two fat 
emulsion meal systems (with a small and large droplet size) using a range of 
bench and MRI techniques and in vitro GLJHVWLRQ PRGHOV 7KH HPXOVLRQV¶
performance was finally tested in vivo in healthy volunteers using MRI.   
 
 
5.1 Background 
 
The relationship between meal structure and composition, the way the meal is 
handled by the body and the resulting sense of satiety are critical to improve 
understanding of how to control and reverse the rising tide of obesity. This is 
particularly true with respect to fat which is a highly palatable and highly caloric 
component of food, often added in marked amounts to pre-processed foods in 
the western world. Magnetic resonance imaging (MRI) can monitor non-
invasively and in a single study session many parameters of gastrointestinal 
(GI) function [84], including the spatial distribution of fat and water in the 
stomach separately [23, 25, 85] and these parameters can be related to 
hormonal responses and the sense of satiety [23, 26] in complex physiological 
studies on healthy volunteers, of which the Nottingham group has a long and 
successful track record.  
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 One question remains unanswered thus far from previous experiments: for 
a given amount of fat in a well characterized, model fat emulsion meal, what is 
the effect of the fat emulsion droplet size on the gastrointestinal physiological 
responses and the resulting sense of satiety? 
 The work described in this chapter aimed to provide an answer to this 
research question. Two sunflower oil fat emulsion model meals developed 
initially by colleagues in Unilever were used. These fat emulsion meals have 
the same volume, amount of fat and taste but two markedly different fat droplet 
sizes, one of the order of 400 nanometers (called here throughout the Fine 
emulsion) and one of the order of 8 micrometers (called here throughout the 
Coarse emulsion). After an initial MRI assessment these emulsions were 
characterised in vitro in the Unilever laboratories using a range of techniques 
such as bench rheology for viscosity profiles, laser diffractometry for droplet 
size and in vitro digestion models with gas chromatography / mass 
spectrometry (GC-MS) for fat hydrolysis. The performance of the two emulsion 
systems was subsequently assessed in vivo in a limited series of pilot studies 
in healthy volunteers. 
 
5.2 Initial development and characterisation 
 
The emulsions were made of 79% distilled water, 20%, sunflower oil and 1% 
Tween20. Two tablets of sweetener (Hermesetas mini sweetener) and 1.5g 
coffee flavour (Dr. Oetker coffee flavouring) were added in order to improve 
the taste of the emulsion.  
The main two fat emulsion to be investigated were:  
x a Coarse emulsion with a mean diameter of approximately 8 µm (the 
µCoarse¶ emulsion) 
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x a Fine emulsion with a mean diameter of approximately 0.4 µm (the 
µFine¶HPXOVLRQ 
The overall preparation procedure for the emulsions is shown schematically 
below in Figure 5.1. To produce the Coarse fat emulsion an Ultra-Turrax was 
used. The Ultra-Turrax is a rotor/stator system where shear force and 
turbulent flow cause the breakdown of the droplets, resulting in 
homogenisation. The Coarse emulsion was produced using the Ultra-Turrax 
for 20 minutes with a rotation speed of 13,500 rpm. To produce the Fine 
emulsion the Ultra-Turrax was used again for 20 minutes with the same 
rotation speed. After this step the emulsion was passed through a 
Microfluidizer. The Microfluidizer as shown previously in paragraph 4.1.1 is 
based on a high pressure emulsification system. It consists of a high pressure 
pump and a high pressure dispersal unit (Figure 5.2).  
 
Materials:
 Sun flower oil (20%)
 Tween 20 (1%)
 Distilled water (79%)
Methods:
M
Microfluidizer
oil
Water
+
Tween 20 Ultra-Turrax
Coarse
emulsion (~8µm)
Fine
emulsion (~400nm)
+ sweetener
+ coffee flavour
 
Figure 5.1: schematic representation of fat emulsions preparation method. 
 
The emulsion was passed through the system with a pressure of 1 bar at the 
inlet, which corresponded to 233 bar in the interaction chamber. The mixed 
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compounds were put into the storage tank (A), which was connected with the 
reservoir (B). From there it was passed into the interaction chamber (C) where 
the main reduction of the droplet size took place. There the stream of fluid is 
separated by a barrier, creating two streams of fluid which are subsequently 
recombined at high speed. During this collision the droplets break-up and 
reduce their size. 
 
Figure 5.2: Schematic design of the homogenisation process using the high 
pressure Microfluidizer 110S®. 
 
 
5.2.1 Initial MRI assessment 
 
Figure 5.3 shows examples of the initial MRI images of the fat emulsion 
systems. This initial assessment was undertaken to verify in vitro that the 
emulsions could actually be imaged well before progressing their detailed 
bench characterisation. Such images showed that the Coarse emulsion, 
acidified with HCl to mimic stomach conditions, rapidly separated into two 
layers (fat creaming towards the top and water at the bottom due to density) 
whilst the Fine emulsion remained homogeneous as predicted. The T2 
relaxation times were measured to give an idea of the range of T2s in the two 
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fat emulsion systems and this is shown in Figure 5.4. These initial T2 
measurements were carried out with the Philips proprietary T2CALC 
sequence. This generates automatically a T2 map using a spin echo type of 
sequence with an EPI readout. It acquires 5 echoes for 40 transverse slices 
with 0.90 mm × 0.90 mm × 3 mm resolution. The acquisition lasts about 6 
minutes. This initial MRI experience was positive and showed that the two fat 
emulsions should provide good imaging characteristics in vivo.  
a b
Water Coarse Fine
 
Figure 5.3: (a) Shows an example of moderately T2 weighted water imaging 
sequence (a Turbo Spin Echo TSE sequence with 59 ms echo time) of a vial 
of water, a laboratory tube containing Coarse emulsion and another tube 
containing Fine emulsion acquired 30 minutes after acidification with HCL. (b) 
shows the corresponding fat selective images. 
 
5.2.2 Fat emulsions stability 
 
5.2.2.1 Introduction to emulsion stability work 
 
Having reflected on the differences in creaming observed in the initial fat 
emulsion systems it was decided to evaluate thickened fat emulsion systems 
(containing Coarse and Fine fat emulsions) that will empty the fat phase from 
the stomach at the same rate. This would allow testing of the hypothesis that 
the GI/small bowel effects observed depend on surface area of the droplets 
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and not on differences in gastric emptying due to creaming of the Coarse 
emulsion.  A number of thickening food materials were investigated including 
guar gum (GG), locust bean gum (LBG), citrus fibres and xanthan gum (XG). 
 
Fine baseline Coarse baseline
Fine acidified Coarse acidified Coarse acidified
10 min later
375 ms 70 ms
391 ms
1154 ms 1260 ms
77 ms
67 ms
 
Figure 5.4: T2 measurements of the Fine and Coarse emulsions before and 
after acidification with HCl. The white box shows the region of interest used to 
sample the T2CALC Philips sequence T2 maps. 
 
Most of these are common food thickeners and all showed to be unstable in 
gastric condition due to impurities such as protein and other compounds. 
However the pure LBG from CPKELCO (Denmark) performed very well so an 
assessment of the concentrations needed to make the Coarse emulsion stable 
was made. The aim was to stabilize the emulsion for a period of several hours 
without compromising the texture i.e. viscosity and acceptability for our 
volunteers. In other words the aim was to prepare emulsions that were 
minimally thickened but stable (no creaming) throughout the gastric emptying 
process. 
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5.2.2.2 Specific methods for LBG concentrations 
 
3 different emulsions with different LBG concentration (0.3%, 0.5% and 0.7%) 
were prepared. The LBG was incorporated with both the Coarse (creaming in 
GI tract) and Fine emulsions. For example, to obtain a final 0.5% w/w 
LBG/water solution, 5 g of LBG powder was weighed in a weighing boat and 
dispersed in 495g of boiling water whilst stirring using a Silverson blender.  
Any aggregates were manually dissolved using a clean spatula and dispersed 
whilst stirring for 5 minutes. After this, H2O (101.5g) + Tween 20 (3.5g) + LBG 
(175g of 1%LBG) solution were placed in 600ml glass beaker and mixed well 
(due to thickness of the solution). Then the sunflower oil (70g) was added in 
and the mixture was placed in an Ultra-Turrax for 5 minutes at high speed. 
This yielded a final 0.5% LBG fat emulsion. 
 
5.2.2.3 Specific methods for preparation of gastric solutions 
 
The stomach environment is acid and gastric secretion contain salts so in 
order to dilute the fat emulsion systems in a biologically relevant manner 
simulated gastric solution and not distilled water should be used. Dilution of 
the fat emulsions systems will be important to assess and predict intragastric 
stability. For this purpose in this work the gastric solution was prepared by 
dissolving the salts in distilled water to 200ml in a volumetric flask. The 
amounts and the type of salts added are listed in Table 5.1. The solution was 
then acidified with HCL as needed to reach pH=2. 
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Salts Mw 
(g/mol) 
Concentration 
(mM) 
% 
Concentration 
(w/w) 
Mass of 
Salt (g in 
200ml) 
KCl 74.55 5 0.037 0.075 
CaCl2·2H2O 147.01 5 0.074 0.147 
NaCl 58.44 150 0.877 1.753 
 
Table 5.1: Salts used to prepare the gastric solution 
 
5.2.2.4 Stability test 
 
Different ratios of emulsion to gastric solution were used.  These ratios were 
1:1, 1:2 and 1:3 gastric solution:emulsion as shown on Figure 5.5. For 
example to prepare a 3:1 ratio (emulsion: gastric solution): 30g of emulsion 
was placed in a 50ml measuring cylinder and (10g) of simulated gastric 
solution was added in. The mixture was shaken until an homogenized solution 
was achieved. Then the cylinder was placed in an oven at 37°C. Visual 
observations of the creaming layer appearance and height in cm were 
subsequently made and recorded on the lab book every hour for 6 hours and 
the following day at the 24 hour time point. The same procedure was repeated 
for different ratios and emulsions (Coarse and Fine). The movement of the 
creaming part of the emulsions were measured hourly for 24 hours. 
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Baseline photo 1 hour later after gastric juice added in
1:1 2:1 3:1
 
Figure 5.5: Illustration of the set up for bench observations of creaming for 
gum-stabilised Coarse emulsions with different amount of gastric solutions. 
 
 
5.2.2.5 Results 
 
Figure 5.6: shows the laser diffractometry data for 5 emulsions: 4 Coarse 
emulsions were shown to have similar droplet sizes whereas the Fine 
emulsion showed a smaller droplet size. The data are reported in Table 5.2. 
Figure 5.7 shows the height of the aqueous phase for three different ratios of 
0.5% LBG Coarse emulsion to gastric solution. The 1:1 ratio showed fast 
creaming. When the gastric solution ratio was reduced this slowed the 
emulsion creaming process. A simple calculation at t=6 hour (assuming 
linearity) shows that the 1:1 ratio emulsion creamed at a rate of 5.2 cm3/h, the 
2:1 ratio emulsion creamed at a rate of 3.2 cm3/h and the 3:1 ratio emulsion 
creamed at a rate of 1.7 cm3/h.   Figure 5.8 shows the experimental set up for 
these observations. 
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Figure 5.6: the droplet size analyses for different emulsions 
 
 
 
Fine
+0.5% LBG
Coarse
+0.3% LBG
Coarse
+0.5% LBG
Coarse
+0.7% LBG
Coarse 
no LBG
Measurements Mean (micron) Mean (micron) Mean (micron) Mean (micron) Mean (micron)
D [3, 2] 0.43 6.92 7.01 6.58 8.10
D [4, 3] 0. 59 4.21 8.14 4.58 14.12
D [0, 5] 0.45 5.45 6.47 6.41 7.12
 
Table 5.2: Summary of laser diffractometry data for the 5 emulsions used in 
the stability studies. The table reports the emulsion droplet size using the most 
commonly reported measures: D[3,2] (the surface area mean diameter), D[4, 
3] (a volume mean diameter) and D[0,5] (a mass median diameter). 
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Figure 5.7: 0.5% LBG Coarse emulsion with different gastric solution ratios.  
 
Coarse + 0.5% LBG 
(all 3 samples) 
Inside the Oven
Temperature and 
humidity controller
 
Figure 5.8: Image taken 1 hour after start of stability study for 0.5% LBG 
Coarse emulsion with different gastric condition ratio carried out inside an 
oven at 37°C condition.  
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Figure 5.9 plots the data for the stability tests of different emulsions as shown 
in Figure 5.10, namely a Coarse emulsion (without LBG), a Coarse emulsion 
with different LBG concentration and a Fine emulsion with LBG. The ratio of 
emulsion to gastric solution used was 3:1. Figure 5.9 shows that the Coarse 
emulsion without stabiliser creamed up very rapidly whereas the introduction 
of LBG in the emulsion caused it to cream slower (the highest LBG 
concentration that was used was 0.7% which behaved the same as the Fine 
emulsion, with no creaming observed for more than 6 hours). The drawback of 
this was that the emulsion became very viscous which might make it difficult 
for the volunteers to consume. Therefore the maximum thickener to be used 
was chosen as a compromise to be 0.5% LBG.  
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Figure 5.9: Stability behaviour of different emulsion composition in gastric 
condition. 
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Figure 5.10: Example image of the 24 h time point of the study of fat emulsion 
stability with different LBG concentrations. 
 
 
 
5.3 In vitro gastric model experiment 
 
Fat hydrolysis in the stomach is key to fat digestion. An in vitro gastric model 
of lipolysis was used in the Unilever laboratories, with the help of several 
colleagues there, to investigate the Fine and Coarse fat emulsioQV¶K\GURO\VLV
This may help in the prediction of the likely % hydrolysis of triglycerides in the 
subsequent in vivo studies and it will be useful in order to assist in the 
interpretation of the in vivo study data.  
The main outcome here was the measure of the % hydrolysis of triglycerides 
of the Fine and Coarse droplet size fat emulsions. The aim was to understand 
whether emulsion droplet size and/or LBG addition could influence the rate 
and extent of hydrolysis. Also of interest was the comparison of the % of TG 
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K\GURO\VLV YDOXHV REWDLQHG IURP WZR GLIIHUHQW PHWKRGV QDPHO\ WKH ³S+ VWDW´
method (which measures the product of fat digestion soluble in the aqueous 
SKDVH DQG WLWUDEOH E\ 1D2+ RQO\ DQG WKH ³*DV &KURPDWRJUDSK\ *&´
method (which extracts the total hydrolysed products, aqueous and oil 
phases). 
 
5.3.1 Preparation of fat emulsions and LBG solutions 
 
There were 4 different droplet sizes, sunflower oil-Tween20 emulsions 
prepared for this task, namely: 
a) Fine (without LBG) - 350g o/w-emulsion with 20% sunflower oil/1% 
7ZHHQZLWKȝPPHDQGURSOHWVL]H 
b) Coarse (without LBG) - 350g o/w-emulsion with 20% sunflower 
RLO7ZHHQZLWKaȝPPHDQGURSOHWVL]H 
c) Fine + LBG - 350g o/w-emulsion with 20% sunflower oil, 1% 
7ZHHQZLWKȝPPHDQGURSOHWVL]HZLWK 0.5% Locust Bean Gum  
d) Coarse + LBG - 350g o/w-emulsion with 20% sunflower oil/ 1% 
7ZHHQZLWKaȝPPHDQGURSOHWVL]HZLWK/RFXVW%HDQ*XP 
 
5.3.2 Preparation of gastrointestinal model solutions 
 
The gastrointestinal model solution was prepared by dissolving the salts in 
distilled water to 200ml in a volumetric flask. The amount and the type of 
different salts added were listed in Table 5.1 above. 25mg of lipase RO and 
60mg of pepsin were each dissolved in 2ml of gastric solution. The pH of the 
pepsin solution was approximately 4.25 whereas the pH of the lipase solution 
was approximately 3.80. The pH stat titrator is very sensitive when the pH of 
the mixture is below the predetermined pH and may cause overshooting of 
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NaOH when lipase and pepsin solution are added to the emulsion mixture in 
the pH stat sample chamber. Thus the pH of the lipase and pepsin solutions 
was adjusted to the desired pH using 0.1M NaOH before adding them to the 
emulsion mixture. The pH was adjusted between 5.5 and 6.5 (approximately 
1-3 drops of NaOH solution were required depending on the pH needed). 
 
5.3.3 Droplet size measurements 
 
The droplet size of the emulsion was measured with laser light scattering 
using a Mastersizer 2000 (Malvern, Worcestershire, UK) using known 
refractive index of sunflower oil and water. Before the sample was dispersed 
into the sample chamber, the stirred regulator was set at 2000rpm. The 
emulsion sample was dispersed in re-circulating water in the Hydro SM 
measuring cell until an obscuration rate of 12± 14% was obtained.  
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Figure 5.11: Examples of laser diffractometry Mastersizer data for different fat 
emulsion samples.  
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The dispersed sample was stirred and pumped through the laser beam 
measuring zone. The mean emulsion droplet size is reported here as the 
surface-weighted mean diameter D[3,2]. The measurement was carried out in 
triplicate on each emulsion. The mean droplet sizes D[3,2] for Fine + LBG and 
Fine control was of the order of 400 nm, where the Coarse + LBG and Coarse 
Control were of the order of 7 µm. The Fine emulsion had a broad peak 
compared to Fine+LBG emulsion. The Coarse and Coarse+LBG emulsions 
were similar apart from the Coarse+LBG emulsion size distribution was shifted 
slightly to larger values (green line on the right hand side of Figure 5.11). The 
data for the droplet size measurements are given in Table 5.3. 
 
Fine+LBG Coarse+LBG Fine Coarse 
Measurements Mean (micron) Mean (micron) Mean (micron) Mean (micron) 
D [3, 2] 0.45 6.47 0.43 7.48 
D [4, 3] 0. 69 7.82 0.56 12.14 
D [0, 5] 0.42 6.12 0.48 14.21 
 
Table 5.3: Summary of laser diffractometry data for Fine+LBG, Coarse+LBG, 
Fine and Coarse emulsions for the gastric solution studies. The table reports 
the emulsion droplet size using the most commonly reported measures: D[3,2] 
(the surface area mean diameter), D[4, 3] (a volume mean diameter) and 
D[0,5] (a mass median diameter). 
 
 
5.3.4 pH stat experiment 
 
The pH stat experiment is an established method to measure the hydrolysis of 
fat emulsions under continuous titration of the pH of the solution. The T70 
titrator in Figure 5.12 allows simulation of the change in pH to maintain or 
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³VWDW´ S+ GXULQJ OLSRO\VLV ,Q VLPXODWHG JDVWULF FRQGLWLRQV WKH S+ LV ILUVW
adjusted to 6.0 where lipase and pepsin are added. The fungal lipase used is 
not active at low pH and therefore the pH stat experiments were conducted at 
pH 6. This value of pH may appear high compared to acid stomach secretion 
but is nevertheless relevant for pH conditions within the stomach during fed 
conditions [48]. 
The pH stat method used followed established laboratory procedures. Briefly, 
3g of the emulsion was weighed out and placed in a 100 ml beaker. 53g of 
gastric solution were added into the emulsion and transferred into the sample 
holder of the pH stat titrator instrument. The sample holder with the mixture 
was attached to its position and the experiment was started by adjusting both 
the temperature (37.0 ± 0.2 oC) and pH (6 ±0.2) for five minutes. After titration 
optimisation was achieved, the pepsin solution was added followed by the 
lipase solution. Then the baseline sample was collected and samples were 
taken every 15 minutes for two hours (except the 2 Coarse formulations as 
they were slow to be hydrolysed and therefore sampling intervals were 
changed accordingly).  
The data in Figure 5.13 is the % hydrolysis calculated from the raw pH stat 
data: Coarse (Figure 5.13a) shows 3 phases, an initial short lag phase 
followed by a faster hydrolysis up to approximately 20 minutes  and then a 
slower hydrolysis phase reaching approximately 5% hydrolysis after 2 hours. 
The Fine emulsion (Figure 5.13b) shows initial rapid hydrolysis which slows 
after approximately 30 minutes, reaching >25% hydrolysis after 2 hours. The 
Coarse + 0.5% LBG (Figure 5.13c) shows an initial slow hydrolysis phase 
followed by an increased hydrolysis rate at later stages. 
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Figure 5.12: schematic diagram for pH stat adapted from McClements [53]. 
 
 
Some differences between the duplicates were observed and one of the 
samples was allowed to run for longer than the other, so they are plotted 
separately. The Fine + 0.5% LBG emulsion (Figure 5.13d) shows some 
differences between the two runs, one of which appeared to have a longer lag 
phase than the other. After this point (>20minutes) the hydrolysis has a rapid 
phase reaching approximately the same level of hydrolysis as the Fine 
emulsion without LBG. 
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Figure 5.13: % Hydrolysis data from pH stats: (a) Coarse Control; (b) Fine 
Control; (c) Coarse +LBG; and (d) Fine +LBG. 
 
 
5.3.5 Tributyrin experiment 
 
The tributyrin method was used in order to eliminate the possibility that LBG 
did not bind to the enzyme, thereby reducing its efficacy. The tributyrin is a 
solubilised lipid substrate. This was hydrolysed with and without LBG to check 
for possible difference in hydrolysis. The tributyrin method used followed 
established laboratory procedures. 0.016 g Tributyrin was weighed out into a 
200ml bottle and 160 g of distilled water was added. The mixture was stirred 
for 24 hours by using a heated magnetic stirrer at 37°C. 3g of the 0.01% 
tributyrin solution (w/w) was weighed out and put into a 100 ml beaker. 53g of 
gastric solution was added into the emulsion and transferred into the sample 
holder of the ph stat titrator instrument. The sample holder with the mixture 
was attached to its position and the experiment was started by adjusting both 
the temperature (37.0 ± 0.2oC) and pH (6 ±0.2) for five minutes. After titration 
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optimisation was achieved, the pepsin solution was added in followed by the 
lipase solution. The above procedure was repeated using 0.01% Tributyrin 
solution (w/w) that contained 0.025% of LBG (w/w). 
 
5.3.6 Gas chromatography 
 
Gas Chromatography (GC) analysis was used to determine the relative 
quantity of different components of the hydrolysed products. The GC 
characterisation of lipids was conducted according to standard laboratory 
protocols. Briefly, during the lipolysis, a 1 mL aliquot was withdrawn from the 
emulsion mixture every 15 minutes and added to 10 mL of 2:1 
chloroform/methanol mixture (prepared in advance), followed by the addition 
of 5 mL of a 1 % sodium chloride solution. After vigorous shaking, two phases 
separated with the upper layer constituting the aqueous solution and the 
bottom layer constituting the chloroform with extracted lipids. Three drops of 
concentrated HCl were then added to transfer any soap products to FFA. 
Following acid addition, the aqueous phase looked much clearer. A pH of 
approximately 2.0 was reached and pH paper was used to confirm this. The 
bottom phase was transferred into a new vial using a Fine glass pipette and 
placed on a heating block at 80 ºC. The chloroform was removed by blowing 
nitrogen over the surface for 5-10 minutes. The lipid extract was then 
derivatised by adding 1 mL pyridine and 1 mL BSTFA (N,O-bis-
(trimethylsilyl)trifluoroacetamide) reagent and heated on a heating block at 80 
ºC for 30 min. Silyation with BSTFA converts reactive hydroxyl and carboxyl 
groups to stable trimethylsilyl ethers, facilitating improved resolution, peak 
shape, and quantification. 200 PL of the derivatised extract were pipetted into 
a clean auto-sampler vial and 300 PL of toluene were added. This extract was 
then characterised by GC. GC analysis was performed on a Perkin Elmer 
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Autosystem XL. Lipids were separated on a 10 m, 0.53 mm I.D, 0.1 Pm film 
thickness Quadrex Methyl 5 % phenyl silicone bonded phase fused silica 
capillary column. The injection volume was 0.5 PL and the carrier gas was 
helium set at 60 kPa. The GC column oven was programmed from an initial 
temperature of 120 °C, for 0.5 minutes, ramping to 325 °C at 10 °C/minute, 
followed by ramping from 325 °C to 350 °C at 5 °C/minute with a 2 minute hold 
at 350 oC. PTV injection was used, ramping from 70 °C to 350 °C at 200 
°C/minute after 0.1 minutes, with a 3 minute hold at 350 °C. The detector 
temperature was set at 360 °C. An Agilent gas chromatograph, HP 6890 
series (Agilent, Wokingham, UK) was used to separate different components 
in the extract. A typical chromatogram is displayed in Figure 5.14.  
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Figure 5.14: Gas chromatogram of lipid extract and assignment of peaks. 
FFA: free fatty acids, MG: monoglycerides, DG: diglycerides, TG: triglycerides. 
 
 
 
 
 
Chapter 5 ± Development work  
90 
 
5.3.7 Analysis 
 
x Calculation of the molecular weight (MW) of triglycerides and  average 
free fatty acids (FFA). 
 
The average molecular weight of the long chain triglyceride sunflower oil 
(SFO) sunflower oil was determined as 787.03g/mol according to the fatty acid 
composition of sunflower oil as listed in Table 5.4 below. 
The average Mw of Triglyceride is thus calculated as follows:  
3*Mw (FA) +Mw (Glycerol)-3*Mw (H2O) = 878.03 g/mol ,  [4.1] 
and the average composition of fatty acid (FA) is calculated as: 
Total composition/% of composition= 27978.30/99.93 = 279.78 .  [4.2] 
 
x Calculation of % hydrolysis using pH stat 
 
The volume of added 0.1 M NaOH reflects the amount of FA released from 
lipolysis. The % hydrolysis as a function of time, was depicted as a measure of 
the hydrolysis of the TG by the lipase. 
Since the enzyme specifically hydrolyses the ester bonds at 1 and 3 positions 
(Figure 5.15), 100 % hydrolysis was determined as when the lipase 
hydrolysed 2 free fatty acids (FFA) per triglyceride (TG) using the following 
equation: 
Maximum volume of NaOH added= X*2/ (MWTG *[NaOH])  . [4.3] 
Where: X is the amount of oil in the emulsion (g) =0.6 g. The factor 2 is 
required since every mole of TG produces 2 mol of FFAs. MWTG is the 
molecular weight of TG (g/mol); [NaOH] is the concentration of NaOH (0.1M) 
with MW of Triglycerol (TG) = 878.03; Mass of TG in our emulsion 0.6 (g); 
Number of moles of TG (n) = Mass/MW= 0.00068335 
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Number of moles of NaOH (n) = n of TG*2 =0.0013667; the Vmax of NaOH = 
number of moles*0.1 ([M] of NaOH) = 0.0013667*0.1 = 0.01367L (converting 
this into ml by multiplying by 1000) =13.67ml. 
 
 
Fatty acid (FFA) 
 
Mw (g/mol) 
 
% composition 
 
Total 
Composition 
16:0 228.37 0.2 45.67 
16:1 256.42 6 1538.52 
18:0 254.4 0.1 25.44 
18:1 284.48 5.6 1593.09 
18:2 282.46 17.8 5027.79 
18:3 280.45 68.7 19266.92 
20:0 178.43 0.2 35.69 
20:1 312.53 0.3 93.76 
22:00 310.51 0.1 31.05 
24:00 340.58 0.8 272.46 
Average Mw of FA - - 279.98 
Average Mw of 
Triglycerides 
 
- 
- 
878.03 
 
Table 5.4: Fatty acid composition and molecular weight of soybean oil [86]. 
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Figure 5.15: Hydrolysis of triglyceride (TG) producing the 2-monoglycerol and 
FFAs 
 
x Calculation Vmax for tributyrin test 
 
The volume of added 0.1 M NaOH reflects the amount of butyric acid released 
from tributyrin lipolysis. The % hydrolysis as a function of time was depicted as 
a measure of the hydrolysis of the TG by the lipase. Since the enzyme 
specifically hydrolyses the ester bonds at 1 and 3 positions (Figure 5.16), 100 
% hydrolysis was determined as when the lipase hydrolysed 3 butyric acid 
molecules per tributyrin using the following equation: 
Maximum volume of NaOH added= X*3/ (MWtributyrin *[NaOH]) , [4.4] 
where: X is the amount of tributyrin in the solution (g) =0.006 g. The factor 3 is 
required since every mole of tributyrin produces 3 moles of butyric acids; MW 
of tributyrin is the molecular weight of tributyrin = 302.36(g/mol); [NaOH] is the 
concentration of NaOH (0.1M). 
With MW of Tributyrin= 302.36; Mass of tributyrin in solution 0.006 (g); Number 
of moles of tributyrin (n) = Mass/MW= 1.984 10-5; Number of moles of NaOH 
(n) = n of tributyrin*3 =1.984 10-5*3= 5.95 10-5; the Vmax of NaOH = number of 
moles*0.1 ([M] of NaOH) = 0.000595L (this can be converted into ml by 
multiplying by 1000) =0.595ml. 
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Figure 5.16: the schematic reaction pathway of butyrin hydrolysis. 
 
 
x Calculation of % hydrolysis for gas chromatography 
 
The area of each peak in Figure 5.14 directly corresponds to the mass ratio of 
individual lipid compounds. In order to have a direct comparison between pH 
stat and GC results, % FFA (w/w) was used instead of % hydrolysis. For GC, 
the % FFA, as a function of time, was depicted as a measure of actual 
hydrolysis. The relative ratio of % FFA detected by pH stat to % FFA 
characterised by GC was interpreted as a measure of FFA solubility in 
aqueous phase. From pH stat method, % FFA (w/w) was calculated as 
follows: first of all, the response factor (RF) was established as it depends on 
type of oil and its composition. The data of each peak (e.g. TG) was then 
normalised by multiplying the area of peak by the response factor which is 1 
for FFA and 1.2 for TG.  % hydrolysis of FFA= [(x0 ± xí)*100/(x0)]. 
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5.3.8 Results 
 
5.3.8.1 Comparison of pH stat and GC hydrolysis data 
 
Figure 5.17 shows a direct comparison of the data from the pH stat 
experiments with the GC data.: The Coarse emulsion in Figure 5.17a shows a 
marked difference between the GC and pH stat calculated hydrolysis where 
the former shows much faster hydrolysis, reaching approximately 60% 
hydrolysis in 20 minutes and up to 80% at the end of the experiment. This is 
approximately a 70% increase in hydrolysis compared to the pH stat 
experiment. The Fine emulsion data is shown in Figure 5.17b and, again, 
there was a big difference in calculated hydrolysis between the 2 methods with 
GC data approximately 65% higher after 2 hours of hydrolysis. The Coarse + 
LBG in Figure 5.17c shows the duplicate data separately since the 2 runs 
could not be averaged due to different sampling times. Both pH stat and GC 
data show slow hydrolysis initially then at approximately 2 hours the data 
diverge with the GC data reaching much higher levels of hydrolysis. At ~5 
hours the pH stat data reaches <10% hydrolysis whereas the GC data 
reaches approximately 90%. The Fine + LBG emulsion (Figure 5.17d) data 
shows that the GC-derived hydrolysis data (orange line) reaches between 70-
80% after 20 minutes then plateaus whereas the pH stat data was again much 
lower in terms of hydrolysis, reaching <25% after 2 hours. There was some 
difference between the GC duplicates which are shown separately, one of 
which seemed to have a longer lag phase than the other. After that point, the 
hydrolysis again shows a rapid increase. Also, it is important to mention that 
the enzyme that was used for this study can only transform 1 TG into 2 FFA, 
so 100% hydrolysis represents 66% FFA in composition, and we have over 
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66% FFA composition which means 100% hydrolysis were achieved for all 
samples. 
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Figure 5.17: % Hydrolysis data from pH stats and GC (a) Coarse Control; (b) 
Fine Control; (c) Coarse +LBG; and (d) Fine +LBG. 
 
 
5.3.8.2 Tributyrin hydrolysis data 
 
Figure 5.18 shows the raw data from the pH stat experiments using tributyrin: 
in Figure 5.18(a1) and Figure 5.18(a2) the data for the emulsion without LBG 
shows an initial fast hydrolysis followed by a step-like gradual increase 
throughout the 100 minute run. The raw data of the pH stat experiment for 
tributyrin + LBG are shown in figure 5.18(b1), with again an initial rapid 
hydrolysis followed by a step-like process.  One of the two runs for the 
tributyrin + LBG experiment was terminated before the end point due to limited 
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time for the experiment to complete; therefore the two runs are showed 
separately.  
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Figure 5.18:  (a1) an example of raw pH stat for tributyrin; (a2) calculated % 
hydrolysis data from pH stats for Tributyrin; (b1) an example of raw pH stat for 
tributyrin+LBG; and (b2) calculated % hydrolysis data from pH stats for 
tributyrin+LBG; 
 
 
 
5.4 In vivo pilot studies without thickener 
 
Having observed and characterised the fat emulsion systems in vitro the next 
logical step was to run small scale pilot studies in vivo using MRI. This was 
done with a view to gathering information on the gastrointestinal response to 
the fat emulsion meals and also to build experience on MRI and optimise 
methods and protocols. The pilot study was also used to gain experience with 
the 13C breath analysis. 
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Two healthy volunteers were used for this first pilot study. Each of them 
attended on two separate mornings, having fasted overnight. On each 
occasion their abdomens were imaged at 3T at baseline (fasted). Having 
completed the baseline scanning; the volunteers were asked to drink 300 ml of 
a flavoured 20% sunflower oil fat emulsion (Fine or Coarse) labelled with 
100mg 13C-triolein. The volunteers therefore consumed 60g SFO in total. 
After this, the postprandial scanning was carried out and they were 
imaged at intervals for up to 6 hours with a range of 1H MRI sequences (e.g. 
T1 and T2 weighted, water selective and fat selective images) to follow the 
journey of the emulsion meals along the GI tract. Additionally, breath samples 
were collected (2 at baseline and after feeding every 15 min for 6 hours) to 
measure the absorption and excretion of the label compound (100mg 13C-
triolein). These breath samples were analysed using an IRIS®-Lab analyser 
(Wagner Analysen Technik, Bremen, Germany) calculating the change in 
delta over baseline 13CO2/12CO2 ratio in the breath samples from baseline and 
plotting it against time. From these breath-test time curves it will be possible to 
calculate the areas under the curve, the time to peak and the initial slope. This 
is of interest because the arrival of the 13C label in the breath of the subjects is 
a marker of digestion and absorption of the label in the fat. Differences in 
digestion caused by the different droplet sizes should reflect in differences in 
13C label appearance in the breath. 
 
 
5.4.1 Gastric emptying 
 
Examples of the MRI images of the meal in the stomach of a volunteer are 
shown below in Figure 5.19. The water images are 3T axial TSE images 
(Echo time TE 59 ms, TR 1511 ms, 3 stacks of 15 slices with no gap between 
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them, reconstructed resolution 0.78x0.78x7mm3). The fat images are 3T, T1 
weighted 3D FFE images (Echo time TE 3.6 ms, TR 9.9 ms, 64 slices with no 
gap between them, reconstructed resolution 0.63x0.62x2.5mm3). These show 
that the Fine emulsion remained stable in the stomach up to 4 hours, whereas 
the course emulsion creamed up in the stomach forming two layers (water at 
the bottom and fat on the top), which is in good agreement with the in vitro 
stability data shown at the beginning of this chapter. 
 
2h
4h
WaterFat Fat
FINE COARSE
 
Figure 5.19: Example water and fat-selective MRI images from one of the pilot 
study subjects, acquired 2 hours and 4 hour after feeding. The panel (a) on 
the left is from the Fine emulsion meal and the panel (b) on the right from the 
Coarse emulsion meal.  
 
The MRI gastric volume measurement in this thesis was done using balanced 
turbo field echo (bTFE) sequences. The gastric emptying/volume were 
processed using the Analyze9 software (MayoClinic, Rochester, MN, USA) by 
manually drawing around the contents of the stomach as regions of interests 
(ROI) and summing them. The final stage of data processing was done using 
Microsoft Excel to present the time courses graphically. The initial gastric 
emptying pilot data points for this study are shown in Figure 5.20. Although 
very preliminary, from this data it can be seen that the Coarse emulsion 
emptied faster than the Fine emulsion, with a large portion of the fat emulsion 
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meal remaining in the stomach 4 hours after feeding. This is might be due to 
the Coarse emulsion creaming up in a layer on the top of the stomach and/or 
to droplet size effect of interest. 
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Figure 5.20: Gastric volumes for the two emulsions systems. No error bars 
are shown as only n=2. 
 
 
 
 
 
 
 
 
 
Chapter 5 ± Development work  
100 
 
5.4.2 Gallbladder contraction 
 
 
Figure 5.21: In vivo data about gallbladder contraction. 
 
The gallbladder contracted in response to both fatty meals as shown in Figure 
5.21 and Figure 5.22. The imaging sequence is the same TSE sequence as 
detailed for water images in the previous page. This is due to the release of 
CCK from mucosal cells which causes gallbladder contraction and releases 
the bile salt through the duct. The gallbladder seemed to respond differently 
for the two emulsions with the Coarse emulsion showing a smaller % 
gallbladder contraction. The % gallbladder contraction was calculated as [1 - 
gallbladder volume at time t / gallbladder volume at baseline] x 100 expressed 
in %. 
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Figure 5.22: Average % gallbladder contraction. No error bars are shown as 
only n=2. 
 
5.4.3 Small bowel water content 
The small bowel water contents were calculated by using a method developed 
in this group [5] and showed substantial inflow of liquid into the small bowel 
(Figure 5.23). The Fine emulsion generated more SBWC than the Coarse 
emulsion as shown in Figure 5.24. The sequence was a coronal RARE 
sequence (Echo time TE 400 ms, TR 1511 ms, 2 stacks of 11 slices with no 
gap between them, reconstructed resolution 0.78x0.78x7mm3). There was a 
difference in initial baseline volumes of the order of 100 ml which makes the 
interpretation of differences between emulsions more difficult. The sources of 
the small bowel water content are normally considered to be a combination of 
gastric fluid, gallbladder secretion, pancreatic and small intestine fluid 
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secretions. Therefore there is a considerable amount of fluid/water fluxes 
through the small intestine which occur during the digestion of this kind of fat 
emulsion meal. 
 
 
Figure 5.23: Series showing the small bowel water contents for both subjects 
fed the Fine and the Coarse fat emulsions. 
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Figure 5.24: Graph to show how small bowel water content changes with 
time. No error bars are shown as only n=2. 
 
To rule out a systematic effect from the emulsifier Tween20 on enhancing 
small bowel water content a separate experiment feeding the meal system 
without the fat was carried out. Both the samples were prepared using the 
methods used for the Coarse emulsion formulation, although there was no fat 
added. A control sample with no fat and no Tween20 was also prepared. Two 
healthy volunteers were used in this pilot study where each one of them 
attended on two separate mornings, having fasted overnight. On each 
occasion their abdomens were imaged at 3T at baseline (fasted) and after 
drinking flavoured Tween20 and non-Tween20 formulations respectively. 
This showed some presence of water in the small bowel, but not as a 
high volume as that observed in the study using fat and no difference between 
the drink with and without the emulsifier. Therefore, it was concluded that the 
high volume of SBWC was predominantly due to an effect of the emulsified 
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fat, with a greater effect for the Fine emulsion and not to an unknown effect of 
the emulsifier on its own. 
Figure 5.25 shows an example HASTE MRI image (a) which indicates the 
content of stomach and coronal RARE image (b) at 3T to show the SBWC. 
The gastric emptying was fast as predicted due to the lack of fat as shown in. 
Figure 5.26. The mean small bowel water content volume (SBWC) 
measurements are shown in Figure 5.27. The SBWC is low (order of 50-
100ml) compared to the values observed with the fat emulsions. Therefore it 
was concluded that the high volume of SBWC observed using the fat 
emulsions was predominantly due to an effect of fat on digestion with only a 
limited contribution from the bulk solution containing surfactant.  
 
 
Figure 5.25: Example transverse HASTE MRI image (a) to show stomach 
contents and coronal RARE MR images (b) to show small bowel water 
contents. 
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Figure 5.26: Gastric emptying for Tween20 emulsifier formulation with no fat 
and control sample with no fat and no Tween 20. No error bars are shown as 
only n=2. 
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Figure 5.27: Small bowel water content for Tween20 emulsifier formulation 
with no fat and control sample with no fat and no Tween 20. No error bars are 
shown as only n=2. 
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5.4.4 13C breath test 
 
The 13C breath test results (Figure 5.28) showed that the label materials were 
absorbed, metabolised and became detectable in the breath, but the data 
appeared to be particularly noisy. It was found that unfortunately the IRIS 
machine was not calibrated correctly when this set of samples was analysed 
and one of the series (subject 02 Fine emulsion) was not run correctly for this 
technical reason so this comparison was inconclusive, however this technical 
problem was detected and solved for future analyses.  
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Figure 5.28: Graph to show the changes from baseline of the ratio of 13C to 
12C in the breath samples. 
 
 
5.4.5 Introducing a gum stabiliser in the emulsion 
 
The pilot studies showed a possible effect of droplet size on gastrointestinal 
physiology but the observed creaming of the Coarse emulsion introduces a 
confounding factor. In order to investigate the role of droplet size one needs to 
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make both fat emulsions equally spatially stable in the stomach in terms of 
spatial distribution so that, for example, differences in gastric emptying may 
not be caused by simple layering [26].  One solution is the use of a food 
thickener in order to avoid the creaming effect.  
A wide range of stabilizers or thickeners was considered to select the most 
appropriate. The thickeners that were looked at included Guar Gum, Citrus 
fiber and Locust Bean Gum (LBG) which all commonly added to foods. The 
aim was to obtain emulsions that are minimal thickened but spatially stable 
throughout the gastric emptying process. The choice fell on locust bean gum 
(LBG). Stability tests were carried out as detailed in section 5.3 suggesting 
that 0.5% was an optimal concentration to improve emulsion stability without 
making the solution too thick to drink. Another small pilot study was carried out 
using 0.5% LBG thickener in the bulk phase of the fat emulsion. The 
hypothesis was that addition of LBG makes the spatial distribution of a fat 
emulsion in the stomach more homogeneous (i.e. preventing creaming) which 
in turn also will enhance the gastrointestinal and satiety responses.  
 
5.5 In vivo scouting pilot with thickener 
 
For this purpose a Coarse and Fine droplet size oil in water emulsions 
containing 20% SFO and 0.5% LBG as a thickener were prepared. To obtain a 
Fine emulsion with LBG the emulsion is passed through the Microfluidizer 
once, with a pressure of 2.6 bar at the inlet, which corresponds to 606 bar in 
the interaction chamber. Microbiological clearance was obtained for 
refrigerated storage up to 2 weeks. An in vivo pilot study was carried out. Two 
healthy volunteers visited on two separate occasions to consume 300 g of the 
emulsions. Gastric emptying, gall bladder contraction and small bowel water 
content were measured and compared to the previous pilot study (emulsions 
Chapter 5 ± Development work  
108 
 
containing no LBG, Coarse emulsion creamed in the stomach). The timing of 
this protocol was shortened to 3 hours as more emphasis was put on the 
intragastric behaviour of the meals than on later small bowel effects. 
The two emulsions prepared were:  
a) Fine+LBG - 350g o/w-emulsion with 20% sunflower oil (containing 100 mg 
13C-labelled octanoic acid),1% Tween ZLWK ȝP PHDQ GURSOHW size 
with 0.5% Locust Bean Gum 
b) Coarse+LBG - 350g o/w-emulsion with 20% sunflower oil (containing 100 
mg 13C-labelled octanoic acid), 1% Tween ZLWK ȝP PHan droplet 
size with 0.5% Locust Bean Gum 
 
5.5.1 Gastric emptying 
 
The MRI images (examples given in Figure 5.29 a-d) showed that the Coarse 
emulsion containing LBG was stable in the stomach for over three hours in 
agreement with the in vitro results. The gastric emptying for the Coarse 
emulsion with LBG appeared to be faster than for the Fine emulsion (Figure 
5.29e) suggesting that the feedback from the duodenum depends on droplet 
size and that this experimental set up was appropriate to investigate the 
effects of fat droplet size on gastrointestinal responses. 
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Figure 5.29: Example images of the stomach taken 3 hours after the subject 
ingested a Fine emulsion stabilised with LBG (a water and b fat image) or a 
Coarse emulsion stabilised with LBG (c water and d fat image). e shows the  
gastric  emptying curve for fat emulsions stabilised with LBG. No error bars 
are shown as only n=2. 
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5.5.2 Gallbladder contraction  
 
This is expressed as % of baseline volume. The data in Figure 5.30 show 
contraction of the gallbladder but differences between formulations were not 
clearly shown because of small numbers and individual variations.   
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Figure 5.30: % Gallbdder contraction for the fat emulsions with LBG. No error 
bars are shown as only n=2. 
 
5.5.3 Small Bowel water content 
 
Again, a high amount of freely mobile water was observed in the small bowel 
as shown in the images in Figure 5.31 and in the graph in Figure 5.32. The 
Coarse emulsion with LBG showed larger SBWC than that with no LBG 
(though the subjects were different).  
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Figure 5.31:  Example images of the small bowel water content following 
the two different emulsion droplet sizes. 
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Figure 5.32: volume of small bowel water contents (SBWC) curve for the two 
fat emulsions with LBG. No error bars are shown as only n=2. 
 
 
5.6 Discussion 
 
5.6.1 In vitro bench characterisation 
 
The aim of this study was to mimic triglyceride hydrolysis in the stomach and 
observe the performance of the Fine and Coarse fat emulsions. It is well 
documented in the literature that only 10-40 % of lipolysis can be achieved in 
the stomach by the lipase enzyme, where this enzyme is inhibited by 
protonated free fatty acids [48, 50, 63, 87]. This occurs when free fatty acids 
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are produced and dominate the fat droplet interface preventing further access 
of lipase to the lipid substrate [88]. 
The % hydrolysis data obtained from the pH stats method for all 4 emulsions 
showed that the Coarse control emulsion displayed a slower hydrolysis 
compared to the Fine control emulsion.  Similarly the Coarse +LBG emulsion 
showed very slow hydrolysis for greater than 2 hours compared to the Fine 
+LBG emulsion which was rapid. Both Coarse formulations reached 10-15% 
hydrolysis after 4 hours whereas the 2 Fine formulations reached >25% 
hydrolysis after approximately two hours. This indicates that there is a droplet 
surface area (size) effect on fat hydrolysis where the smaller droplet size 
hydrolyses faster than a larger droplet size. There are a number of studies 
showing that the droplet sizes of fat emulsion can influence triglyceride 
hydrolysis [63, 89, 90]. Similarly, Armand and co-workers [91] reported that 
their Fine emulsion changed its droplet size by 10 fold after digestion, whereas 
the Coarse emulsion did not change.  
The pH stat data also showed that the LBG has a more significant effect on 
hydrolysis of the Coarse emulsion compared to the Fine emulsion. The 
duplicate data for the Coarse + LBG samples showed negligible hydrolysis for 
the first 2 hours whilst the duplicate runs for the Fine +LBG samples behaved 
very differently. There was a small (more noticeable for one of the duplicates) 
lag phase for both Fine +LBG duplicates, but overall the hydrolysis was rapid 
and behaved more or less like the Fine control emulsion. Although LBG 
addition appears to be able to slow the hydrolysis of an emulsion with reduced 
surface area, it has negligible effect on meals with large surface area. As both 
Coarse meals (with and without LBG) underwent less gastric hydrolysis 
compared to Fine counterparts, it can be concluded that there was an overall 
droplet size effect as well as the addition of LBG effect in reduced surface 
area emulsions only.  
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For all emulsions, the GC data showed much higher hydrolysis than the pH 
stat data (between 10-30% hydrolysis was achieved for pH stat), where 60-
80% hydrolysis was achieved within the first hour for all formulations except 
the Coarse +LBG where only approximately 10% hydrolysis was achieved.  
The maximum % hydrolysis achieved from GC data were 87 % for Fine +LBG 
emulsion, 92% for Fine control emulsion; 78% for Coarse control emulsion (all 
for first hour) and 91% for Coarse with LBG emulsion (at 5th hour). The 
maximum % hydrolysis was achieved within first hour for all meals except the 
Coarse with LBG which was 91% at 5th hour. Again, this suggests that both 
the LBG and the reduced surface area of the Coarse emulsion resulted in a 
reduction in lipid hydrolysis. Both Fine emulsions (with and without LBG) 
showed a rapid hydrolysis and this may have been due to its greater surface 
area compared to the Coarse formulations.  
However, the Coarse emulsion with LBG showed a period of limited activity or 
³ODJSKDVH´7KHHPXOVLRQVZLWKELJJHUGURSOHWVL]Hs have less surface area 
compared to the Fine formulations, which have larger surface areas, therefore 
less surface area for enzyme, less enzyme-substrate interaction and ultimately 
less hydrolysis.  
 
It was possible to get more than 66 % FFA as FA chains on monoglyceride 
can migrate from ester position 2 to 1 leading to higher hydrolysis. Dependant 
on their solubility (or hydrophobicity) fat or lipids may be in different phases 
and thus the hydrolysis measured using different techniques may depend on 
which phase particular fat/lipids exist in a mixture. The pH stat only titrates the 
FFAs that are in the aqueous phase and titratable by NaOH[53]. Pregent and 
colleagues (Personal Communication, 2011) have previously shown that the 
amount of FFA in the aqueous phase depends on the pH of the solution and 
that in the gastric condition used here (about pH 6) only about 30 % hydrolysis 
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is recorded because the rest of the FFA is in another phase, probably in the 
oil, or in lamellar phase [48, 92, 93]. This explains that pH stat data 
underestimates hydrolysis due to limited solubility of FFAs in aqueous phase 
and GC represents true hydrolysis obtained.  
These experiments were very interesting and showed that droplet size was the 
main factor influencing lipid hydrolysis with the presence of LBG only 
influencing hydrolysis of emulsions with reduced surface area. These gastric 
model experiments can be used to help explain in vivo results.  
In order to eliminate the possibility that LBG did not bind to the enzyme, 
thereby reducing its efficacy, the tributyrin test was used. This was a 
solubilised lipid substrate, hydrolysed with and without LBG. Since both results 
were similar this suggests that LBG did not bind to the lipase reducing 
tributyrin hydrolysis (tributyrin hydrolysis produces 3 butyric acid molecules 
plus 1 glycerol molecule). Therefore, the tributyrin data (soluble lipid substrate 
i.e. not emulsion droplets) did not show a clear effect of LBG in hydrolysis of 
tributyrin so the effect was probably at the emulsion droplet surface. 
 
5.6.2 In vivo pilot MRI studies 
 
The purposes of this pilot study were to gain information on the intragastric 
behaviour of the two fat emulsion systems and to start assessing the 
physiological responses to them in healthy volunteers. The number of subjects 
studied was necessarily very small but the insights provided proved very 
useful for the planning for the subsequent work. The two emulsions seem to 
trigger a diverse gastrointestinal response which affected gastric emptying 
(Fine slower), gallbladder contraction (Fine greater) and small bowel secretion 
(Fine greater). A suspicion that the observed strong small bowel secretory 
responses could be caused by the emulsifier (Tween20 surfactant) used was 
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ruled out by carrying out pilot experiments in vivo using the same ingredients 
and preparation methods but no fat. The pilots were very informative. The fat 
emulsions provided good images in vivo. The pilot studies also indicated the 
need to stabilise the fat emulsions intragastrically so that the true effect of 
droplet size could be assessed. The gum-stabilised fat emulsion meals were 
minimally thickened and appeared stable throughout the gastric emptying 
process. 
 
5.7 Conclusion 
 
The pilot studies on the bench and in vivo supported the initial hypothesis that 
there is an overall droplet size effect on gastrointestinal responses to emulsion 
meals. Although carried out in only two subjects the data informed the 
direction of the subsequent work which investigates the droplet size effect in 
more depth in the next chapter. 
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6 Effect of fat emulsion intragastric 
stability and droplet size on 
gastrointestinal responses  
 
 
 
This chapter describes a study aimed to monitor, in the gastrointestinal tract, 
the physiological effects of fat droplet size and intragastric stability by the 
combined use of magnetic resonance imaging and spectroscopy. The 
conclusion was that manipulating food microstructure, especially intragastric 
stability and fat emulsion droplet size, can influence human gastrointestinal 
physiology and satiety responses.   
 
 
6.1 Background 
 
 The information gathered from the pilot studies described in the previous 
Chapter was valuable and indicated that changes in fat emulsion droplet size 
seem to affect the gastrointestinal response. A hypothesis that the observed 
strong small bowel secretory responses could be caused by the emulsifier 
(surfactant) used to keep the fat emulsions together was ruled out by carrying 
out further pilot experiments in vivo using the same ingredients and 
preparation methods but no fat.   
 At this point, from the bench work and the MRI images of the stomach it 
was clear that the fat in the Coarse fat emulsion meal tended to cream 
upwards more than the Fine emulsion. Therefore this introduced a 
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confounding variable since the output from the stomach and, in turn, 
gastrointestinal and satiety responses, could be modulated by either 
intragastric creaming or droplet size. To control for this problem, together with 
colleagues from Unilever, development work was carried out to select the best 
possible thickener. The integration of the thickener into both fat emulsion 
meals was planned in order to stabilise the meal against creaming inside the 
stomach hence ruling out this variable for future studies. A wide range of 
properties had to be considered such as purity and solubility; the thickener had 
to be as inert as possible and also leave the droplet size profiles unchanged. 
This in vitro development work, described in Chapter 5, led to the selection of 
Locust Bean Gum (LBG) which is a common food thickener used for example 
in breads and icecreams. LBG was particularly suited to the task since it is 
quite resistant to the acidic environment of the stomach. The Fine+LBG and 
Coarse+LBG fat emulsion meals behaved as desired preventing fast 
creaming of the Coarse emulsion. This was also checked in vivo in the 
stomach in small scale pilot work. For this larger subsequent study the Coarse 
emulsion with no LBG (called Coarse Control) was also used. All this work 
allowed definition of the study design and protocol for the full in vivo study 
which is reported here. 
The aim of this study was to monitor in the gastrointestinal tract the 
physiological effects of fat droplet size and intragastric stability by the 
combined use of MRI and MRS. 
The main hypothesis was that a difference in oil droplet size of fat 
emulsion meals will modulate gastrointestinal handling of the fat emulsion as 
determined by MRI, MRS and 13C breath test. 
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6.2 Specific methods and protocol 
 
6.2.1 Fat emulsions 
 
The three fat emulsions prepared were:  
a) Fine+LBG - 350g o/w-emulsion with 20% sunflower oil (containing 100 mg 
13C-labelled octanoic acid)7ZHHQZLWKȝPPHDQ
droplet size with 0.5% Locust Bean Gum 
b) Coarse+LBG - 350g o/w-emulsion with 20% sunflower oil (containing 100 
mg 13C-labelled octanoic acid), 1% Tween 20, wiWK ȝP
mean droplet size with 0.5% Locust Bean Gum 
c) Coarse Control (without LBG) - 350g o/w-emulsion with 20% sunflower oil 
(containing 100 mg 13C-labelled octanoic acid), 1% Tween 
 ZLWK ȝP PHDQ GURSOHW VL]H ZLWKRXW DQ\ /RFXVW %HDQ
Gum 
 
The predicted behaviour in vivo is represented schematically in Figure 6.1 
below with the black dots representing fat droplets in the emulsion within the 
gastric lumen. 
The fat emulsion meals were prepared in the Unilever Food laboratory 
(A104A) in Building 50 of Unilever Discovery Colworth. All ingredients and 
suppliers obtained Unilever Safety and Environmental Assurance Centre 
(SEAC) approval (reference number for this study was no 95724). The 
preparation procedures follow multiple checklist and Standard Operating 
Procedures (SOPs) and HACCP (Hazard Analysis and Critical Control Points) 
which were designed specifically for this study and were supervised by the 
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studentship collaborators there. Each emulsion had a unique identifier number 
and its preparation was recorded in a specially designed checklist. 
Following the meal preparation, SOPs guaranteed that all prepared meals 
were free from microbial contamination for up to the expiry date from their 
prepared time as determined by the Microbiology department of Unilever 
Colworth.  
An initial microbiology storage trial was carried out and this indicated the 
storage conditions and allowed length of storage limitations (i.e. expiry date of 
4 weeks) to be adhered to. The emulsions were stored in a food grade fridge 
in the experimental kitchen room next to the MRI scanner and used within the 
expiry date. The temperature of the storage fridge was monitored routinely 
and the values logged in the Trial Master File. The acceptable range was 
5±3°C. 
 
Fine emulsion 
with LBG
Coarse emulsion 
with LBG
Coarse emulsion 
control
 
Figure 6.1: Schematic diagram of the predicted behaviour in the stomach of 
the three fat emulsion meals. The black dots represent the fat droplets, small 
for Fine emulsion and large for Coarse emulsion. 
 
 
The droplet sizes were assessed for each sample (not batched, each sample 
was prepared individually and characterised individually for inclusion/rejection 
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from the study) as soon as they were prepared. LBG (0.5% w/w) was added 
into each of the Fine and the Coarse emulsions to stabilise the coarse 
emulsion and unify the Fine with the Coarse, therefore the viscosity of each 
meal including the Coarse control were obtained. The flavouring was added to 
improve palatability (1% coffee flavouring and 5 tablets of Hermesetas Gold 
sweetener.  
The acceptable range of droplet size was 0.3- ȝP IRU the Fine emulsion 
and 6-ȝPIRUWKHCoarse emulsion. The measured D[3,2] range for droplet 
sizes for Fine+LBG emulsion was 0.402-0.389 (SD 0.0071), for the 
Coarse+LBG was 6.95-6.54 (SD 0.12) and for the Coarse Control was 7.5-
5.58 (SD 44). The data for the droplet sizes measured for these emulsions are 
tabulated in Table 6.1. 
Fine+LBG Coarse+LBG Coarse Control
Measurements Mean (micron) Standard deviation (+/-) Mean (micron)
Standard 
deviation (+/-) Mean (micron)
Standard 
deviation (+/-)
D [3, 2] 0.44 0.04 6.3 0.4 6.0 0.9
D [4, 3] 0. 7 0.1 9 4 15 1
D(0.5) 0.52 0.06 7.0 0.5 14 1
 
Table 6.1: Summary of laser diffractometry data for Fine+LBG, Coarse+LBG 
and Coarse Control emulsions. The table reports the emulsion droplet size 
using the most commonly reported measures: D[3,2] (the surface area mean 
diameter), D[4, 3] (a volume mean diameter) and D[0,5] (a mass median 
diameter). 
 
 
6.2.2 Subjects 
 
Nineteen healthy volunteers aged 19-32 years, of normal height/body frame 
(Body Mass Index, BMI, 23±3 kg/m2) with no history of GI disease were 
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recruited from the University of Nottingham campus and asked to attend on 3 
mornings each having fasted overnight. Details of the demographic data are 
given below in Table 6.2.  
Initial baseline MRI scans were acquired and then the volunteers were given 
300g of one of the 3 fat emulsion meals (60g fat in each meal) in random 
order. Scanning was performed hourly for 5 hours afterwards. 11 out of 19 
subjects entered the final analysis. Equipment failure of the fridge where the 
test meals were stored meant that a batch of meals was inadvertently frozen 
causing 4 volunteers to be excluded. 2 subjects withdrew after the first visit 
whereas the other 2 completed 2 ways and could not make the 3rd visit 
appointment due to a change in their diary. The test meals were given to the 
volunteers following a latin square randomisation schedule to avoid order 
effects.  
 
N 
 
Age yrs (sd) 
min-max 
 
Height m (sd) 
min-max 
 
Weight kg 
(sd) 
min-max 
 
BMI 
kg/m2(sd) 
min-max 
 
19 
 
24 (3) 
19-32 
 
1.7 (0.1) 
1.49-1.91 
 
71 (13) 
50-102 
 
23 (3) 
19-30 
 
Table 6.2: Demographic data for the volunteers 
 
The study was approved by both the University of Nottingham local 
Medical School Research Ethics Committee and Unilever Critical Functional 
Capabilities Clinicals department. ThH VWXG\ UHFRUGV ZHUH NHSW WR D µ*RRG
&OLQLFDO 3UDFWLFH¶ OHYHO RI D SKDVH  GUXJ FOLQLFDO WULDO UHVXOWLQJ LQ 9 Case 
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Report Forms and 4 large lever arch file folders, which were formally 
monitored by a Unilever representative who was not involved in this study. 
The records kept passed the monitoring session. All subjects gave written 
consent prior to any examination. 
Volunteers were scanned when they arrived at the test centre to 
ensure an empty stomach and to acquire fasting baseline measurements of 
small bowel water content, All volunteers were asked to consume one meal of 
each type on 3 separate occasions. All meals were provided to the volunteer 
at a physiological temperature of 37ºC to avoid rapid changes in relaxation 
times due to changes in temperature within the stomach. Volunteers were 
WLOWHG VOLJKWO\ RQ WKHLU ULJKW KDQG VLGH WR HQFRXUDJH QRUPDO ³XSULJKW´ JDVWULF
emptying profile since previous research had shown that lying with the left side 
down (left lateral position) allows some fat of an oily meal to be delivered to 
the duodenum early resulting in delayed gastric emptying of the entire meal 
[85]. Volunteers were then given the test meal and they were then scanned 
every hour, for approximately 15 minutes, for five hours after the beginning of 
the meal ingestion. After each set of scans satiety visual analogue scores 
(VAS) were collected. At regular intervals (at baseline and, after feeding, every 
15 min for 2 hours and subsequently every 30 min for up to 5 hours) the 
subjects were asked to blow in 13C breath test bags which were stored for 
analysis. These breath samples were analysed using an IRIS®-Lab analyser 
(Wagner Analysen Technik, Bremen, Germany) calculating the change in 13C 
breath signal from baseline and plotting it against time. 
 
6.2.3 MRI methods 
 
MR data were acquired using the Philips 1.5T Achieva whole body scanner 
and the SENSE-body coil. A range of abdominal scans were acquired in ~15 
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minutes: bTFE to quantify gastric volumes: 40 transverse slices, 7 mm thick, 
acquired in 2 breath-holds 13 s acquisition time each, covering the whole 
abdomen, flip angle=80o, TR/TE 2.8/1.4 ms FOV=400 mm, in plane resolution 
1.56x1.56 mm2, SENSE factor 2.0. Proton spectroscopy was acquired using 
STEAM (90ox90ox90o), TR 4s, TE 9ms, 2 dummies, voxel size 25x25x25 mm3, 
spectral bandwidth 1000 Hz, 512 samples, 4 repeats acquired in 24 s; 
acquired separately for 2 VOIs in the upper (top) and lower (bottom) parts of 
the gastric lumen corresponding to different components of the gastric 
contents due to layering in the supine position were identified on the bTFE 
images. The areas of the water and fat peaks were measured using in-house 
software written by Dr Mary Stephenson in Matlab®, and lipid/water ratios 
were calculated. To measure Small Bowel Water Content (SBWC): 24 coronal 
FSE images in a single breath-hold, in-plane resolution =1.56x2.83 mm2, SL=7 
mm, with no gap between slices. The gastric and gallbladder volumes were 
calculated by using Analyze® software (Analyze9®, Biomedical Imaging 
Resource, Mayo Foundation, and Rochester, MN), where the volumes of 
individual regions of interest on individual slices were summed across. SBWC 
data were analysed with in-house methods and software developed by Dr. 
Caroline Hoad [5]. 
 
6.2.4 Blood sampling 
 
The volunteers were cannulated in a forearm vein by a qualified research 
nurse. 9 serial (6.5ml each) blood samples were collected during the study day 
to correlate the MRI results with the relevant gut peptide CCK. CCK is one of 
the most likely candidates to mediate effects of fat on satiety. Its release 
correlates with immediate satiation; CCK antagonists inhibit post-prandial 
satiety and CCK alters taste preferences. The blood was immediately 
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separated and the plasma snap-frozen in liquid nitrogen. CCK plasma levels 
were measured using commercial radioimmunoassay by Dr Gulzar Singh in 
the UoN School of Biomedical Sciences. 
 
6.2.5 Objective pasta meal 
 
Satiety was also measured objectively using an ad libitum weighed pasta meal 
buffet at the end of the study day. This is a standardized tomato and 
mozzarella pasta meal (purchased ready-PDGHIURP6DLQVEXU\¶VVXSHUPDUNHW
and heated using a microwave). The subjects are given a very large amount of 
pasta .JVRWKDW WKH\ZLOOQRW IHHODVPDOO µSODWHVL]H¶HIIHFWDQGWROG WR
eat as much as they feel like. The final amount of pasta left over is weighed 
therefore yielding the real amount of food eaten to satisfaction. The pasta meal 
provides 127 kcal per 100 g (4.9 protein, 18.2 g carbohydrate and 13.8 g fat). 
This method has been used extensively in Unilever. The volunteers were 
presented with a very large amount of pasta (1.2 kg) and asked to eat as much 
as they felt like, with the remaining amount weighed again. 
 
6.2.6 Statistics 
 
Statistical significance of differences was evaluated where appropriate using 
2-way repeated measures ANOVA, 2-way repeated measures ANCOVA 
(analysis of covariance for the satiety VAS scores), 1-way ANOVA of the 
Areas Under the Curves (AUCs) followed by post-hoc individual t-tests 
corrected for multiple comparison or paired t-test. The software GraphPad 
Prism 5, SPSS and SAS 9.3 were used. 
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6.2.7 Safety and efficacy 
 
The volunteers tolerated well the scanning and blood sampling procedures as 
well as the 3 test meals.  
In terms of safety, all subjects filled in a MRI safety questionnaire on 
enrollment to ensure their suitability for the MRI scanner environment. 
Adverse events (AEs) were defined in the Protocol and monitored throughout 
the study and standard operating procedures (SOPs) were in place to deal 
with them, if any. 
There were two adverse events in this study. One subject complained 
of headache before drinking the test meal. History of migraine was reported 
and this was a minor to moderate event judged to have no link with the study. 
Another subject reported that after the first study day felt nauseous, sweaty 
and had an episode of diarrhoea overnight. The subject was fine the following 
day, did not feel the need to report this immediately and classed this episode 
to us on the second occasion as a moderate severity (score 2). The subject 
was happy to come back for the other study days, which were completed with 
no further events. We classed the episode as possibly related to the study 
procedures (score 2) and took no action (score 1). 
At the beginning of each study day the subjects were also asked a 
standard questLRQ³$UH\RXZHOO"´DQGWKHDQVZHUUHFRUGHGLQWKHFDVHUHSRUW
form (CRF).  
During each study day the investigator was always present and ready 
to monitor how the subjects were feeling in case there was need of any action. 
A medical expert was available to consult if needed. 
This study used food grade fat emulsions as intervention, healthy 
volunteers as subjects and non-invasive magnetic resonance imaging as 
research methods hence the risk assessed by the investigators was very low. 
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In terms of efficacy, fat digestion activates gastrointestinal feedback 
that slows down gastric emptying, a mechanism mediated amongst other 
pathways by the duodenal release of cholecystokin (CCK). The efficacy of the 
test product was therefore assessed on gastric emptying (which was the main 
outcome of the study). This was also an imaging study so it is worth pointing 
out that good quality images of the fat emulsion meals in the stomach were 
obtained.  
 
6.3 Results 
 
6.3.1 Bench checks on the test meals 
 
The Mastersizer laser diffractometer (Malvin Mastersizer 2000 particle size 
analyzer) was used again to analyse the droplet sizes of all individual test 
meals upon preparation since droplet size range was an acceptance/rejection 
criteria for meal preparation in the Unilever laboratory. Figure 6.2 shows the 
droplet size distributions.  
The surface weighted mean D[3,2], which reflects more the surface weight 
rather than volume was used here. The mean droplet sizes for Fine + LBG 
was 400nm, where the Coarse + LBG and Coarse Control were 7 and 8 
microns respectively. The cup and bob geometry (Anton Paar, Physica MRC 
501) consisting in coaxial cylinders configuration, smooth with 17mm 
diameter, was used to check the viscosity of the test meals. 
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Figure 6.2: Example laser diffractometry Mastersizer data for the droplet size 
of the 3 meals. 
 
The cup and bob geometry seemed to provide more reproducible profiles 
compared to other geometries. The duplicates and the data in Figure 6.3 show 
the good reproducibility. Due to sensitivity issues with the low viscosity Coarse 
Control (no LBG) sample, the initial readings at the low shear rate showed a 
number of negative torque values and the rheometer struggled until ~10s-1. 
The Fine + LBG showed slightly higher viscosity at the lower shear rate. The 
Coarse + LBG had slightly higher viscosity at high shear rates compared to 
the Fine + LBG. Turbulent flow is often an issue when using this geometry at 
the high shear rates.  
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Figure 6.3:  shows the rheology data for the 3 test meals, in duplicate. 
 
6.3.2 MRI imaging 
 
Good quality images of the fat emulsion meals in the stomach were obtained 
as shown in Figure 6.4. 
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Figure 6.4: The upper panel shows typical bTFE (water) images taken across 
the stomach of the same subject at time t=2 hours after consumption of each 
test meal on the three separate study days. On the lower panel the 
corresponding fat-only images. These show that the LBG stabilised emulsions 
did not phase separate in the stomach whilst the Coarse Control shows a 
clear creamed fat layer on top of the stomach contents.  
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6.3.3 Gastric emptying 
 
The time courses of mean meal intragastric volumes are shown in Figure 6.5a. 
It can be seen that the Fine emulsion with LBG emptied from the stomach 
slower and the Coarse Control faster. The corresponding mean AUCs are 
shown in Figure 6.5b. Adding LBG to the Coarse control emulsion significantly 
delayed gastric emptying (Coarse+LBG versus Coarse Control p=0.0002). 
Reducing droplet size in the two meals containing LBG significantly delayed 
gastric emptying (Fine+LBG versus Coarse+LBG, p=0.0006).  
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Figure 6.5: shows differences in gastric emptying curves for total meal volume 
(a) and AUC for each meal data (b). * p=0.0006; ** p=0.0002. 
 
6.3.4 Fat/water ratio using MRS 
 
Figure 6.6a shows a typical bTFE image of a fat emulsion in the stomach and 
Figure 6.6b shows a typical water and fat proton MRS spectrum obtained in 
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vivo on the intragastric contents. Figure 6.7 shows the time courses of the 
processed lipid/water ratio MRS data including overall mean for upper voxel 
and lower voxel. The data show no significant difference over time in fat 
content for the Fine + LBG and Coarse+LBG emulsions. Conversely there was 
a significant difference between upper (p=0.0003) and lower (p<0.0001) voxel 
for Coarse+LBG versus Coarse Control with higher fat content in the upper 
voxel. 
 
 
 
 
Upper
Lower
a b
 
Figure 6.6: (a) bTFE images showing creaming of Coarse Control meal and 
typical upper and lower voxels used for the MRS acquisitions; (b) an example 
of typical water and fat peaks from a spectrum acquired in vivo on the gastric 
contents.  
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Figure 6.7: (a1) and (a2) show the time course of lipid/water ratio measured in 
Upper voxels and AUC respectively; (b1) and (b2) show time course of 
lipid/water ratio measured in lower voxels and AUC respectively. * p=0.0003; 
** p<0.0001. 
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Figure 6.8: (a1) and (a2) show the time course of gallbladder volumes 
measured and % contraction respectively; (a2) and (b2) show the respective 
mean AUCs. 
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6.3.5 Gallbladder contraction  
 
The mean gallbladder volumes and % contraction plus their AUCs are plotted 
in Figure 6.8. There were no significant differences between meals. 
 
6.3.6 Small bowel water content  
 
Figure 6.9 shows the small bowel water content images for the 3 tested meals 
and Figure 6.10 the mean SBWC volume time courses with their AUCs.  
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Figure 6.9: 7KHSDQHOVKRZVRQWKHOHIWDFRURQDODQDWRPLFDOµURDGPDS¶GXDO
echo MRI image. The other figures are corresponding small bowel water 
images taken across the small bowel of the same subject at time t=4 hours 
after consumption of each test meal on the three separate study days. These 
show the large amount of freely mobile fluid present in the small bowel in 
response to the fat emulsion meals. 
 
Adding LBG to the Coarse control emulsion significantly increased SBWC 
(p=0.0077). Also, reducing droplet size significantly increased SBWC 
(p=0.0086). The mean time to peak in the SBWC data, simply extracted 
manually from the spreadsheet data, showed a trend to be longer for the 
Fine+LBG meal (4 hours) and than for both the Coarse+LBG and the Coarse 
Control meals (3 hours). 
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Figure 6.10: (a) shows the mean small bowel water content volume time 
courses for the three fat emulsion meals and (b) the corresponding mean AUC 
for SBWC. * p=0.0077; ** p=0.0086. 
 
6.3.7 Plasma cholecystokinin 
 
Figure 6.11 shows the mean CCK plasma level time courses. Adding LBG to 
the Coarse Control emulsion significantly increased plasma CCK (p=0.0274). 
There were no significant differences in plasma CCK between Fine+LBG and 
Coarse+LBG.  
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Figure 6.11: (a) mean CCK plasma data for the three meals and (b) the 
corresponding AUCs. * p=0.0274. 
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6.3.8 Breath test  
 
The mean changes from baseline (tracer appearance in the breath due to 
absorption from the gut and metabolism of the label) and the corresponding 
AUCs are shown below Figure 6.12.  As the graph 6.12a shows, soon after 
ingestion the Delta Over Baseline (DOB) of the 13C-label in the breath 
appeared to be increased for the Coarse Control fat emulsion faster than for 
the LBG-stabilised meals in the first 2 hours. Figure 6.13 shows the 13C label 
T1/2 data across the 3 meals. 
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Figure 6.12: (a) shows mean changes from baseline of the ratio of 13C to 12C 
in the breath samples for the three fat emulsion test meals and (b) the 
corresponding mean AUCs. * p<0.0001. 
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Figure 6.13: The mean T1/2 of the appearance of the 13C label for each of the 
three fat emulsion meals. * p=0.0035. 
 
Adding LBG to the Coarse control emulsion significantly increased the 13C 
label T1/2 (p=0.0035) and reduced delta over baseline (p<0.0001). Also, 
reducing droplet size appeared to increase T1/2 though the change failed to 
reach statistical significance (p=0.127). The delta over baseline appeared to 
be higher for the Fine + LBG emulsion but only after 3 hours post prandially as 
shown in Figure 6.12a. 
 
6.3.9 Satiety questionnaires  
 
The mean data of the fullness, hunger and appetite satiety scores are shown 
in Figure 6.14. 
 Fullness and hunger showed a tend appearing to be higher for the LBG 
containing meals; however, this failed to reach statistical significance (Fullness 
AUC versus Coarse control was p=0.1930 for Coarse+LBG and p=0.1649 for 
Fine+LBG; Hunger AUC p=0.8667 and p=0.6783 respectively). Analysis of the 
satiety VAS data using RM ANCOVA as recommended in the literature also 
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showed no significant differences between meals as summarized in the Table 
6.3 below. 
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Figure 6.14: (a1) and (a2) show the mean visual analogue scale (VAS) 
fullness scores and its AUC respectively; (b1) and (b2) show the mean VAS 
hunger scores and AUC respectively; and (c1) and (c2) show mean VAS 
appetite scores and its AUC respective (standard deviation of the mean). 
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Time 
Time × 
Meal 
Meal 
Fullness 
VAS 
Coarse Control versus 
Coarse LBG 
P<0.0001 P<0.955 P<0.611 
Fine LBG versus Coarse 
LBG 
P<0.0001 P<0.993 P<0.984 
Hunger VAS 
Coarse Control versus 
Coarse LBG 
P<0.0001 P<0.203 P<0.656 
Fine LBG versus Coarse 
LBG 
P<0.0001 P<0.125 P<0.767 
Appetite 
VAS 
Coarse Control versus 
Coarse LBG 
P<0.0001 P<0.264 P<0.907 
Fine LBG versus Coarse 
LBG 
P<0.0001 P<0.492 P<0.657 
Table 6.3: ANOVA results for the satiety visual analogue scores. 
 
 
6.3.10 Objective satiety assessment 
 
Figure 6.15 shows the effects of feeding the 3 fat emulsion meals on a 
subsequent objective pasta meal to assess the satiety. Adding LBG to the 
Coarse Control emulsion significantly reduced the amount of pasta meal eaten 
afterwards (p<0.0293). Reducing droplet size also significantly reduced the 
amount of pasta meal eaten afterwards (p<0.0417). 
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Figure 6.15: shows the mean weight of ad libitum, objective pasta meal eaten 
by the volunteers after they completed the study day for each arm of the fat 
emulsion test meal. * p<0.05; ** p<0.03. 
 
 
 
6.4 Discussion 
 
From the images and the spectroscopy data it can be seen that the LBG 
helped to stabilise the spatial distribution of the fat emulsions intragastrically, 
preventing creaming. This was the desired outcome since creaming of the 
larger droplet size emulsion was one of the limitations demonstrated by the 
previous pilot work. Having obtained an homogeneous spatial distribution in 
the stomach now allowed inferences to be drawn on the effect of droplet size 
on the gastrointestinal and satiety response to fat emulsion meals. 
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The choice of test meals and the study design allow two main effects to be 
investigated: (a) the effect of stabilizing the intragastric spatial distribution of a 
coarse fat emulsion and (b) the effect of decreasing droplet size in a gastric 
stabilized fat emulsion. 
Gastric emptying was faster for the Coarse Control fat emulsion meal, which 
was predicted since creaming of fat to the top of the lumen away from the 
pylorus would lead to delivery to the small bowel of a fat-depleted watery 
phase during early gastric emptying, supported by the CCK data. The LBG-
stabilised meals ensured steady delivery of fat to the duodenum during gastric 
emptying. This would trigger duodenal receptors which form part of the 
feedback loop that slow gastric emptying. Interestingly the Fine+LBG emulsion 
emptied slower than the matched Coarse+LBG emulsion possibly reflecting 
increased activation of duodenal fat receptors by the more finely emulsified 
droplets which therefore present a larger surface area for hydrolysis. This 
however was not reflected in the CCK data, which was likely due to the high 
variability and the relatively small number of subjects. Similar observations 
were reported by Armand et al [63]. The increased viscosity of the LBG-
containing meal may have reduced gastric mixing and slowed enzyme-
substrate interactions. 
The gastric behaviour and gastric emptying response to these fat emulsions 
was analogous to that observed using acid-stable and acid-unstable fat 
emulsions [79]. 
There was substantial inflow of secretion into the small bowel. This was higher 
for the Fine+LBG meal, possibly reflecting again increased small bowel 
stimulation from the higher surface area offered to digestion by the smaller 
droplets. There are many factors driving SBWC and pancreatic secretion. A 
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direct vagal effect is possible or perhaps the coarse emulsion exerts inhibitory 
effects. Fat entering the ileum inhibits pancreatic secretion. 
Initial gallbladder contraction differences which could be expected given the 
different intragastric behaviour of the meals may have been missed because 
of the hourly sampling frequency. 
The 13C breath data also suggested that the different fat emulsion systems 
resulted in differences in availability of the fat to digestion and metabolism.  
Ultimately, the combined effect of these different gastrointestinal responses to 
the test meals resulted in real differences in objective satiety (pasta meal) 
assessment. This is potentially important since it has been shown that small 
reductions in calorie intake can lead to significant improvements in weight 
management in obesity. 
 
6.5 Conclusions  
 
A highly emulsified intragastrically-stable emulsion leads to delayed gastric 
emptying, increased SBWC and reduced consumption of food at the end of 
the study day. Manipulating food microstructure especially intragastric stability 
and fat emulsion droplet size can influence human gastrointestinal physiology 
and satiety responses. 
The work described in this chapter showed the importance of monitoring and 
quantifying fat fraction and spatial distribution in vivo in the gastric lumen to be 
able to relate fat emulsion performance to the gastrointestinal response and 
satiety. There is more work to be done to improve such methods and this is 
the subject of the next chapter using magnetic resonance imaging and 
spectroscopy methods. 
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7 Optimisation of fat quantification in 
vivo  
 
 
This chapter describes the final part of the work. This required a deeper 
insight into the MRI characteristics of the fat emulsion systems including 
relaxometry, dilution, fat fraction quantification and cross-field experiments in 
vitro. Finally, imaging and spectroscopy methods were compared in a pilot 
study in vivo. 
 
7.1 Background 
 
The work described in the previous chapters showed the importance of the 
spatial distribution of fat in the stomach and of the droplet size delivered from 
the stomach to the duodenum as they both modulate gastrointestinal 
responses. The droplet size of a fat emulsion may also change in the stomach 
due to competing processes of coalescence [63] and gastric emulsification 
[87]. It would therefore be desirable to be able to monitor fat spatial distribution 
and fat droplet size in the stomach at different time points during digestion. 
The only method thus far available to assess fat fraction and droplet size is 
nasogastric aspiration, which is an invasive procedure and sampling is 
generally limited to a small volume of gastric contents around the catheter tip. 
Imaging methods would overcome both these limitations. The following two 
paragraphs describe the rationale for making such measurements in more 
detail. 
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7.1.1 Fat fraction quantification and m-DIXON method 
 
Gastrointestinal function and satiety are strongly influenced by the spatial 
distribution of fat. Early studies using radiolabelling of the fat component of a 
meal [94, 95] made it possible to assess gastric emptying of fat with gamma 
scintigraphy [96]. Such studies have provided evidence that the isolated lipid 
component of a test meal empties much more slowly than the aqueous 
component of the meal [94, 95], whilst lipid integrated within the matrix of solid 
food particles empties with the solid phase of a meal [97]. MRI has an 
advantage in that the chemical shift between the resonances of the water and 
the fat protons can be exploited to image fat and water components separately 
by selectively exciting one or suppressing the signal arising from the other 
component. MRI studies have exploited the ability of MRI to discriminate 
between changes in the proton environment of water and fat components of a 
multiphase aqueous and oil meal to measure the emptying rates of oil and 
water components separately and to observe how posture altered gastric 
emptying [85]. When the subject was lying with the right side down, the lipid 
phase was observed to float in the fundus and emptying of the aqueous phase 
was rapid. With the subject lying with the right side up, the lipid layer filled the 
duodenum, where it could stimulate the duodenal receptors, and gastric 
emptying was significantly slower. It was also found that the longitudinal 
relaxation time T1 was relatively insensitive to droplet size and a method to 
assess the fat fraction in an oil-in-water emulsion both in vitro and in vivo 
within the gastric lumen using inversion recovery EPI and a two non-
exchanging compartments empirical model was shown [25]. The intragastric 
behaviour of fat emulsions designed to be stable or break in the acidic gastric 
environment was shown to have an effect on the sense of satiety [23] and to 
stimulate greater cholecystokinin release which was associated with delayed 
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gastric emptying [26] compared to acid unstable emulsions in which the fat 
layer empties after the aqueous phase.  
Established MR-based methods to quantify the fat fraction in a sample are 
magnetic resonance spectroscopy (MRS) and Dixon MR imaging sequences. 
MRS is widely used and validated across peer reviewed literature to determine 
the fat/water ratio of a sample or organ [98-106]. It is based on integrating the 
fat and the water peaks of the frequency spectrum obtained from a small 
volume of interest within the region of interest. We have used this method 
successfully to determine the fat fraction of the fat emulsions in the previous 
study described in Chapter 6. The MRS assessment of fat fraction has an 
inherently poor spatial resolution as the signal is collected from a large volume 
of interest (typically 25×25×25 mm3). Using an imaging method would provide 
fat fraction information at a much higher spatial resolution both in plane and in 
three dimensions on a multislice set. In 1984, Dixon introduced a technique for 
decomposing the fat and water components of the proton signal of a subject 
into two separate images [107]. This exploited the phase shift between water 
and fat signals and acquired two images, one with water and fat in-phase and 
one with opposite phase. By adding and subtracting the two images, water-
only and fat-only images can be obtained. The method is elegant but suffers 
from signal to noise ratio problems, and issues related to shimming problems 
[108, 109]. The DIXON method has been constantly improved leading to the 
latest multi-echo (m-DIXON) methods [110]. The m-DIXON sequence collects 
data when the fat and water signals are in and out of phase. In a single breath 
hold of about 20 seconds the Philips 3D m-DIXON sequence can collect data 
to produce 4 image types using a simple algebraic manipulation: an in-phase 
image, an opposite phase image, a water only image and a fat only image. 
This has a clear advantage over previous methods which had to acquire 2 
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separate breath holds to obtain an in-phase image and an opposite phase 
image first and then a water only image. Unfortunately these fat and water 
images have signal that depends on the T1 and T2  weighing of the sequence 
for both fat and water as well as shimming effects which will change the 
absolute time for on and off resonance signals. 
 
7.1.2 Droplet size measurements 
 
When fat is emptied from the stomach into the small bowel, long chain fatty 
acids trigger active responses from the GI tract [111] and the length and site of 
exposure of the small bowel can influence hunger and food intake [112]. 
However, it is not just the presence of fat that plays a key role in modulating 
WKH*,UHVSRQVHV,QDUHFHQWUHYLHZ*ROGLQJVWDWHGWKDW³7KHVXUIDFHDUHDRI
an emulsion is probably the key physicochemical parameter affecting the rate 
RI IDW GLJHVWLRQ´ [113]. There is substantial evidence supporting this 
conclusion, starting from early studies in a rat model [114]. Increasing the size 
of droplets in fat emulsions delivered directly to the small intestine reduced 
gastric antral pressure waves and attenuated plasma cholecystokinin (CCK) 
and peptide YY (PYY) and reduced hunger and energy intake [115]. 
Emulsified fat delivered, again intra-duodenally, in another study increased 
CCK, pancreatic polypeptide (PP) and gallbladder contraction compared to 
un-emulsified fat [116]. In another key study coarse (10 Pm) and fine (0.7 Pm) 
fat emulsions were delivered intra-gastrically and gastric and duodenal 
aspirates were taken at intervals to measure fat droplet size and lipase 
activities [63]. This showed a marked increase in the stomach in droplet size 
for the fine emulsions (2.75-6.20 Pm) although the fine emulsion retained a 
higher gastro-duodenal lipolysis [63]7KHµGURSOHWVL]HHIIHFW¶FDQEHH[SODLQHG
with the fact that a smaller droplet size for a given mass of fat offers a larger 
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lipid surface area [63]. The increased surface area will allow in turn a higher 
number of lipase molecules to bind at the oil-water interface because lipase is 
generally present in excess [63]. The body of evidence in the literature 
therefore shows the importance of the fat droplet size delivered from the 
stomach to the duodenum and that this may change in the stomach from the 
initial, ingested size due to competing processes of coalescence [63] and 
gastric emulsification [87]. 
It would therefore be desirable to be able to measure fat droplet size in 
the stomach at different time points during digestion, however the only method 
thus far available is nasogastric aspiration, which is an invasive procedure and 
sampling is generally limited to a small volume of gastric contents around the 
catheter tip. 
MRI imaging could provide the solution to this problem. The transverse 
relaxation time T2 will depend on the size and distribution of any microscopic 
susceptibility perturber that gives rise to magnetic field gradients affecting the 
bulk water itself [117-119]. A distribution of fat droplets in solution will do this. 
Hence it should be possible to exploit this mechanism to measure fat droplet 
size. Indeed, an in vitro study showed that it is possible to measure fat droplet 
size non-invasively using MRI by measuring T2. That study used 20% fat 
emulsions with droplet sizes ranging from 3 Pm to 12 Pm. Such measurements 
were in good agreement with predictions from Montecarlo simulations and 
analytical solutions [24].  
Thus far there are no examples in the literature of in vivo intragastric 
fat emulsion fat fraction measurements using m-DIXON nor of fat emulsion 
droplet size measurements in vivo in the stomach using the transverse 
relaxation times T2. 
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Building on the experience and samples described thus far, this 
Chapter describes work to gain familiarity in vitro on the methods and carry 
out an initial assessment in vivo.  
 
7.2 In vitro studies 
 
This in vitro study was divided into 2 main experimental areas: (1) cross-field 
(X-Field) experiments to identify any field effect on the MRI parameters for 
these emulsion and (2) dilution studies, to establish calibration curves for the 
m-DIXON method and to evaluate possible droplet size effects on the 
observables.   
 
7.2.1 Cross field experiment 
 
The relaxation times and also the susceptibility effects of the presence of the 
fat droplets in solution (as perturbers) are expected to be different at different 
static magnetic fields. Hence this study aimed at gaining a preliminary 
experience of these effects using two different magnetic fields (1.5T and 3T) 
and 6 different droplet sizes (for a fixed fat volume). In this experiment 6 
emulsions with different droplet sizes ranging from 0.4 µm to 10 µm (named 
sample A, B, C, D, E and F) were scanned both on the Philips Achieva 1.5T 
and 3T MRI scanners. The sequences run on each sample at both fields were 
T1, T2, MRS and m-DIXON. The sequence parameters were kept as much as 
possible the same both at 1.5T and 3T. The sequence used to measure T1 
was an Inversion Recovery EPI using 15 inversion times from 0 to 4900 ms, 
scan duration was 8.5 minutes with a repetition time TR of 15 seconds and an 
echo time TE of 31 ms. The image resolution was 2mm×2mm×8mm, on a 
single slice acquired with a 96×96 matrix. The sequence used to measure T2 
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was a spin echo EPI using 12 echo times from 31 ms to 600 ms, the scan 
duration as approximately 2 minutes with a repetition time of 3 seconds. The 
image resolution was 2mm×2mm×8mm, on a single slice acquired with a 
96×96 matrix. The m-DIXON sequence was a proprietary Philips 3D TFE 
double echo sequence, scan duration approximately 20 seconds with echo 
time one (TE1) 1.8 ms and echo time 2 (TE2) 4.0 ms and repetition time TR 
5.4 ms (these values changed at 3T as follows: TE1 1.1 ms, TE2 2.4 ms, TR 
3.9 ms). The image resolution was 1.49mm×1.95mm×3mm with 65 slices 
acquired in one average. The data were subsequently reconstructed to water 
only, fat only, in-phase and out of phase images automatically on the Philips 
platform. 
 
Samples Droplet size (µm) 
A 0.42 
B 0.55 
C 2.25 
D 7 
E 8 
F 10.25 
 
Table 7.1: The droplet sizes of the six 20% fat emulsions that were scanned in 
vitro. Data on T1,T2, MRS and m-DIXON was acquired for each sample A-F at 
both at 1.5T and 3T. 
 
 
These emulsions were prepared using the same methods described in Section 
5.2 and characterised by Malvern Mastersizer in order to measure their droplet 
size accurately. The differences in droplet sizes are simply obtained by 
varying the homogenising times. 
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7.2.2 Dilution experiment 
 
In this experiment, batches of two emulsions with different droplet sizes (Fine 
and Coarse as described previously) were progressively diluted to lower fat 
fractions as described in Table 7.2. These samples in vitro were scanned both 
on the Philips Achieva 1.5T and 3T MRI scanners. In an initial series of 
experiments only 2.5%, 5%, 10% and 20% fat samples were used. In a 
VHFRQGVHULHVRIH[SHULPHQWVWHUPHGµUHSHDW¶ WKHDQGVDPSOHV
were also prepared after initial results showed it would have been beneficial to 
have additional data points in that range. The sequences run on each sample 
at both fields were T1, T2, MRS and m-DIXON as detailed above. 
 
 
Fine emulsion 
samples 
Coarse 
emulsion 
samples 
Emulsion fat 
content (%) 
G O 20 
H P 12.5 
I Q 10 
L R 7.5 
M S 5 
N T 2.5 
 
Table 7.2: The % fat content of the six progressive dilutions of fat emulsions 
prepared for both Fine and Coarse emulsions. Data on T1, T2, MRS and m-
DIXON was acquired for each sample G-N at both at 1.5T and 3T. 
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7.3 Results in vitro 
 
7.3.1 Cross-field T1 relaxation 
 
Figure 7.1 shows a comparison of two different T1 sequences ProSet_watsat 
and ProSet_fatsat on both emulsion (Fine and Coarse) at 1.5T. The MRI 
sequence and scan parameters are the same as detailed above using a 
standard inversion pulse but using in the EPI readout a spectrally selective 
pulse to excite only the fat or water protons. This was set to be a 1-2-1 
binomial pulse. The fat suppressed sequence showed high T1 for both 
samples and lower T1 was recorded for water suppressed sequences with no 
apparent effect of fat concentration. 
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Figure 7.1: T1 values measured in vitro at different fat fractions from Coarse 
and Fine emulsion samples at 1.5T using two different T1 sequences at 1.5T. 
 
 
T1 relaxation showed an apparent effect of static magnetic field in that the 
Coarse and Fine T1 values were apparently higher at 3T than for 1.5T. No 
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effect of droplet size could be inferred from the data as shown in Figure 7.2 
because the Coarse and Fine T1 values were in opposite directions for the two 
fields, probably due to experimental error (maybe temperature differences). 
No statistical analysis was attempted as n=1 for each fat %.  Also, the T1 
relaxation times for these emulsion samples were apparently higher at lower 
field (1.5T) than at higher field (3T).  The field effect on T1 is consistent on 
both Fine and Coarse emulsions. This data includes signal from both water 
and fat, so the reduction in T1 at high fat fraction is probably due to 
multiexponential relaxation and being fitted as a shorter T1. Also, the fat signal 
may be suppressed in smaller droplets due to field inhomogeneities. 
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Figure 7.2: T1 values measured in vitro at different fat fractions from Coarse 
and Fine emulsion samples at 1.5T and 3T. 
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7.3.2 Cross-field T2  relaxation 
 
There were both apparent field effects as well as apparent droplet size effects 
on T2 relaxation as shown in Figure 7.3. The Fine emulsion showed a longer 
T2 compared to the Coarse emulsion at both 1.5T and 3T. The field 
dependence of T2 seemed to be greater for the Fine emulsion than for the 
Coarse. This was a n=1 sample for each dilution point so no statistical 
analysis was attempted. 
Figure 7.4 shows that T2 was high for small droplet sizes at 1.5T (order 
of 2000 ms) but it was reduced by approximately a factor of 4 to the order of 
500ms for droplet sizes greater than 3 microns. There was no further variation 
for droplet sizes larger than 3 microns.  
There seemed to be also a field effect on T2 relaxation times with T2 
values of the various emulsions consistently higher at 1.5T as one would 
expect because of reduced field distortions due to susceptibility effects.  
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Figure 7.3: T2 values measured in vitro at different fat fractions from Coarse 
and Fine emulsion samples at 1.5T and 3T. 
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Figure 7.4: T2 values measured in vitro for different droplet sizes at 1.5T and 
3T.  
 
 
7.3.3 Cross-field m-DIXON fat/water ratio 
 
Figure 7.5 shows the m-DIXON fat/water ratio measurements for both Coarse 
and Fine emulsions. This is the initial signal intensity ratio before any 
calibration was attempted. The graph seem to show an apparent field effect on 
fat emulsion above 10% fat content, with a limited droplet size effect. The 
relationship between measured fat/water ratio and fat % seems to be non 
linear. It is possible that this deviation at low fat/water ration could be a 
limitation of the m-DIXON sequence at low fat fraction. Figure 7.6 indicates the 
reproducibility of the m-DIXON measurements with a test-retest on different 
batches on different days. 
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Figure 7.5: m-DIXON signal intensity fat/water ratio measured in vitro at 
different fat fractions from Coarse and Fine emulsion samples at 1.5T and 3T. 
 
 
Figure 7.7 confirms that with the m-DIXON sequence a higher fat/water ratio is 
obtained at lower field. However the graph also shows no marked differences 
in m-DIXON fat/water ratio with varying droplet sizes at both fields. 
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Figure 7.6: Test-retest on two different batches of samples for the m-DIXON 
signal intensity fat/water ratio measured in vitro at different fat fractions from 
Coarse and Fine emulsion samples at 1.5T. 
 
 
 
0
0.5
1
1.5
2
2.5
3
3.5
0 2 4 6 8 10 12
m
-
DI
XO
N 
Fa
t/W
a
te
r 
ra
tio
Emulsion droplet sizes
Droplet sizes (1.5T)
Droplet sizes (3T)
 
Figure 7.7: m-DIXON signal intensity fat/water ratio measured in vitro (n=1 for 
each sample) at different droplet sizes at 1.5T and 3T. 
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7.3.4 m-DIXON calibration for in vivo study 
 
The data shown in the previous paragraph are based on a simple ratio of 
signal intensity between corresponding regions of interest drawn on the fat-
only and water-only m-DIXON images. These ratios do not correspond to fat 
fractions imaged because the m-DIXON sequence is T1-weighted and the 
water and fat samples have a inherently large difference in T1. The signal 
depends also on T2 . It would be desirable to be able to convert these to actual 
fat fraction and this can be done simply by calibrating, at a given field, the 
signal intensity ratios measured with the known fat fractions in the samples.   
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Figure 7.8: m-DIXON fat/water signal intensity ratio data obtained in vitro at 
1.5T for both the Fine and Coarse fat emulsions at varying dilution points. 
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Figure 7.8 shows the m-DIXON fat/water signal intensity ratio data obtained in 
vitro at 1.5T for both the Fine and Coarse fat emulsions at varying dilution 
points. The Fine and Coarse data for each dilution were close to each other 
indicating that droplet size does not introduce a systematic variation in the m-
DIXON fat/water ratio data. Based on this observation the data were all pooled 
together for the fit. The linear fit of the data is poor but assuming linearity of 
the data across this dilution interval is a simple option and the linear fit has an 
R2 value of 0.7895. This yields a calibration curve for the in vivo data as: 
 
Emulsion fat fraction = (m-DIXON fat water SI ratio + 0.8213) / 19.719 . [7.1] 
 
7.3.5 MRS fat fraction 
 
Figure 7.9 shows the MRS fat fraction data for both Coarse and Fine emulsion 
dilutions (i.e. different fat fractions). The data showed good correspondence of 
the MRS method with known fat fraction. There was an apparent field effect on 
fat/water ratio measured by MRS but there was no marked variation in the 
MRS fat fraction data with varying droplet sizes. Figure 7.10 shows repeated 
experiments with a larger number of fat fractions at 1.5T. 
 
Chapter 7 ± Fat quantification  
158 
 
0
5
10
15
20
25
30
0 5 10 15 20
Fa
t/w
a
te
r r
a
tio
 
(%
)
% Fat
Coarse emulsion (1.5T)
Fine Emulsion (1.5T)
Fine  emulsion (3T)
Coarse Emulsion (3T)
0
5
10
15
20
25
30
0 2 4 6 8 10 12
Fa
t/w
a
te
r r
a
tio
 
(%
)
Emulsion droplet size (ȝm)
Fat Emulsions (1.5T)
Fat Emulsions (3T)
a b
 
Figure 7.9: (a) The MRS data from Coarse and Fine emulsion samples at 
1.5T and 3T and (b) Cross-field experiment for emulsions with different droplet 
sizes. 
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Figure 7.10:  MRS fat fraction data from Coarse and Fine emulsion samples 
repeated with freshly prepared and also additional dilution samples at 1.5T. 
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7.4 Discussion: in vitro study 
 
As hypothesised there were both field and droplet size effects on T2  relaxation 
times of the Fine and the Coarse emulsions with the Fine emulsion having T2 
values much longer than the Coarse at both 1.5T and 3T fields. The 
differences in T2  values between the 20% fat Fine and Coarse emulsions was 
encouraging and should be possible to detect in vivo as the effect size would 
likely be greater than increased variation due to imaging the gastrointestinal 
environment and motion although this remains to be assessed. For droplets 
sized greater than 3 microns there was not much difference in T2 at a given 
field which would make it difficult to detect changes in droplet size in that 
range. There was also an effect of fat fraction on T2. These effects could be 
due to two mechanisms. One mechanism is droplet size effects whereby 
different size of the droplets results in different perturbation of the bulk water 
signal. T2 is changed by local field effects due to susceptibility and also 
because the T2 data are fitted to a single exponential when the relaxation is in 
effect multiexponential. This means that when the single exponential T2 of 
water is greater than the single exponential T2 of fat, if fat fraction increases 
then bulk T2 decreases.  This was indeed seen in the in vitro data. 
The T1 sequence that was used for this experiment was ProSet-fatsat (fat 
suppression).  Comparison of two different T1 sequences saturating fat or 
water (ProSet_watsat and ProSet_fatsat) on both Fine and Coarse emulsions 
at 1.5T showed as expected a marked difference in T1 values between 
sequences but no droplet size effect.  
The MRS data on fat/water ratio for both Coarse and Fine emulsion dilutions 
showed good correlation with known fat fraction and a field effect. In Figure 
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7.10 the MRS-derived fat fraction data seem to show a plateau at around 10% 
fat content for both Coarse and Fine emulsions. The reason for this plateau is 
unclear. These sample dilutions were all made individually from a 20% sample 
stock and following a printed (and re-checked) Excel file dilution plan, hence a 
systematic dilution mistake is unlikely. This plateau could reflect changes in 
field inhomogeneities created by fat droplet concentration (not size) and 
warrants further investigation as it could also be an artifact generated by a 
couple of points with high noise. Adding further dilution points either side of 
the 10% fat fraction would be beneficial to investigate this further. There is no 
major variation between the fat/fraction of these two emulsions, therefore 
there was no droplet size effect.  However, it seemed the 1.5T was slightly 
over estimating the fat/water ratio whereas the 3T seemed to have more 
accurate fat fraction. Comparing this MRS data to the m-DIXON data in vitro, it 
can be concluded that MRS was more accurate to estimate the fat fraction of 
these fat emulsion samples than the m-DIXON data, although the MRS 
method lacks the 3D spatial resolution that is offered by the m-DIXON method. 
One possible explanation for discrepancies is also that the m-DIXON method 
may need a more sophisticated calibration using more data points. 
 
7.5 In vivo study 
 
7.5.1 Aims and objectives 
 
The data gathered in vitro showed the complex interplay of fat fraction, field 
and droplet size effects on the MRI and MRS parameters. Based on this 
experience the next logical step was to evaluate these methods in vivo in the 
gastric environment. The small scale pilot study described below was 
designed primarily to assess feasibility of measurement methods. It aimed to 
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measure the spatial location and fraction of fat in the stomach comparing the 
m-DIXON high resolution MR imaging method with the standard MRS method. 
It also aimed to measure T2 relaxation times on the stomach contents to 
evaluate changes in T2 due to ingested (Fine and Coarse) droplet size and due 
to predicted changes in emulsification of the fine emulsion with time of 
digestion  
 
7.5.2 Specific methods 
 
The two emulsions used for this study were the 20% fat Coarse (droplet size 
Mass Median Diameter range 12-15 Pm) and Fine (droplet size Mass Median 
Diameter range 0.4-0.6 Pm) emulsions with no gum stabiliser as described in 
Chapter 5. The LBG stabiliser was not added to these samples as the aim of 
this study was not to make physiological measurements requiring intragastric 
stability. 
The study samples were previously approved by Unilever Safety and 
Environmental Assurance Centre (SEAC), approval reference number 95724. 
The composition here was the same as the previous study with only a change 
LQ WKH ³RII WKH VKHOI´ IRRG IODYRXU FRIIHH IODYRXULQJ LQ FRQFHQWUDtions below 
7KHVHVDPSOHVKDYHEHHQGHHPHG³ORZULVN´E\D6($&H[SHUW IRU WKLV
study. Full Ethics approval was obtained from the local Ethics Committee and 
all subjects gave informed written consent.  
Eight healthy male subjects with age 25±1 years and Body Mass Index 
22.0±0.4 kg/m2 were recruited. One subject was withdrawn as he presented 
with a stomach full of liquid and particulate at baseline as shown by fasted 
baseline MRI, despite stating at baseline checklist that he had not eaten any 
food or drunk any drink apart from water since 10pm the evening before. 
Another subject vomited the test meal on his first visit. The event was mild in 
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nature, possibly related to study procedures and was resolved quickly. 
Therefore the data presented are from N=6 subjects. A simple randomisation 
schedule was employed to avoid test product order effects. The two study 
days were approximately one week apart. The data for processing was 
renamed in a randomized way by a study-independent member of the 
investigator team according to standard operating procedures used also in the 
previous study. Hence following these procedures the author processed all 
data blind. The blind code was broken only when the study was finished and 
all data processed had undergone a blind data review. 
On each study day MRI was carried at fasted baseline, immediately 
following consumption of the fat emulsion drink and every hour for the 
following 3 hours. All scans were acquired across the abdomen using the 
Philips 1.5T Achieva MR scanner and the 16-channel parallel imaging body 
receiver coil. The duration of each postprandial scan including set up was 
about 12 minutes. Two or three subjects were alternated throughout the test 
day.  After each scan they were taken out of the scanner and asked to sit 
TXLHWO\LQWKHYROXQWHHUV¶ORXQJH 
At each time point the following scans were acquired: 
Standard scouts scan to locate the abdominal organs. This was acquired 
during free-breathing and lasted less than a minute. A calibration scan to allow 
automated calibration of the parallel imaging was acquired during free-
breathing and lasted 1 minute. One bTFE sequence across the stomach (as 
located from the scout scan) to measure gastric volumes: 40 transverse slices 
acquired in two 13s breath-holds, flip angle=80°, TR/TE=2.8/1.4ms, 
FOV=400mm, in plane resolution 1.56x1.56mm, slice thickness 7mm, SENSE 
factor 2.0. This sequence also helped planning the position of the subsequent 
volumes of interest for the spectroscopy. Proton spectroscopy (MRS) to 
determine intra-gastric fat fraction: one STEAM sequence (90ox90ox90o), 
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TR=4s, TE=9ms, 2 dummies, resolution =25x25x25mm3, spectral bandwidth 
1000 Hz, 512 samples, 4 repeats in 24 s. This was acquired twice, once in the 
upper and once in the lower regions of the gastric lumen as identified on the 
bTFE images. Transverse m-DIXON sequence to determine intra-gastric fat 
fraction across whole stomach: 3D TFE double echo sequence with 
400x370x150 mm3 coverage, slice thickness 3 mm, in-plane resolution 
1.49x1.95 mm2, FA = 15, TE1=1.8 ms TE2=4.0 ms TR = 5.4 ms, 1 average.  
Data were acquired in a single breath-hold (<20s). Data was then 
reconstructed to water-only, fat-only, in-phase and out-of-phase images.  A 
single-slice T2 -prepared bTFE sequence [120] to measure the relaxation time 
T2  of the gastric contents: TR/TE = 3.0/1.5 ms, TEprep values (ms): 20, 29, 
43, 63, 93, 137, 201, 295, 434, 637, resolution 2.00 mm x 1.56 mm and a slice 
thickness of 7 mm. For this sequence the volunteers held their breath only for 
a few seconds for each TEprep value, the whole measurement lasting a 
couple of minutes. 
Measurements of gastric volumes and gallbladder volumes were carried out 
as described in previous chapters.   
Within this section of this chapter the regions of interest drawn on different 
spatial locations in the gastric lumen will be referred to as: 
x UP voxel = a region of interest drawn in the upper layer of the gastric 
contents 
x DOWN voxel = a region of interest drawn in the lower layer of the 
gastric contents 
For the spectroscopic data, the areas of the water and fat peaks were 
measured using in-house software written by Dr. Mary Stephenson, and 
lipid/water fat fraction ratios were calculated. Briefly, the operator corrects the 
baseline of the spectrum and marks the peaks to be integrated and the 
software yields the two integral values for the area under the peak of fat and 
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water. The m-DIXON provided water and fat only images. On these images 
regions of interest can be drawn using Analyze9 software (Biomedical Imaging 
Resource, Mayo Foundation, Rochester, MN, USA) summing across all the 
slices to determine the fat and water volume distribution at each time point. T2 
data sets were processed, firstly using Analyze9 to generate a region of 
interest in the stomach contents. Then using the mean of this region at all the 
different echo times to calculate the T2  of the tissue using a in-house program 
written by Dr. Caroline Hoad which models the effect of the T2-prepared 
scheme and subsequent imaging sequence for the T2 -prepared bTFE 
sequence as described and used previously [120, 121]. Briefly, the software 
fits the mean signal intensities in the regions of interest for T2 using a program 
which models the evolution of the magnetisation after each radiofrequency 
pulse used in the MRI sequence. The parameters fitted are T2, T1, M0 and an 
additional parameter Į (which is a measure of radiofrequency pulse 
imperfections). 
The statistical analysis was carried out using GraphPad Prism version 
5 (GraphPad software Inc., San Diego,CA, USA). The sample size is very 
VPDOOVRQRQSDUDPHWULF:LOFR[RQ¶VPDWFKHd paired signed rank test was used 
to test differences between areas under the curves (AUCs). 
 
7.5.3 Emulsions characterisation 
 
Following the initial microbiological storage trial, the production process was 
cleared and subsequently the emulsions were prepared according to these 
approved SOPs. The droplet sizes were assessed for each sample (not 
batched, each sample was prepared individually and characterised individually 
for inclusion/rejection from the study) as soon as they were prepared. No 
rheology test was carried out during this preparation phase. Figure 7.11 below 
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shows the laser diffractometry profiles of Fine and Coarse emulsions. Droplet 
size data are reported in the Table 7.3 below. 
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Figure 7.11: Laser diffractometry data for Fine and Coarse emulsions. 
 
Fine Coarse
Measurements Mean
(micron)
Standard 
deviation 
(+/-)
Mean 
(micron)
Standard 
deviation 
(+/-)
D [3, 2] 0.79 0.06 15.1 0.5
D [4, 3] 0.39 0.02 8.3 0.3
D [0, 5] 0.58 0.03 14.0 0.5
 
Table 7.3: Summary of laser diffractometry data for Fine and Coarse 
emulsions. The table reports the emulsion droplet size using the most 
commonly reported measures: D[3,2] (the surface area mean diameter), D[4, 
3] (a volume mean diameter) and D[0,5] (a mass median diameter).  
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Figure 7.12: Example water only (WO) and fat only (FO) m-DIXON images of 
a Fine (upper panel) and Coarse (lower panel) fat emulsion in vivo. A lipid-rich 
upper layer formed by a Coarse fat emulsion meal is clearly seen in the 
bottom right image. 
 
7.5.4 Gastric emptying 
 
Good quality images of the fat emulsion meals in the stomach were obtained 
as shown in Figure 7.12. The time courses of mean meal intragastric volumes 
are shown in Figure 7.13. It can be seen that the Fine emulsion emptied from 
the stomach slower than the Coarse. The corresponding mean AUCs are 
shown on the right panel. The AUCs were 1104±72 ml·h for the Coarse 
emulsion and 1383±84 ml·h for the Fine emulsion. The Fine emulsion 
significantly delayed gastric emptying (p=0.03). 
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Figure7.13: Volumes of the intragastric contents with time for Fine and 
Coarse emulsions (a) and AUC for each meal data (b). * p=0.03. 
 
 
7.5.5 Gallbladder contraction 
 
Although this was not a planned secondary outcome, the gallbladder volumes 
were measured in keeping with the previous study. The mean gallbladder 
volumes and % contraction plus their AUCs are plotted in Figure 7.14. The 
AUCs for gallbladder volumes were 52±8 ml·h for the Coarse emulsion and 
55±6 ml·h for the Fine emulsions. There were no significant differences 
between meals (p=0.69). 
 
7.5.6 m-DIXON fat fraction 
 
The m-DIXON fat fraction measurement was calibrated using in vitro data as 
reported in Appendix. There was a clear difference between the m-DIXON fat 
fraction for Fine and Coarse as shown in Figure 7.15. The pattern is very 
similar to the MRS data. The Coarse emulsion meal showed an immediate 
separation in an UP (upper) layer of high lipid/water ratio compared to a 
DOWN lower voxel at t=0 whereby the fat fraction DOWN has markedly 
reduced (but it is not zero) (p=0.03). There is no difference between Fine UP 
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and Fine DOWN (p=0.2). There are significant differences between Fine and 
Coarse UP voxels (p=0.03) and Fine and Coarse DOWN voxels (p=0.03). 
THE m-DIXON datasets cover the whole stomach and allow not only region of 
interest but also line profile analysis as shown in Figure 7.18. Interestingly the 
line profiles (drawn from the bottom of the stomach upwards) seem to show a 
gradient for the Fine emulsion, which appears moderately darker towards the 
top. This could reflect a mild creaming effect whereby the upper parts of the 
stomach contain a more concentrated fat than the bottom. By contrast the 
Coarse profile showed a clear jump between the two phases.  
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Figure7.14: (a) and (b) show the time course of gallbladder volumes and of 
the corresponding % contraction; (c) and (d) show the respective mean AUCs. 
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Figure 7.15: m-DIXON calibrated fat fraction for both emulsion meals and UP 
and DOWN voxels (a) and respective AUCs (b). 
 
 
 
For Coarse
For FineFor Coarse
For Fine
0
20000
40000
60000
80000
100000
0 20 40 60
In
te
n
s
ity
 
(a.
u
.
)
Coarse line profile
Coarse line 
profile
0
20000
40000
60000
80000
100000
120000
0 50 100
In
te
n
s
ity
 
(a.
u
.
)
Fine line profile
Line profile 
for Fine
 
Figure 7.18: Examples of line profiles measured through the stomach 
contents for both Fine and Coarse. 
 
 
 
 
7.5.7 MRS fat fraction 
 
Figure 7.19 shows on the left an image of the stomach of a volunteer who had 
eaten a Coarse emulsion and the positioning of the UP and DOWN voxels in 
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the upper and lower layer of the stomach contents respectively. There was a 
clear difference in lipid/water ratio between Fine and Coarse as shown in 
Figure 7.20. The Coarse emulsion meal showed an immediate separation in 
an UP (upper) layer of high lipid/water ratio (around 0.4 which is double that of 
the original drink at 0.2) compared to a DOWN lower voxel whereby the fat 
fraction has more than halved (but it is not zero), the difference is just outside 
the significant threshold probably due to higher variability of the UP voxel 
values (p=0.06). The fine emulsion fat fraction values remain close to 0.2 
throughout with no difference between UP and DOWN voxels (p=1). There are 
differences between Fine and Coarse UP voxels (p=0.09) and Fine and 
Coarse DOWN voxels (p=0.09) but these are outside the significance level.  
 
a
D
U
D
 
Figure 7.19: (a) shows the positioning of a spectroscopy voxel in the upper 
layer of the stomach contents (UP) and of a corresponding voxel in the lower 
layer (DOWN), (b) shows a typical MRS fat/water spectrum in vivo. 
 
The large error bars for the Coarse UP voxel have to be noted. This large 
variability is probably due to the fact that positioning the fixed size voxel in 
thinner upper layers could have been more difficult. Also, differences in 
holding the breath after the positioning axial images were taken could have 
Chapter 7 ± Fat quantification  
171 
 
contributed to this variability. The size of the DOWN layer was usually greater 
therefore minimising these possibilities. 
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Figure 7.20: Spectroscopic lipid/water ratio for both emulsion meals and UP 
and DOWN voxels (a) and respective AUCs (b). 
 
 
7.5.8 Comparison m-DIXON and MRS fat fractions 
 
Plotting all m-DIXON fat % values against the corresponding spectroscopy 
data points as shown in Figure 7.21 yields a good correlation between the two 
PHWKRGV 6SHDUPDQ¶V U  S $ FOXVWHU RI P-DIXON values 
around fat fraction 0.05 can be seen. These belong mostly to Coarse DOWN 
regions of interest but removing them does not improve greatly the correlation. 
Overall the graph suggests that at low fat % MRS was better at discriminating 
differences between voxels whilst m-DIXON was less sensitive. At higher fat 
% the data for Coarse UP are largely scattered which confirms once again the 
variability of that measurement on the MRS side, probably due to difficulties in 
positioning the acquisition voxel in the first place. At t=0 the MRS measures of 
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total fat content of the stomach and the average fat fraction of the emulsion 
(Figure 7.22) agreed better with fat in ingested meal (assuming only small 
meal dilution at t=0) than mDIXON measures. Interestingly the net rate of 
emptying of fat (calculated from volumes and MRS fat fractions) was fairly 
similar for both meals. Considering the different intragastric spatial 
distributions of these two emulsions without the LBG stabiliser this is not 
contradicting the difference in gastric (volume) emptying whereby the Coarse 
emulsion tends to empty more quickly a fat-depleted lower layer thus reducing 
gastric emptying times compared to a more stable Fine emulsion. 
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Figure 7.21: Comparison of m-DIXON (MRI) and spectroscopy (MRS) fat % 
comprising all data points available. The solid line indicates the identity 
between MRI and MRS measurements. 
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Figure 7.22: Total fat in gastric contents estimated for both emulsions and by 
MRS and mDIXON.  
 
 
7.5.9 T2  relaxation times in vivo 
 
An example of the single slice images used to measure the T2 relaxation time 
on the gastric contents is shown in Figure 7.23.  The mean transverse 
relaxation data for both Fine and Coarse and voxels UP and DOWN are 
shown in Figure 7.24. This shows that the DOWN voxels (e.g. the lower layers 
of the stomach contents for both emulsions) have much longer T2s than the 
UP voxels (e.g. the upper layers of the stomach contents). The AUCs for the 
Fine emulsion were 2600±500 ms·h for the UP voxel and 3600±400 ms·h for 
the DOWN voxel (p=0.03). 
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Figure 7.23: Example images of single-slice T2-prepared bTFE sequence to 
measure the relaxation time T2 . These show the echo time TE=27ms from 
Subject 3 after he received the Fine (right column) and Coarse (left column) 
fat emulsion meals. The three rows correspond to the three consecutive time 
points of the acquisition (T= 1hour, 2 hours and 3 hours). 
 
The AUCs for the Coarse emulsion were 800±500 ms·h for the UP voxel and 
3600±400 ms·h for the DOWN voxel (p=0.03). There was no difference 
between DOWN voxels (p=1) for the two meals, whereas the main visible 
difference is between the UP voxels (p=0.03), with the UP Coarse emulsion 
having a T2 of 270±80 ms (average of all time points and all subjects) four 
times shorter than the UP Fine emulsion T2 of 860±80 ms. The corresponding 
average T2 values DOWN were 1180±90 ms for Fine and 1220±80 ms for 
Coarse. There are no marked temporal changes in T2 for both emulsion meals 
and voxel positions. 
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Figure 7.24: (a) the mean transverse relaxation T2 data for both Fine and 
Coarse voxels UP and DOWN and (b) respective AUCs. * p<0.03.  
 
 
7.6 Discussion: in vivo study 
The overall aims of this pilot feasibility study were to compare MRS and m-
DIXON fat fraction estimates in vivo and to observe variations in relaxation 
time T2 of the emulsions in the gastric lumen. 
Gastric emptying was faster for the Coarse fat emulsion meal than for 
the Fine emulsion. This was predicted and it is in keeping with the results of 
the previous studies. This may be explained with both creaming of the Coarse 
emulsion fat to the top of the lumen away from the pylorus (leading to delivery 
to the small bowel of a fat-depleted watery phase during early gastric 
emptying) and to an effect of droplet size on gastric emptying (possibly 
reflecting increased activation of duodenal fat receptors by the more finely 
emulsified droplets which present a larger surface area for hydrolysis).  
The m-DIXON measurement was successful in that it provided 
information on the 3D distribution of fat in the gastric lumen as opposed to 
MRS which has to use a single large voxel. It has to be noted that for m-
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DIXON the errors on the Coarse UP measurement are much smaller than the 
corresponding spectroscopy error bars. This is likely due to the fact that the m-
DIXON post-processing ROI can be aimed much more precisely than 
positioning in vivo a large spectroscopy voxel, which sometimes may include 
(due to motion or limited stomach volumes) other layers different from the 
desired one. High fat fractions are determined with the same calibration which 
did not have such concentrated samples to use so it is a linear assumption 
which may well be slightly inaccurate though the substance remains. 
The MRS assessment of fat fraction was successful and showed large 
differences between the two emulsion meals. The Coarse emulsion results are 
YHU\ PXFK LQ NHHSLQJ ZLWK WKH µ&RDUVH &RQWURO¶ H[DFWO\ WKH VDPH VDPSOH
results from the previous study described in Chapter 6. 
A reasonable correlation between MRI m-DIXON method to determine 
IDW IUDFWLRQDQG WKH µJROG-VWDQGDUG¶056VSHFWURVFRSLFPHWKRGZDVIRXQG$
closer look at the cluster of low values measured on m-DIXON shows they 
mostly belong to DOWN region of interest measurements for the Coarse 
emulsion. The fact that these are lower than the MRS values may be due to 
the fact that the m-DIXON ROI on Analyze was smaller in size than the MRS 
voxel and on post-hoc processing on screen could be placed accurately just in 
the lower, fat depleted layer, thereby reflecting a much lower fat value than the 
MRS. In this respect the m-DIXON imaging method has advantages since it 
allows positioning of ROIs in the gastric lumen. 
Additional information can be gained by comparing gastric emptying and fat 
fraction data. Gastric emptying of the Fine emulsion was significantly delayed 
compared to the coarse emulsion although the differential volume 
measurements showed that both the upper and lower layers of the gastric 
contents emptied steadily and MRS showed the fat content of the upper layer 
gradually reduced over 3 hours. Interestingly the net rate of emptying of fat 
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(calculated from volumes and MRS fat fractions) was similar for both meals 
(Figure 7.22). 
The measurement of the transverse relaxation time T2 as a measure of 
droplet size was another endpoint for this study. The study was successful in 
detecting different relaxation times for different droplet sizes of 20% fat 
emulsions in vitro. There was little subsequent change, suggesting no marked 
changes in droplet size, but any changes were difficult to separate from 
creaming effects in vivo. Both fat emulsification (smaller droplet sizes) and 
emulsion dilution (smaller fat fractions) increase T2 making it difficult to 
separate clearly these effects from just relaxometry measures. It was possible 
to detect differences in T2  values between each emulsion between the upper 
DQGORZHUOD\HURIWKHVWRPDFKFRQWHQWV7KHUHOD[DWLRQWLPHVRIWKHµ'2:1¶
voxels for bRWK WKH)LQHDQG WKH&RDUVHHPXOVLRQVDUHKLJKHU WKDQ WKH µ83¶
voxels. This is likely to be because of creaming of the emulsions. A higher 
fraction of mobile water (high water proton density) with lower fraction of oil 
would indeed yield a higher T2 value. Interestingly a marked difference in T2 
values IRU WKH µ83¶ YR[HOV EHWZHHQ HPXOVLRQV ZDV GHWHFWHG ZLWK WKH )LQH
having T2 values 4 times longer than Coarse. This could be due to two 
mechanisms. One mechanism is droplet size effects whereby different size of 
the droplets results in different perturbation of the bulk water signal. Another 
mechanism is fat concentration whereby both the proton density (reduced 
amount of bulk water) and the effect of the more concentrated perturbers (fat 
droplets) will reduce T2. The in vitro studies indeed showed an effect of 
increasing droplet size on reducing T2 and an effect of increasing fat fraction in 
reducing T2. Overall therefore the study was successful in detecting 
intragastric T2 differences between the two emulsion meals. However the fact 
that the Coarse emulsion creamed up more than the Fine emulsion made it 
more difficult to separate in vivo the effect of creaming from the effect of 
Chapter 7 ± Fat quantification  
178 
 
droplet size on T2. No clear time trend in changing T2 with time of digestion was 
detected for either emulsion nor UP or DOWN voxels which suggests it was 
not possible here to detect effects of emulsification in vivo. 
 
7.7 Conclusions 
 
This chapter describes a pilot study aimed at evaluating in vitro and in vivo 
MRI imaging methods to assess fat fraction and relaxation times of two fat 
emulsion meals of different droplet size. The m-DIXON imaging method to 
determine the intragastric fat fraction of fat emulsion meals compared well with 
WKH µJROG VWDQGDUG¶ VSHFWURVFRSLF PHWKRG EXW JDYH PRUH spatial information 
since it provided three dimensional data on the whole stomach and allowed 
more flexible post-processing. The relaxometry data showed in vitro expected 
apparent differences in T2 between Fine and Coarse droplet size. Such 
differences were difficult to interpret in vivo due to combined effects of 
intragastric dilution and creaming. Further work is needed to achieve a 
comprehensive MRI based measurement package capable of monitoring both 
fat fraction and fat droplet size in vivo in the stomach. This would enable in the 
future to relate the microstructure and location of different fatty food 
formulations with, for example, the time it takes to empty from the stomach, 
the levels of hormones in the blood and the sensation of satiety, thus aiding 
the design of foods with desired health promoting characteristics and check 
their performance in vivo. 
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8 Conclusions 
 
 
8.1 Brief summary of main findings 
 
The main hypothesis underpinning this work was that fat emulsion droplet size 
has a profound effect on fat digestion and, in turn, on the gastrointestinal and 
satiety responses. To test this hypothesis two fat emulsion meal systems were 
used. The two fat emulsions had exactly the same composition but a small or 
a large emulsified fat droplet size was achieved using different homogenising 
methods. The two emulsions were termed the Fine emulsion (with a droplet 
size of 400 nm) and the Coarse emulsion (with a droplet size of 8 µm). The 
two fat emulsion systems were characterised using a range of bench 
techniques, in vitro digestion models and MRI techniques in vitro.  
The microstructure difference caused, as predicted, different temporal 
creaming characteristics for the emulsions and different percentage hydrolysis 
profiles in a gastric digestion model in vitro. The Fine emulsion showed initial 
rapid hydrolysis whilst the Coarse emulsion showed an initial slow hydrolysis 
phase with the hydrolysis rate increasing at later stages. This indicated that 
there was indeed a droplet surface area (size) effect on fat hydrolysis whereby 
the smaller droplet size hydrolysed faster than a larger droplet size. 
The HPXOVLRQV¶ SHUIRUPDQFH ZDV ILQDOO\ WHVWHG in vivo in healthy 
volunteers using MRI in a series of pilot studies leading to a main 
physiological study. The fat emulsions provided good images in vivo. The pilot 
studies also indicated that creaming differences in the gastric lumen were a 
confounding factor that made the physiological responses more difficult to 
Chapter 8 ± Conclusions  
180 
 
dissect mechanistically. The two emulsion systems were therefore redesigned 
using a locust bean gum (LBG) thickener to stabilise them intragastrically so 
that the true effect of droplet size could be assessed. The gum-stabilised fat 
emulsion meals were characterized once again on the bench and in small pilot 
studies in vivo and they appeared stable throughout the gastric emptying 
process. This initial phase suggested that there was indeed an overall droplet 
size effect on hydrolysis and gastrointestinal responses to fat emulsion meals. 
This was investigated in more depth in a major physiological and 
satiety study in healthy volunteers. This was a three-way study that used 
Coarse emulsion meals without and with LBG (i.e. emulsions with different 
intragastric creaming stability) and Fine+LBG emulsion meals (i.e. small 
droplet size compared to Coarse+LBG but same stability). In this complex 
study serial MR imaging and spectroscopy, blood sampling, 13C breath test 
and also a final objective weighed meal satiety assessment were used. The 
results showed that a highly emulsified, intragastrically stable emulsion 
delayed gastric emptying, increased small bowel water content and reduced 
consumption of food at the end of the study day. The clear conclusion was 
that manipulating food microstructure especially intragastric stability and fat 
emulsion droplet size can influence human gastrointestinal physiology and 
satiety responses. 
The final part of this work aimed to explore further magnetic resonance 
imaging, spectroscopy and relaxometry techniques to assess fat emulsion 
parameters in vitro and in vivo in the gastric lumen. Main static magnetic field 
and droplet size effects on T2 relaxation times of the Fine and the Coarse 
emulsions were observed. T1 was higher for the Coarse emulsion compared to 
the Fine emulsion, possibly due to surface area effects. T1 values varied 
depending on imaging sequence used but showed no droplet size effect. 
There was reasonable correlation between m-DIXON and spectroscopy 
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methods to quantify fat fraction both in vitro and in vivo. Differences in T2  
relaxation times for different droplet sizes of 20% fat emulsions were detected 
in vitro. These changes were however difficult to separate from creaming 
effects in vivo with a view of draw meaningful inferences on droplet sizes. 
 
8.2 Advantages 
 
This work had clear advantages. One of the main strengths was the industrial 
and academic collaboration whereby leading food science research and 
development worked alongside state-of-the art in-body MRI imaging to 
generate novel insights on the gastrointestinal fate of foods. Another 
advantage was the use of MRI as imaging technique. MRI uses non-ionising 
radiation, has multi-planar, three dimensional, high resolution capability, an 
excellent contrast for tissue and liquid food components, and the capability to 
µWXQH¶ this contrast differently depending on the sample of interest and to 
quantitate many different parameters in the same study session. The human 
studies were generally well tolerated and recruitment from the large campus 
population was never a problem. 
  
8.3 Limitations 
 
This work also had some limitations. One limitation is the physiological 
variability of individual human healthy subjects. The studies were powered 
appropriately for the main outcomes however secondary outcomes would 
have benefitted from larger numbers of subjects due to variability. Another 
limitation is the horizontal imaging position which is necessary due to scanner 
configuration. In the supine position there is a risk that large floating creamed 
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fat layers may enter the duodenum first. Imaging the subjects moderately tilted 
helped prevent this. The high cost of these MRI serial studies was also an 
issue since the experimental design became more demanding as the project 
developed dramatically increasing the cost of the programme of work. 
 
8.4 Future directions 
As pointed out above, this project provided exceptional synergy between using 
model food systems developed and characterised with the unique know-how 
DQGODERUDWRU\HTXLSPHQWRIDPDMRUIRRGPDQXIDFWXUHU¶VUHVHDUFKGHSDUWPHQW
on the one side and cutting edge, in-body MRI imaging on the other. This 
needs to be further exploited to generate novel insights on mechanisms of 
digestion and satiety of food actives and novel food microstructures. Such 
insights could ultimately help manipulate food products microstructure (and 
monitor product performance) to enhance desired health-promoting effects. 
The use of relaxometry to measure intragastric droplet size needs 
further exploration, possibly using fat emulsion systems that are more 
resistant to creaming such as the ones stabilised using LBG as shown in 
Chapter 6. However, intragastric dilution of the gum could itself affect T2 [11] 
so more work to find a more relaxation-independent intragastric stabilizer 
would also be needed. 
From the MRI point of view the use of MRS to monitor gastrointestinal 
fate of foods is novel and should be pursued, possibly further along the 
gastrointestinal tract beyond the stomach. The availability of scanners with 
ultra-high field strength (7T) could then provide increased signal and 
enhanced contrast mechanisms (e.g. magnetic susceptibility or chemical 
exchange saturation transfer or CEST [122-124]) well worth exploring though  
 
 
Chapter 8 ± Conclusions  
183 
 
practical limitations such as the current difficulties with whole-body imaging at 
such high resonance frequencies, still need to be overcome fully. 
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10.1 Specific list of materials and equipment used in Unilever  
x Sunflower Oil (KTC Edibles, cholesterol free) supplied by Anglian Oils 
Ltd, Bexwell, Norfolk, U.K. 
x Distilled water (Food lab (A104A) 
x Coffee Flavouring: Dr. Oetker (UK) Ltd., Sherburn-in-Elmet, Leeds 
LS25 6JA, England.  
x Sweetener: Hermesetas gold (Sodium saccharin) (E 954), Tesco 
supermarket U.K. 
x Tween20: Sigma Aldrich, Gillingham, U.K. 
x LBG: GENU® GUM type RL-200Z locust bean gum, CP Kelco, 
Leatherhead, U.K. 
x 13C Octanoic acid: Octanoic acid (13C-marked) Euriso-Top, Parc des 
Algorithmes, Bâtiment Homère, Route de l'Orme, F-91194 Saint Aubin 
cedex, France . 
x Balance:   Sartorius Model  LC4800P  (Asset number:  C910300)   
x Silverson:  Model L5R  (Serial no: 20281)     
x Ultra-Turrax: Model IKA  T25BS2 (Serial no:  10.011161)   
x Microfluidiser:   Model 110S (Asset number:  C2007072) 
x Medi-Wipes, a hard surface disinfectant containing chlorhexidine 
(Boston Healthcare, Bedford, U.K). 
x Glassware (Beakers, flask and bottles) 
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10.2 Detailed methods for preparation of emulsions 
 
10.2.1 Area and equipment cleaning 
 
The bench area used for the preparation of the emulsions is wiped down using 
Medi-Wipes, a hard surface disinfectant containing chlorhexidine (Boston 
Healthcare, Bedford, U.K.). 
All glassware is checked for damage before use. Any damaged glassware is 
discarded immediately. If the glassware becomes damaged during the 
preparation of the emulsion, this will be discarded, the area will be cleaned 
and the emulsion re-prepared. 
The ultra-turrax and Silverson heads are sterilised in boiling water before use. 
The microfluidiser is cleaned according the relative SOP before use.  
 
10.2.2 Preparation of 1% LBG Solution 
 
 
All glassware and utensils are sterilised using boiling water before use. 
A weighing boat is wiped using Premi-wipes, a food safe, non-toxic 
disinfectant wipe (Shermond, Brighton, UK) and allowed to dry. 16 g LBG 
powder is weighed in a weighing boat.  
The Operator boils ~2 litres of water and uses thermal gloves when handling 
hot objects. 1584g boiled water is weighed in a 2000ml plastic beaker. 
The LBG is dispersed in 1584g boiling water whilst stirring using Silverson at 
full speed. The beaker is covered with aluminium foil whilst using the 
Silverson. Any aggregates are manually dissolved using clean spatula and 
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dispersed whilst stirring for 10 minutes with Silverson. The final solution 
concentration is 1% w/w LBG/water. 
1600ml of this 1% LBG solution will be stored in a 2000ml Borosil bottle  
The operator cools the glass bottle down rapidly by placing in an ice bath and 
then stores the glass bottle in the A104 fridge until use for a maximum of 4 
weeks. 
 
10.2.3 Preparation of coarse emulsion with no LBG (Coarse Control) 
 
1 All glassware and utensils are sterilised using boiling water before use 
2 H2O (276.5g) +Tween0 (3.5g) 
3 Using a dedicated precision pipette (serviced and calibrated on an 
annual basis by an external contractor), 117 mg 13C-octanoic acid is added to 
the SFO (70g) and the bottle is swirled gently to ensure the label is well mixed 
with the SFO. 
4 The beaker is covered with a foil and the mixture is ultra-turraxed for 
20 minutes at speed 3 
5 The emulsion is transferred to a labelled 500ml new glass bottle. 
6 3.5g of coffee flavour and 5 sweetener tablets was added to this 
emulsion and mixed well by shaking if necessary. 
7 The emulsion is then stored in the A104 fridge located in the food 
laboratory for a maximum 4 days until it is shipped to Nottingham.   
 
10.2.4 Preparation of the fine emulsion  
 
 
To obtain a fine emulsion steps (1-4 as above)  to prepare coarse emulsion, 
then step (5) was used where the emulsion is passed through the 
Microfluidizer once, with a pressure of 2.6 bars at the inlet, which corresponds 
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to 605.8 bars in the interaction chamber and steps (6 and 7) was repeated as 
above coarse. 
 
 
10.2.5 Preparation of the coarse emulsion with 0.5% LBG  
 
1 All glassware and utensils are sterilised using boiling water before use. 
2 H2O (241.5g) + Tween20 (3.5g) + 1% LBG stock solution (175g) 
solution are placed in 600ml glass beaker and mixed well using a spatula (due 
to thickness of the solution). 
 
 
 
Table 10.1: Summary of the ingredients of coarse emulsion with no LBG 
 
3 Using a precision pipette (serviced and calibrated on an annual 
basis by an external contractor), 117 mg 13C-octanoic acid is added to the 
SFO (70g) and the bottle is swirled gently to ensure the label is well mixed 
with the SFO 
 
Materials Weight % 
Distilled water 276.5g 79 
Sunflower Oil 70g 20 
Tween20 3.5g 1 
Coffee flavour 3.5g 1 
sweetener 5 tablets - 
13C-octanoic acid 117 mg - 
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Table 10.2: Summary of the ingredients of coarse emulsion with 0.5% LBG 
and fine emulsion with LBG 
 
4 The beaker is covered with a foil and the mixture is ultra-turraxed for 5 
minutes at speed 2. 
5 The emulsion is transferred to a labelled 500ml new glass bottle 
6 3.5g of coffee flavour and 5 sweetener tablets is added to this 
emulsion and mixed well by shaking. 
7 The emulsion is then stored in the A104 fridge (for a maximum of 4 
days) until it is shipped to Nottingham. 
 
10.2.6 Preparation of the fine emulsion with 0.5% LBG (Fine+LBG) 
 
To obtain a fine emulsion with LBG steps (1-4 as above)  to prepare coarse 
emulsion with LBG, then step (5) was used where the emulsion is passed 
through the Microfluidizer once, with a pressure of 2.6 bars at the inlet, which 
corresponds to 605.8 bars in the interaction chamber and steps (6 and 7) was 
repeated as above coarse with LBG prep. 
Materials Weight % 
Distilled water 101.50g 29 
1% LBG solution 175.0g 50 
Sunflower Oil 70g 20 
Tween20 3.5g 1 
Coffee flavour 3.5g 1 
sweetener 5 tablets - 
13C-octanoic acid 117 mg - 
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More specifically, the Table 10.3 below shows a comprehensive list of 
contents of the study products: 
Ingredient Concentration 
in sample (%) 
Weight 
per 
emulsion  
Additional 
Information 
Supplier 
 
 
 
Octanoic 
acid (13C-
marked) 
0.03%  
 
 100mg In vivo breath 
test labels  
Euriso-Top 
Parc des 
Algorithmes 
Bâtiment 
Homère, 
Route de 
l'Orme 
F-91194 Saint 
Aubin cedex 
France 
Sunflower 
oil 
20%  60g Food 
ingredient.  
Anglian Oils 
Ltd, Bexwell, 
Norfolk, U.K. 
 
Supercook 
coffee 
flavour 
1%  3g Flavour; food 
ingredient. 
Ingredients: 
Water, 
Alcohol, 
colour: Plain 
Dr. Oetker 
(UK) Ltd., 
Sherburn-in-
Elmet, Leeds 
LS25 6JA, 
England 
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caramel; 
Flavouring. 
Locust 
Bean Gum 
(GENU® 
GUM type 
RL-200Z) 
0.5%  1.5g Food 
thickener 
CPKelco, 
Leatherhead, 
U.K. 
Hermestas 
gold 
(Sodium 
saccharin)  
(E 954) 
5 tablets in 
350 g 
 Sweetener 
(sodium 
saccharin) 
Tesco 
Supermarkets 
UK 
Tween 20 
(Polysorbat 
20) (E 432) 
1%   3g Emulsifier 
 
Sigma 
Aldrich, 
Gillingham, 
U.K. 
Water  237 g  
for 
emulsion 
without 
LBG and  
235.5g  
for 
emulsion 
with 
LBG 
De-ionised 
water (Elga 
water 
purification 
system) 
 
Table 10.3: list of ingredients contained in the study products 
